,isolateID,ORF_ID,Contig,Start,Stop,Orientation,Cut_Off,Pass_Bitscore,Best_Hit_Bitscore,Best_Hit_ARO,Best_Identities,ARO,Model_type,SNPs_in_Best_Hit_ARO,Other_SNPs,Drug Class,Resistance Mechanism,AMR Gene Family,Predicted_DNA,Predicted_Protein,CARD_Protein_Sequence,Percentage Length of Reference Sequence,ID,Model_ID,Nudged,Note,Hit_Start,Hit_End,Antibiotic
358,bc_500_030218_02,NODE_59_length_8238_cov_3.778414_6 # 4859 # 7981 # 1 # ID=59_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.653,NODE_59_length_8238_cov_3.778414_6,4859,7981,+,Strict,750,767.7,adeF,43.8,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCCGCAATTCTTCATTGACCGTCCGGTGTTCGCCTGGGTGGTCGCCTTCTTCATCCTGATCGGCGGCGCCCTGGCGATCCCCCAGTTGCCGGTGGCCCAGTACCCCAACGTCGCCCCGCCGCAGATCGAGATCGCCGCCACCTACCCGGGTGCCTCGGCCCAGACCATGGACGAGTCGGTGGTCAGCCTGATCGAGCAAGAGCTCAACGGCGCCGACCACCTGCTGTACTTCTCGTCCCAGAGCAGCCTGGGCAGTGCCACCATCACCGCCACCTTCCAGCCGGGCACCAACCCGGAGCTGGCCCAGGTGGACGTGCAGAACCGCCTCAAGGCGGTGGAGCCACGCCTGCCCCAGACCGTGACCCAGCAAGGCCTGCAAGTGGAGAAAGTCTCTGCCGGCTTCCTGCTGCTGATCACCCTGAGCTCCAATGACGGGCGCCTGGACGAGGTCGCGCTCAGCGACTACATGGCGCGCAGCGTGCTGAACGAGATCCGCCGCCTGGATGGCGTCGGCAAGGCCCAGTTGTATGGCGCCGAACGGGCCATGCGGATCTGGCTCGATCCGCAGAAGCTGATCGGCTTCAACCTGACTCCGGCCGACGTCAACGCCGCCGTAGCCGCGCAGAACGCCCAGGTACCGGCAGGCAGCATCGGCGACCTGCCCGGCCCTTCCAGCCAGGAAATCACCGCCACCGTGCTGGTCAAGGGCCAACTGAGCAACCCGGAGGAGTTCGCCGACATCGTCCTCAAGGCCAACCCCGACGGTTCCACCGTGCGTATCGGCGACGTGGCGCGGGTGGAAGTGGGCAGCCAGGAATACCAGTTCGGCACGCGCCTGAACGGCAAGCAGTCCACCGCCGTCGGCGTGCAGCTGTCTCCCGGAGCCAATGCGCTGAACACCGCGACCCTGATCCGGGCAAAGATGGATGAGCTGTCGCGCTACTTCCCCGCCGGCGTGGAATACAAGATCCCCTACGACACCTCGCCGTTCGTCAAGGTCTCGATCACCAAGGTGCTCTACACCCTGCTCGAGGCCATGGTCCTGGTGTTCCTGGTGATGCTGCTGTTCCTGCAGAACATCCGCTACACCCTGATCCCGACCCTGGTGGTCCCGGTGGCGCTGATGGGCACCTTCGCCACCATGCTGGCCCTGGGTTTCTCCATCAACGTGCTGACCATGTTCGGCATGGTGCTGGCCATCGGCATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGATCATGGCCGAGGAGGGCCTGCCCCCGACCGAAGCGACGATCAAGGCGATGAAGCAGGTGTCCGGTGCCATCGTCGGTATCACCCTGGTGTTGTCCGCGGTGTTCATGCCGCTGGCGTTCATGAGCGGTTCGGTGGGCGTCATCTACCAGCAGTTCTCGGTATCCCTTGCGATCTCGATCCTGTTCTCCGGCTTCCTGGCCCTGACCTTCACCCCGGCCCTGTGCGCCACGCTGCTCAAGCCGATCCCTGAAGGCCATCACGAGAAGCGCGGTTTCTTCGGTGCCTTCAACCGTGGCTTCGCCCGCGTCACCGAGCGCTATTCGGTGCTCAGTTCCGGGCTGGTCAAGCGTGCCGGCCGCTTCATGCTGGTGTACGCCGGTATCGTCGCGGTGCTGGGCTACACCTACCTGCGCCTGCCGGAAGCCTTCGTCCCAAGCGAAGACCTGGGCTACATGATCGTCGACGTGCAGCTGCCGCCCGGCGCCAGCCGCATGCGTACCGATACCACCGGCAAGGAACTTGAGCAGTACCTGATGTCGCGCAAGGCGGTGGACTCGGTATTTCTCGTCTCCGGCTTCAGTTTCTCCGGCCAAGGCGACAACGCAGCACTCGCATTCCCGGTTTTCAAGGATTGGTCGGTACGCGGCAAGGAAGAGTCTGCTGCTGCCGAGGTAGCGGCGCTGAACGAGCATTTCGCACTGCCGAGCGACGGCACCATCATGGCGGTCTCGCCGCCACCTATCGACGGCCTGGGCAACTCCGGCGGTTTCGCCCTGCGCTTGATGGACCGTGGCGGTTTGGGCCGCGAGGCCTTGTTGCAGGCACGGGATACGCTGCTGGGCCAAATCAACGGCAACCCGAAATTCCTCTACGGGATGATGGAGGGCCTGTCCGAGGCACCGCAGTTGCGCCTGGTGATCGACCGCGAGAAAGCCCGGGCCCAAGGCGTCAACTTCGAGACCATCAGTTCCACCCTGTCCTCGGCCTTCGGTTCCGACGTGGTCAACGACTTCACCAACGCCGGTCGCCAGCAACGGGTGGTGATCCAGGCCGAGGGCGACCAGCGCAGCCAGGTCGAGGACCTGTTGCGCCTGAACGTGCGCAACAGCGCCGGCAAGATGGTGCCGTTGTCGTCCTTCGTCAGCGCCAGCTGGAAGATGGGCCCCGCACAGTTGACCCGCTACAACGGCTACCCGGCGGTCGACGTCTCCGGCGAGCCGGCAGCGGGCCGCAGCACCGGCGAAGCCATGCAGGAAATCGAACGCCTGGTGGCCCAGCTGCCGAACGGCCTGGGCCTGGAGTGGACCGGCCTGTCGTTGCAGGAGCGCCTGTCGGGCAGCCAGGCCCCGCTACTGCTGGGATTGTCGTTGCTGATCGTGTTCCTGTGCCTGGCGGCGCTCTATGAGAGCTGGTCGATCCCGGCCTCGGTGCTGCTGGTGGTGCCGCTGGGCGTACTCGGCGCAGTACTGGCGGTGACCTTGCGCGGCATGCCCAACGACGTGTTCTTCAAGGTGGGCCTGATCACCATCATCGGCCTGTCGGCGAAGAACGCGATCCTCATCGTCGAGTTCGCCAAGGAACTGTGGGAGAAGGGCCACAGCCTGCGTGACGCCGCCATCGAGGCCGCGCGCCTGCGCTTTCGCCCGATCATCATGACGTCCATGGCCTTCATCCTCGGCGTGGTCCCCCTGGCCATCGCCACCGGCGCCGGTGCGGCCAGCCAGCGCGCCATCGGTACCGGGGTGATCGGCGGGATGCTCAGCGCCACCTTGCTGGGTGTGCTGTTCGTGCCGATCTGTTTCGTCTGGTTGCTGTCGTTGCTGCGTACCAAACGGCCTGCCACCGAACAACCAGCCCTGACCCAGGAGTGA,MPQFFIDRPVFAWVVAFFILIGGALAIPQLPVAQYPNVAPPQIEIAATYPGASAQTMDESVVSLIEQELNGADHLLYFSSQSSLGSATITATFQPGTNPELAQVDVQNRLKAVEPRLPQTVTQQGLQVEKVSAGFLLLITLSSNDGRLDEVALSDYMARSVLNEIRRLDGVGKAQLYGAERAMRIWLDPQKLIGFNLTPADVNAAVAAQNAQVPAGSIGDLPGPSSQEITATVLVKGQLSNPEEFADIVLKANPDGSTVRIGDVARVEVGSQEYQFGTRLNGKQSTAVGVQLSPGANALNTATLIRAKMDELSRYFPAGVEYKIPYDTSPFVKVSITKVLYTLLEAMVLVFLVMLLFLQNIRYTLIPTLVVPVALMGTFATMLALGFSINVLTMFGMVLAIGIVVDDAIVVVENVERIMAEEGLPPTEATIKAMKQVSGAIVGITLVLSAVFMPLAFMSGSVGVIYQQFSVSLAISILFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSVLSSGLVKRAGRFMLVYAGIVAVLGYTYLRLPEAFVPSEDLGYMIVDVQLPPGASRMRTDTTGKELEQYLMSRKAVDSVFLVSGFSFSGQGDNAALAFPVFKDWSVRGKEESAAAEVAALNEHFALPSDGTIMAVSPPPIDGLGNSGGFALRLMDRGGLGREALLQARDTLLGQINGNPKFLYGMMEGLSEAPQLRLVIDREKARAQGVNFETISSTLSSAFGSDVVNDFTNAGRQQRVVIQAEGDQRSQVEDLLRLNVRNSAGKMVPLSSFVSASWKMGPAQLTRYNGYPAVDVSGEPAAGRSTGEAMQEIERLVAQLPNGLGLEWTGLSLQERLSGSQAPLLLGLSLLIVFLCLAALYESWSIPASVLLVVPLGVLGAVLAVTLRGMPNDVFFKVGLITIIGLSAKNAILIVEFAKELWEKGHSLRDAAIEAARLRFRPIIMTSMAFILGVVPLAIATGAGAASQRAIGTGVIGGMLSATLLGVLFVPICFVWLLSLLRTKRPATEQPALTQE,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,98.21,gnl|BL_ORD_ID|133|hsp_num:0,153,,,12,3111,tetracycline
359,bc_500_030218_02,NODE_65_length_8056_cov_4.932602_3 # 1841 # 2179 # 1 # ID=65_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.569,NODE_65_length_8056_cov_4.932602_3,1841,2179,+,Strict,200,204.1,YajC,91.07,3005040,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCTTTTTGATCCCTGCCGCGTATGCGGATGCCGCCGCACCTGCTGCTGCCGGCCCTGCTGGCACTGGTTTCGAGTGGATTTTTCTGGTGGGTTTCCTGGTCATCTTCTATCTGATGATCTGGCGTCCACAGGCCAAGCGCGCCAAAGAGCAGAAGAACCTGCTGGGCAGCTTGCAGAAAGGCGATGAAGTTGTGACCACCGGTGGTATCGCCGGCAAGATCAACAAAGTGACCGACGATTTCGTGGTTCTGGAAGTGTCGGACTCGGTTGAGCTGAAGTTCCAGAAGGGCGCGATCGCGGCCACGCTGCCAAAAGGCACGCTGAAAGCGATCTAA,MSFLIPAAYADAAAPAAAGPAGTGFEWIFLVGFLVIFYLMIWRPQAKRAKEQKNLLGSLQKGDEVVTTGGIAGKINKVTDDFVVLEVSDSVELKFQKGAIAATLPKGTLKAI,MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,100.00,gnl|BL_ORD_ID|2793|hsp_num:0,3783,,,0,336,vancomycin; tigecycline; tetracycline; linezolid; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
360,bc_500_030218_02,NODE_194_length_5781_cov_4.657337_2 # 273 # 689 # -1 # ID=194_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.647,NODE_194_length_5781_cov_4.657337_2,273,689,-,Strict,100,176.8,FosA8,61.03,3007371,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGTTGACCGGCCTCAACCACCTGACCCTGGCGGTTACCGATGTGCCCCGCAGCCTGGCTTTCTACCATTCGCTGCTGCAACTGCGCCTGGAGGCCAGTTGGGATGGCGGCGCCTACCTGTCCCTGCCGGGCCTGTGGTTGTGCCTGTCGCTGGATGGGCAACGCCAGGCGCCTGCGGTGGCCGACTACACCCACTATGCGTTCAGCCTGGAAGCGGGTGATTTCGATTCATTCGTCTCGCGCCTGCGTGAAGCTGGGGTGCAGGAGTGGCGCGACAATCGCAGCGAGGGAGCTTCGTTCTATTTTCTCGATCCGGACGGGCATCGGCTCGAGGCCCATGTCGGCGACCTGGCGTCGCGCTTGCAGGCCTGTCGCCAGAGGCCCTATGCCGGCATGCGTTTCTATCCGGCCGGCTAG,MLTGLNHLTLAVTDVPRSLAFYHSLLQLRLEASWDGGAYLSLPGLWLCLSLDGQRQAPAVADYTHYAFSLEAGDFDSFVSRLREAGVQEWRDNRSEGASFYFLDPDGHRLEAHVGDLASRLQACRQRPYAGMRFYPAG,MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA,97.87,gnl|BL_ORD_ID|4922|hsp_num:0,5899,,,0,408,fosfomycin
361,bc_500_030218_02,NODE_502_length_3747_cov_4.059978_3 # 1775 # 3424 # 1 # ID=502_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.624,NODE_502_length_3747_cov_4.059978_3,1775,3424,+,Strict,400,426.4,ArnT,41.47,3005053,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGACCAGACGCTGGGCCCTGCCGCTGCTGCTGATCGCTTTCGGCCTGTTCTACCTCCTGCCCATGGCCACCCATGGCCTGTGGATTCCCGATGAAACGCGCTACGCGCAGATCAGCCAGGAAATGCTCCATGGCGGGCAATGGGCGTCGCCGCATTTCATGGGCATTCGCTACTTCGAAAAACCGGTGGGCGGTTATTGGCTGATGGCCATCGGCCAAGCGCTGTTCGGTGACAACCTGTTCGGCGTGCGCGTGGCCTCGGCCCTGAGCACCGGCCTGAGCGTAGTCCTGGCCTACCTGTTGGCCATGCGCTTGTGGAACGACTCGCGCAAGGCCGTGGCCAGCGCCTTGCTGTACATGAGCTTCACCGTAGTGGCGCTGCTGGCCGGCTACGCCAATCTCGATCCGCAGTTCACTTTCTGGGTCAACCTGAGCCTGGTGGCATTGTGGTTCACTTTCGACTGCAAGACTTCCCGCGGACAGCTGCTGGCCTGGGTAGTCCTGGGCCTGGCCTGCGGCATGGGCTTCATGACCAAGGGATTCCTGGCCTGGCTGCTGCCGGTGTTGGTGGCCCTGCCCTACGCCATCTGGCAGAAGCGCCTGCGCTCGCTGCTGGTCCTTGGTGGCATCGGTGTGCTCGTCGCGGTGGTCATCAGCCTGCCCTGGGCCCTGGCGGTACATGCGCAAGAGCCGGACTACTGGCGTTTCTTCTTCTGGCACGAGCATATCCGCCGCTTCGCCGGTGAAGACGCCCAGCATGCCTCGCCGTGGTGGTATTACCTGCCGTTGCTGGTGGCCTTCAGTGTGCCGTGGGTCATGCTGCTGCCAGCTACATTCAAACAAGCCTGGCACCAGCGACGCCTGGGCAGTAGCAGGTTCCTGCTGTTGTGGCTGGCGCTGCCACTGGCCTTCTTCAGCCTGAGCAAGGGCAAGCTGCCCGCCTATATCCTGCCGTGCCTGTTGCCTCTGGCGCTGTTGATGGGCAATGCCCTGATGGATCGCCTGAGCAACAAGCAGACGCGCCTCATCAGTCTCAATGGCCTGCTCAATCTGCTGGCGGGCCTGCTGGGACTCCTGGCACTGGTGTACTTCCAGCTGAAGAAGCCAGTGTATGTAGATGAACCGCAGCACCTGGTGCTGGTGTACGTCCTGCTGCTGGGTTGGATCTTCAGCAACCTGCTGGCGGCCATGCGCCCATCGAACATGTGGGCGGCTCCGGCTTTGGGCAGCTTCCTGCTGGTGGCCCTGGCCCCGGCCGCCCTGCCCAATTCGGTGGTCTATAACAAGATTCCCGACCAGTTCATCATCGATCACGTCGCTGAGCTGAGCGAATCCAAGAGCCTGCTGAGCAACGATCTTGGCGCGGCATCGGCGCTGGCCTGGCGCCTGCGCCGCAGCGACGTAACCCTGTACAACACCGAAGGTGAATTGAAGTACGGCCTGACCTACGCTGATTCGGCCCGCCGCAAGGTCGATCTGGACCAGGTCCAGCCGTGGATAACCGAGGCCCGCAAGCAAGGCCCAGTGGGCGTGGTCATGCGGGTCAAGAGCAGCGACGAAGAGCATGAAGTCCAACTGCTGCCACCGGATGCCAAGCGCTACGCCCAGGGCAACATCGTGATCTTCATCATTCCCCAGAGCCAGCCATGA,MTRRWALPLLLIAFGLFYLLPMATHGLWIPDETRYAQISQEMLHGGQWASPHFMGIRYFEKPVGGYWLMAIGQALFGDNLFGVRVASALSTGLSVVLAYLLAMRLWNDSRKAVASALLYMSFTVVALLAGYANLDPQFTFWVNLSLVALWFTFDCKTSRGQLLAWVVLGLACGMGFMTKGFLAWLLPVLVALPYAIWQKRLRSLLVLGGIGVLVAVVISLPWALAVHAQEPDYWRFFFWHEHIRRFAGEDAQHASPWWYYLPLLVAFSVPWVMLLPATFKQAWHQRRLGSSRFLLLWLALPLAFFSLSKGKLPAYILPCLLPLALLMGNALMDRLSNKQTRLISLNGLLNLLAGLLGLLALVYFQLKKPVYVDEPQHLVLVYVLLLGWIFSNLLAAMRPSNMWAAPALGSFLLVALAPAALPNSVVYNKIPDQFIIDHVAELSESKSLLSNDLGAASALAWRLRRSDVTLYNTEGELKYGLTYADSARRKVDLDQVQPWITEARKQGPVGVVMRVKSSDEEHEVQLLPPDAKRYAQGNIVIFIIPQSQP,MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ,99.64,gnl|BL_ORD_ID|2805|hsp_num:0,3795,,,27,1653,colistin A; colistin B
362,bc_500_030218_02,NODE_684_length_3111_cov_4.493835_1 # 1 # 2280 # 1 # ID=684_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.642,NODE_684_length_3111_cov_4.493835_1,1,2280,+,Strict,750,756.9,adeF,56.33,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,AACGCCATCGAGGTCGCCGACGCGGTCCATGCCCGGTTCGCGAGCCTGTCCAAGGAGTTCCCGCAAGGCGTGGGCTACACCAGTGTCTGGGACCCGACCGTTTTCGTCCGCGAATCGATCAGCGCCGTGCGCCATACCTTGTTCGAAGCGATGGTCCTGATCGTCCTGGTGGTGGTGCTCTTCCTGCAGACCTGGCGGGCCTCGATCATCCCGCTGATCGCGGTGCCGGTATCGATTGTCGGCACCTTCGCGGTCCTGTACCTGCTGGGCTACTCCATCAATACCCTGACCTTGTTCGGCCTGGTCCTGGCCATCGGCATCGTCGTGGATGACGCGATCGTGGTGGTGGAAAACGTCGAGCGCCACATCGAGCTCGGCCTGAGCCCGTTGCAAGCGGCCCATCAGGCCATGGCCGAAGTCTCGGGGCCGATCCTGGCGATCGGGCTGGTGCTGTGCGCCGTGTTCATTCCCATGACCTTCATGAGTGGCGTCACCGGGCAGTTCTACAAGCAGTTCGCCGTCACCATTGCGATTTCGACCCTGATCTCGACAGTCAACTCGCTGACCTTGTCGCCGGCCCTGGCGGCCCGCCTGTTGCGTCGGCATGACGCCCCCAGGGACCGCATGACCCGCTGGATGGATGGAACCCTGGGCTGGCTGTTGCGACCGTTCGAGCGATTCTTCAAGCTCAACGCCGAACGCTACGGGGCCAGTATTGCCCGCCTGCTGCCACGGCGCGGAGTCGTCTTCGCGGTGTATGGCGTATTGCTCGGCGCCACCGGGATCCTGTTCAACGCGATTCCCAGCGGCTTCATCCCCAACCAGGACAAGCTCTATCTGTTCGCCGGAGCCACCTTGCCCCCGGGCGCTTCGCTTTCCCGCTCCGAGGCCGTGGCCCGCGAGATGTCGGCCATCGCCTCGAGCGTAGAGGGTGTCGACTACAGCAACTCGTACGTCGGTTCGAACGCCCTGCAAAGCACCACCACGCCGAACCTGGTGACCTCCTACGTCATTCTCAAGCCCTTTGGCCAACGCTCCCGCAGCGCCGAGCAGATCAACGCCGAATTGAACCGCAAGTTCGCGGCGATCAAGGATGGGGCGGCCTATGCCCTGTTGCCGCCACCGATCCAGGGGCTGGGCAACGGCTCCGGATACGCGTTGTTCCTGACGGACCGGGGTGGATTGGGTTACGCGGCACTGCAGCAGGCGCTGGACAGGTTCCAGGCCGAGATCGCCAGCACCCCGGGCATGACCTTCCCGGTGAGTTCCTACCAGTCCAACATCCCGCAGTTGCAAGTGCAGGTCGATCGGACCAGGGCCCAAGCCCAGGGGGTGGAGCTGACAGCCATCTTCGAGACCCTGCAGACCTACCTGGGCTCGGTCTACGTCAACGACTTCAACCTGCTGGGACGGGTGTATCGGGTCGTTGCCCAGGCGGACGCCAGCTTCCGCCAAACCAGGGCGGATGTGGGCAACCTGCAGGTGCGCAATGCCCGGGGCGAAATGCTGCCGCTCAGTTCCGTGGTGAACATCGTGCCGACCTTCGGCCCGGATCCGGTCATGCGCTACAACGGCTATCCGGCGGCTGACCTGATCGGCGACGCCGACCCTCGCATCCTGTCGTCGGGCGAGGCCATCGAGACACTGCAAGAGATCGCCGCCCGCACCCTGCCACGCGGCATCGAACTGGAATGGACCGACCTGAGCTACCAGCAAGTGACCCAGAGCAACAGCGCGGCGATCGTCTTTGCGATCGCCGCCATGCTGGTGTTCCTGGTCCTGGCCGCCCTGTACGAGAGCTGGCTGCTGCCGCTTGCCGTCATCCTGATCGTGCCCATTTGCCTGTTTGCCGCCTTGACGGGGGTCTGGCTGGCGGGTGCGGACAACAATGTCTTCGTCCAGGTGGGACTGGTGGTACTGATGGGGCTGGCTTGCAAGAACGCGATCTTGATCGTCGAGTTCGCGCGGGAACTGGAAATGCACGGCCAAAGCACCGTCGACGCGGCGCTGCAAGCCTGCAGGCTGCGCCTGCGACCGATCGTGATGACCTCCGTGGCCTTTATCGCCGGTGCCGTTCCGCTCCTGATCGGCACTGGGGCAGGTAGCGAAGTGCGCCATGTCACGGGAGTCACGGTGTTTAGCGGCATGCTCGGGGTGACGGTGTTTGGCCTGTTCCTGACCCCGGTGTTCTACGTCGTGCTGAGAAAGCTCGGAGCCACCATTCCCGGCCGCCCCTCAAGCAGCGTGTCTGAAGAAGCACAGGGCCCGAGCCACGGTTGA,NAIEVADAVHARFASLSKEFPQGVGYTSVWDPTVFVRESISAVRHTLFEAMVLIVLVVVLFLQTWRASIIPLIAVPVSIVGTFAVLYLLGYSINTLTLFGLVLAIGIVVDDAIVVVENVERHIELGLSPLQAAHQAMAEVSGPILAIGLVLCAVFIPMTFMSGVTGQFYKQFAVTIAISTLISTVNSLTLSPALAARLLRRHDAPRDRMTRWMDGTLGWLLRPFERFFKLNAERYGASIARLLPRRGVVFAVYGVLLGATGILFNAIPSGFIPNQDKLYLFAGATLPPGASLSRSEAVAREMSAIASSVEGVDYSNSYVGSNALQSTTTPNLVTSYVILKPFGQRSRSAEQINAELNRKFAAIKDGAAYALLPPPIQGLGNGSGYALFLTDRGGLGYAALQQALDRFQAEIASTPGMTFPVSSYQSNIPQLQVQVDRTRAQAQGVELTAIFETLQTYLGSVYVNDFNLLGRVYRVVAQADASFRQTRADVGNLQVRNARGEMLPLSSVVNIVPTFGPDPVMRYNGYPAADLIGDADPRILSSGEAIETLQEIAARTLPRGIELEWTDLSYQQVTQSNSAAIVFAIAAMLVFLVLAALYESWLLPLAVILIVPICLFAALTGVWLAGADNNVFVQVGLVVLMGLACKNAILIVEFARELEMHGQSTVDAALQACRLRLRPIVMTSVAFIAGAVPLLIGTGAGSEVRHVTGVTVFSGMLGVTVFGLFLTPVFYVVLRKLGATIPGRPSSSVSEEAQGPSHG,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,71.67,gnl|BL_ORD_ID|133|hsp_num:0,153,,,894,3117,tetracycline
363,bc_500_030218_02,NODE_1625_length_1288_cov_2.811755_2 # 438 # 1256 # 1 # ID=1625_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.647,NODE_1625_length_1288_cov_2.811755_2,438,1256,+,Strict,50,133.3,vanW gene in vanG cluster,30.71,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGAAGCCGTTGTCTTCGTACCACCCGTTGTTGTACTGGCTGCGCGTGCGCCAGAAGCGTCTGGCGCGCAGCCTGGCCTGGCGTTTTTCCGGTCGGCGTTATGCGCGGCCCGTAGCCGGTAGCCCACGCTTGCCTTATCGCTACATCAAGCACACCTCCAAGCTGATCCGCACCCTGGGCGATTGCGACCTGGCCCTGCAGCACAACAAGGTGATCAATCTCAGGCTGGCGGTGGCTTGCATCGATGGGGTGCGCATCGGTCCGGGGGAGTATTTTTCCTTCTGCCAGCTGGTGGGCCGGCCCAGTCGCGCGCGGGGGTTCGTCGAGGGCATGGAGCTGTCGTTCGGCGAGGCGCGCAGCGGTATCGGCGGGGGCATCTGCCAGCTGAGCAACCTGATCCACTGGATGGCGATCCACTCGCCATTGCAAGTGGTGGAGCGGGCCAACCACAGCTTCGACCCGTTTCCCGACGAGGGCCGGGTGCTGCCTTTCGGCTCCGGCGCGGCGATCTTCTACAACTACATCGACCTGGTGCTGCACAACCCCGGGCCGCACGCCTTCCAGCTCAAGCTGCATGTCGGCGCGCACCAGCTCGAGGGCGAACTGTTGTGCGAGCAACCGCGCGACTACCGCTATCACGTCTACCAGCAGGGCCATCGTTTCGTCCGCGAGGGTGGTCGGGTGCTGCGCGAGAACCAGATCTGGCGCGACATCCGCACCAAGGGCCAGGATTCCGAGCTGGTGCAGCAGGAGTGCCTGTATCGCAACCGGGTGGTGGTCAAGTACCCGGTGGCCGACGACTTGCTGGAGCAAGCCTGA,MKPLSSYHPLLYWLRVRQKRLARSLAWRFSGRRYARPVAGSPRLPYRYIKHTSKLIRTLGDCDLALQHNKVINLRLAVACIDGVRIGPGEYFSFCQLVGRPSRARGFVEGMELSFGEARSGIGGGICQLSNLIHWMAIHSPLQVVERANHSFDPFPDEGRVLPFGSGAAIFYNYIDLVLHNPGPHAFQLKLHVGAHQLEGELLCEQPRDYRYHVYQQGHRFVREGGRVLRENQIWRDIRTKGQDSELVQQECLYRNRVVVKYPVADDLLEQA,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,96.80,gnl|BL_ORD_ID|4756|hsp_num:0,1622,,,30,822,vancomycin
544,tcs_052517_05,NODE_445_length_3493_cov_5.483545_2 # 374 # 3493 # 1 # ID=445_2;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.611,NODE_445_length_3493_cov_5.483545_2,374,3493,+,Strict,750,1349.3,adeF,68.21,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACTTCTCCAAATTCTTCATCACACGGCCCATCTTCGCGGCGGTGCTGTCACTGGTGCTGCTGATCGCAGGCTCCATTTCGCTGTTCCAGTTGCCCATCAGTGAATACCCTGAGGTCGTACCGCCTACGGTTGTGGTACGCGCCAACTTCCCGGGTGCCAACCCCAAGGTCATCGGCGAAACCGTTGCCGCGCCCCTGGAGCAAGCCATTACCGGGGTCGAGAACATGCTCTACATGTCCTCGCAATCCACCGCCGATGGCAAGCTGACCTTGACCATCACCTTCGCCCTGGGGACCGACCTGGACAATGCCCAGGTGCAGGTGCAGAACCGTGTGACCCGCACGCAGCCCAAGCTGCCCGAGGAAGTGACACGTATCGGTATCACGGTGGACAAGGCGTCGCCCGACCTGACCATGGTCGTGCACCTGACTTCACCGGACAACCGCTATGACATGCTCTACCTGTCCAACTACGCCATCCTGAACATCAAGGACGAGCTGGCACGGTTGGGTGGTGTGGGTGATGTGCAGCTGTTTGGCATGGGCGACTACTCCCTGCGCGTCTGGCTGGACCCGAACAAGACCGCCTCGCGCAACCTGACGGCCACCGATGTGGTCACTGCAATTCGCGAGCAGAACCGCCAGGTGGCCGCGGGTCAGCTGGGTGCTCCGCCGGCGCCGGGCTCCACCAGCTTCCAGCTCTCGATCAACACCCAGGGCCGCCTGGTCAATGAGGAAGAATTCGAGAACATCATCATCCGTGCCGGTGCGGACGGTGAGATCACGCGCCTGAAGGACATCGCTCGTGTCGAACTGGGCTCTAGCCAGTACGCGCTGCGCTCGCTGCTCAACAACCAGCCTGCCGTGGCCATCCCAATCTTCCAGCGCCCGGGCTCGAACGCCATCGACATCTCCGATGAAGTACGCGCCAAGATGGCGGAATTGAAGAAAGACTTCCCCGAGGGCATGGACTACAGCATCGTCTACGACCCTACCGTGTTCGTGCGCGGCTCGATCGAGGCGGTGGTGCACACGCTGTTCGAAGCATTGGTACTGGTGGTGCTGGTGGTCATCCTGTTCCTGCAGACCTGGCGTGCATCGATCATTCCGCTACTGGCCGTACCGGTATCGCTGATCGGCACCTTCGCCGTGATGCACCTGTTCGGCTTCTCGCTCAATGCCCTTTCCTTGTTCGGGTTGGTGCTGGCAATCGGCATCGTGGTCGATGACGCCATCGTGGTAGTGGAGAACGTCGAGCGCAACATCGGGCTGGGTCTCAAACCGCTCGAAGCCACGCAAAAAGCCATGAGCGAGGTGACAGGCCCGATCATCGCCACCGCCTTGGTGCTGTGCGCGGTGTTCGTACCCGCAGCGTTCATCTCGGGGCTGACTGGACAGTTCTACAAGCAGTTTGCCCTGACCATTGCGATCTCCACGGTGATCTCGGCGTTCAACTCGCTGACCCTGTCCCCTGCCTTGGCGGCGGTACTGCTCAAGGACCACCATGCGCCCAGGGACAAATTCTCGCGGCTGTTGGACAGGTTGCTGGGTAGCTGGCTTTTTGCGCCCTTCAACCGCTTCTTCGACCGCGCCAGCCATCGCTACGTGGGCGGTGTCCGCCGAGTGATCCGTTCCAGTGGCATCGCCCTGTTCGTCTATGCCGGTTTGATGGGCCTGACCTATCTGGGCTTCTCCTCCACGCCGACCGGTTTCGTGCCTGCCCAGGACAAGCAGTACTTGGTGGCGTTTGCCCAATTGCCGGATGCCGCCAGCCTTGATCGCACCGAAGCGGTGATCAAGCGCATGAGCGAGATTGCCCTCAAGCAACCGGGCGTGGCGGACTCTGTCGCGTTCCCGGGCCTGTCCATCAATGGCTTCACCAACAGCCCCAACAGCGGCATCGTGTTCACGCCTCTCAAGCCCTTCGACGAGCGCAAGGACCCCAGCCAGTCGGCCGCTGCCATCGCCGCAGCCTTGAACGCCCAGTTCGCCGACATTCAGGACGCCTACATCGCGATCTTCCCACCGCCGCCCGTGCAAGGGCTCGGCACCATCGGTGGCTTCCGCCTGCAGATCGAGGACCGTGGCAACCTGGGTTACGAAGCGCTGTACAAGGAAACCCAGAACATCATTGCCAAGAGCCATGAGGTGCCTGAGCTTGCGGGACTGTTCACCAGCTACCAGGTCAACGTGCCGCAGGTCGATGCGGCCATCGATCGCGAGAAAGCCAAGACCCACGGCGTGGCCATCAACGATATCTTCGACACTCTGCAAGTGTACCTGGGGTCGCTGTATACCAATGATTTCAACCGATTCGGACGTACCTACCAGGTCAACGTGCAGGCCGAGCAGCAGTTCCGACTCGACGCCGAGCAGATTGGCCAATTGAAGGTGCGCAACAACCGGGGCGAGATGATCCCATTGGCCACGTTCCTCAAGGTCACCGACACCTCCGGGCCCGACCGCGTGATGCACTACAACGGCTTCATCACCGCAGAAATCAATGGCGCAGCGGCGCCTGGGTACAGCTCAGGCCAGGCAGAAGCGGCCATCGAGAAACTCCTGAAGCAGGAATTGCCCAACGGCATGACCTTCGAGTGGACGGACCTGACCTACCAGCAGATCCTCTCGGGCAACACTGCGCTGTTCGTGTTCCCGTTGTGCGTGTTGTTGGCGTTCCTGGTACTGGCCGCCCAGTACGAGAGCTGGAGCCTGCCCTTGGCGGTGATCCTGATCGTGCCGATGACGCTGCTCTCGGCCATTACTGGCGTCATTGTCTCCGGTGGTGACAACAACATCTTCACCCAGATCGGGCTCATCGTTCTGGTCGGGCTTGCCTGCAAGAACGCCATCCTGATCGTGGAGTTCGCCAAGGACGAGCAGGCCAAAGGCCTCGATCCTCTGGCTGCGGTGCTGGAAGCCTGCCGTCTGCGTTTGCGCCCCATCCTGATGACGTCCATCGCGTTCATCATGGGTGTCGTACCGCTGGTGTTCAGCTCGGGAGCAGGCTCGGAGATGCGTCATGCCATGGGCGTGGCGGTGTTCTCCGGGATGATCGGCGTCACGGTGTTCGGCCTGTTCCTGACCCCGGTGTTCTTCTTCCTGATCCGCCGTTTT,MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKLPEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLFGMGDYSLRVWLDPNKTASRNLTATDVVTAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQGRLVNEEEFENIIIRAGADGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGSNAIDISDEVRAKMAELKKDFPEGMDYSIVYDPTVFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLLAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPLEATQKAMSEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAISTVISAFNSLTLSPALAAVLLKDHHAPRDKFSRLLDRLLGSWLFAPFNRFFDRASHRYVGGVRRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVIKRMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAAAIAAALNAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSHEVPELAGLFTSYQVNVPQVDAAIDREKAKTHGVAINDIFDTLQVYLGSLYTNDFNRFGRTYQVNVQAEQQFRLDAEQIGQLKVRNNRGEMIPLATFLKVTDTSGPDRVMHYNGFITAEINGAAAPGYSSGQAEAAIEKLLKQELPNGMTFEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKDEQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMIGVTVFGLFLTPVFFFLIRRF,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,98.21,gnl|BL_ORD_ID|133|hsp_num:0,153,,,0,3105,tetracycline
545,tcs_052517_05,NODE_509_length_3141_cov_5.644280_3 # 1772 # 2107 # 1 # ID=509_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.580,NODE_509_length_3141_cov_5.644280_3,1772,2107,+,Strict,200,201.8,YajC,91.96,3005040,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCTTCTTGATCCCCGCCGCATACGCGGACGCTGCAGCCCCCGCCGCCGGCCCTGCCGGTACTGGCTTCGAGTGGATTTTCCTGGTCGGTTTCCTGGTCATCTTCTACCTGATGATCTGGCGTCCACAGGCCAAACGTGCCAAAGAGCAGAAGAACCTGCTGGGCAACTTGCAGAAAGGTGACGAAGTTGTCACCAACGGTGGCATTGCCGGCAAGATCGTCAAAGTGGCCGATGATTTCGTGGTGCTGGAAGTGTCCGACACTGTCGAGCTGAAGTTCCAGAAGGGCGCCATTGCCGCGACCCTGCCAAAAGGTACGCTCAAGGCTATCTGA,MSFLIPAAYADAAAPAAGPAGTGFEWIFLVGFLVIFYLMIWRPQAKRAKEQKNLLGNLQKGDEVVTNGGIAGKIVKVADDFVVLEVSDTVELKFQKGAIAATLPKGTLKAI,MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,99.11,gnl|BL_ORD_ID|2793|hsp_num:0,3783,,,0,336,vancomycin; tigecycline; tetracycline; linezolid; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
963,tcs_072017_12,NODE_44_length_26161_cov_16.113003_4 # 3632 # 3973 # -1 # ID=44_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.646,NODE_44_length_26161_cov_16.113003_4,3632,3973,-,Strict,200,202.6,YajC,94.69,3005040,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGTTTTCTGATCCCCGCTGCCTACGCTGACGCCGCAGCCCCCGCCGCTGCCGCCGGCCCGGCCGGCACCGGCTTCGAGTGGGTCTTCCTGGTCGGTTTCCTGGTCATCTTCTACCTGATGATCTGGCGTCCCCAGGCCAAGCGCTCCAAGGAGCACAAGAACCTGCTGTCCGGCCTGCAGAAGGGCGATGAAGTCGTCACCTCCGCCGGTATCGCCGGCAAGGTCACCAAGGTCGCCGAGGACTTCGTCGTCGTCGAGGTTTCCGACAACGTCGAGCTGAAGTTCCAGAAGGCCGCGATCGCCGCGACCCTGCCGAAAGGCACCCTGAAGGCGATCTGA,MSFLIPAAYADAAAPAAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRSKEHKNLLSGLQKGDEVVTSAGIAGKVTKVAEDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,100.89,gnl|BL_ORD_ID|2793|hsp_num:0,3783,,,0,336,vancomycin; tigecycline; tetracycline; linezolid; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
964,tcs_072017_12,NODE_48_length_25718_cov_13.936782_4 # 2217 # 3206 # -1 # ID=48_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.669,NODE_48_length_25718_cov_13.936782_4,2217,3206,-,Strict,200,203.0,vanH gene in vanB cluster,42.81,3002943,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanH; glycopeptide resistance gene cluster,ATGCGCATTATCCTGTTCAGCAACCAGACCTACGACCGTGACAGCTTCCTTGCAGCCAACCACGGCCACGGCTTCGAGCTGCATTTCCAGCAGACCCAGCTGCGCCTGGACACCGTGGCCCTGGCCATGGGTTTCGAAGTGGTCTGCCCGTTCGTCAACGACGACCTCTCGCGCCCGGTGCTAGAGCATCTGGCGGCCGGCGGCACGAAGCTGATCGCCCTGCGCTCGGCCGGCTACAACCACGTCGACCTGGCTGCCGCCCACGCATTGGGGCTGGCGGTGGTGCGGGTACCGGCCTATTCGCCCCACGCCGTAGCTGAACATGGCGTAGGACTAGTCCTGGCGCTCTGTCGGCATCTGCACCGCGCCTACAACCGCACCCGCGAAGGCGACTTCTCCCTGCACGGGCTGACCGGCTTCGACCTGCACGGGCGCACCGTCGGCGTGATCGGCAGCGGGCAGATTGGCGAAGTCTTCGCCCGCATCATGAGCGGCTTCGGCTGCCACATCCTGGCCTACGACCCCTACCCCAATCGCGCCATCGAGGCGCTGGGCGGGCGCTTCGTCGAACTGGACGAGCTGCTCGCGCAGTCCGACATCATCAGCCTGCACTGCCCGCTCAACGAGGCCACCAGACACCTGATCAACGCCCAGAGCCTGGCGCGCATGAAGCGCGGCGCCATGCTGATCAACACCGGGCGCGGCGCACTGGTGGACACCCCGGCACTGATCGAGGCGCTGAAAAGCGGCCAGCTCGGCTACCTCGGCCTGGACGTCTATGAAGAAGAAGCCGACATCTTCTTCGCCGACCGCTCCGACCAGCCGCTGCAGGACGATGTGCTGGCGCGCCTGCTGACCTTCCCCAACGTGATCATCACCGCGCACCAGGCCTTCCTCACTCGCGAGGCGCTGGCCGGGATCGCCCAGACCACCCTCGCCAACATCGCCGCCTGGCAGGGCGGCAACCCGGTCAACCTCGTCGAGGGCTGA,MRIILFSNQTYDRDSFLAANHGHGFELHFQQTQLRLDTVALAMGFEVVCPFVNDDLSRPVLEHLAAGGTKLIALRSAGYNHVDLAAAHALGLAVVRVPAYSPHAVAEHGVGLVLALCRHLHRAYNRTREGDFSLHGLTGFDLHGRTVGVIGSGQIGEVFARIMSGFGCHILAYDPYPNRAIEALGGRFVELDELLAQSDIISLHCPLNEATRHLINAQSLARMKRGAMLINTGRGALVDTPALIEALKSGQLGYLGLDVYEEEADIFFADRSDQPLQDDVLARLLTFPNVIITAHQAFLTREALAGIAQTTLANIAAWQGGNPVNLVEG,MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE,101.86,gnl|BL_ORD_ID|4681|hsp_num:0,626,,,120,936,vancomycin
965,tcs_072017_12,NODE_57_length_23682_cov_11.758339_4 # 5423 # 5608 # 1 # ID=57_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.527,NODE_57_length_23682_cov_11.758339_4,5423,5608,+,Perfect,100,118.2,rsmA,100.0,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGCCGGGTCGGAGAGACCCTGATGGTCGGTGATGACGTCACCGTGACTGTACTGGGCGTCAAAGGAAATCAGGTGCGTATCGGTGTGAATGCGCCGAAGGAAGTTGCTGTGCACCGTGAGGAAATCTACCAGCGCATCCAGAAAGAGAAAGACCAAGAACCAAACCATTAA,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100.00,gnl|BL_ORD_ID|2814|hsp_num:0,3807,,,0,183,trimethoprim; chloramphenicol
966,tcs_072017_12,NODE_74_length_20828_cov_16.889706_15 # 16083 # 19223 # 1 # ID=74_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.654,NODE_74_length_20828_cov_16.889706_15,16083,19223,+,Strict,750,758.4,adeF,41.62,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTCGAAGTTTTTCATTGACCGGCCCATCTTCGCCTGGGTGATCGCCCTGGTGATCATGCTGGCGGGCGGTCTGTCGATCCTCAAGTTGCCGGTGAACCAGTACCCGGCCATTGCGCCGCCGGCCATCGCCATCCAGGTGAGCTACCCGGGCGCCTCCGCCGAAACGGTGCAGGACACCGTGGTGCAGGTGATCGAGCAGCAGATGAACGGTCTCGACCATCTGCGCTACATCTCCTCGGAGTCCAACTCCGACGGCAGCATGACCATCACCGTGACCTTCGACCAGGGCACCAGCCCTGACATCGCCCAGGTCCAGGTGCAGAACAAGCTGCAGCTGGCCACCCCGCTCCTGCCGCAGGAAGTACAGCAGCAGGGCATCCGCGTGACCAAGGCGGTGAAGAACTTCCTGATGGTGGTCGGCGTCGTCTCCACCGACGGCAGCATGACCAAGGAAGACCTGTCGAACTACATCGTCTCCAACATCCAGGACCCGCTGTCGCGGACCGCCGGTGTGGGCGACTTCCAGGTGTTCGGTTCGCAGTACGCGATGCGCATCTGGCTCGATCCGGCCAAGCTCAACAGCTACCAGATGACCCCGGGCGACGTGAAGACGGCGATCCAGGCGCAGAACGTGCAGATCTCCTCCGGCCAGCTGGGCGGCCTGCCTGCGGTCAAGGGCCAGCAGCTCAACGCCACGATCATCGGCAAGACCCGCCTGCAGAGCGCCGAGCAGTTCAAGAACATCCTGCTCCGGGTCAACGCCGACGGCTCTCAGGTTCGCCTGAAGGACGTCGCCGACGTCGCCCTGGGCGGCCAGGACTACAGCATCAATGCCCAGTTCAACGGCAAGCCGGCCTCGGGTATCGCGATCAAGCTGGCCACCGGCGCCAACGCGCTGGACACCGCCAAGTCGATCCGCGCGACCCTGAGCACGCTGGAGCCGTTCTTCCCGCAGGGCATGAAGATCGTCTACCCGTACGACACCACGCCGGTGGTCTCCGCCTCCATCCATGAGGTGGTTAAGACCCTGGGCGAAGCGATCCTGCTGGTGTTCCTGGTGATGTACCTGTTCCTGCAGAACTTCCGCGCCACGCTGATCCCGACGATCGCCGTGCCCGTGGTCCTGCTGGGCACCTTCGGCGTACTCGCCGCCTTCGGCTTTTCGATCAACACCCTGACCATGTTCGGCATGGTGCTGGCGATCGGCCTGTTGGTGGACGACGCCATCGTGGTGGTGGAAAACGTCGAGCGGGTGATGGCCGAGGAAGGCCTGTCGCCCCGCGAGGCGGCGCGCAAGTCCATGGGACAGATCCAGGGCGCGCTGGTGGGCATCGCGCTGGTGCTCTCGGCGGTGTTCCTGCCGATGGCGTTCTTCGGCGGCTCCACCGGGGTGATCTACCGCCAGTTCTCCATCACCATCGTCTCGGCCATGGCCCTGTCGGTGCTGGTGGCCCTGGTGCTGACCCCGGCGCTCTGCGCCACCATGCTCAAGCCCATCGAGAAGGGCGACCACGGCGAGCACAAGCGCGGCTTCTTCGGCTGGTTCAACCGTGCCTTCCTCTCCACCACCCACGGCTACGAGCGCGGCGTGAAGTCGATCCTCTCGCACCGCGTGCCGTACCTGCTGATGTACGTGCTGATCCTGGGCGGCATGGTCTACCTGTTCACCCGCATCCCCACCGCGTTCCTCCCCGACGAGGACCAGGGCGTGCTGTTCGCCCAGGTGCAGACCCCGGCCGGTTCCTCCGCCGAGCGCACCCAGGTGGTGGTGGACTCGATGCGCGAGTATCTGCTGGACAAGGAAAGCAGCTCGGTGGCCTCGGTGTTCACCGTGACCGGCTTCAACTTCGCCGGCCGCGGCCAGAGCTCGGGCATGGCGTTCATCATGCTCAAGCCCTGGGAAGAGCGTCCGGGCGCGGAGAACAGCGTGTTCGCGCTGGCCCAGCGCGCGCAGCAGCACTTCTTCAGCTTCAAGGATGCGATGGTGTTCGCCTTCGCCCCGCCGGCGGTACTCGAACTGGGTAACGCCGTGGGCTTCGACATCTTCCTCCAGGACCAGGCGGGCGTCGGCCACGACGTACTGATGCAGGCGCGCAACCAGTTCCTCGGCCTTGCCGCGCAGAACCCGGTGCTGCAACGCGTGCGTCCCAACGGCCTGAACGACGAGCCGCAGTACAAGCTGCTGATCGACGACGAGAAGGCCAGTGCGCTGGGCATCTCGCTGGCGGACATCAACAGCACCATCTCCATCGCCTGGGGTTCGAACTACGTCAACGACTTCATCGACCGCGGTCGCGTGAAGAAGGTCTACCTGCAAGGCCGCCCGAACGCGCGGATGAGCCCGGAAGACCTGGACAAGTGGTACGTGCGCAACAGCGCCGGCGAGATGGTGCCGTTCAGCGCCTTCGCCACCGGCGAATGGAGCTACGGCTCGCCCAAGCTTGCGCGCTACAACGGCGTGCCGGCCATGGAAGTCCTCGGTGAACCGGCCCCGGGCCGATCCACCGGTGAGGCCATGGCGGCGGTCGAGGACATCGTCAAGCAACTGCCCAAGGGCGTCGGTTACTCCTGGACCGGCCTGTCCTACGAGGAGCGTCTGTCCGGCTCCCAGGCGCCCGCGCTCTACGCACTGTCGCTGATCGTGGTGTTCCTCTGCCTGGCGGCGCTGTACGAGAGCTGGTCGATCCCGTTCTCGGTGATGCTGGTGGTGCCGCTGGGCGTCATCGGTGCGCTGCTGGCGACCTCCATGCGCGGCCTGTCCAACGACGTGTTCTTCCAGGTGGGCCTGTTGACCACCATCGGCCTGTCGGCGAAGAACGCGATTCTGATCGTCGAGTTCGCCAAGGAACTGCACGAGCAGGGCAAGGGCATCGTCGAGGCGGCCATCGAGGCCTGCCGGATGCGTCTGCGCCCCATCGTGATGACCTCCCTGGCCTTCATCCTCGGCGTGGTGCCGCTGGCGATTTCCACCGGCGCCGGCTCGGGCAGCCAGCATGCGATCGGTACCGGCGTGATCGGCGGCATGGTCACCGCGACCGTCCTGGCGATCTTCTGGGTGCCGTTGTTCTACGTGGTGGTCAGTACCCTGTTCAAGGACCCGGCGTCCAGGGAACAGGAATCCACCGAGAAGGGGCATTGA,MSKFFIDRPIFAWVIALVIMLAGGLSILKLPVNQYPAIAPPAIAIQVSYPGASAETVQDTVVQVIEQQMNGLDHLRYISSESNSDGSMTITVTFDQGTSPDIAQVQVQNKLQLATPLLPQEVQQQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTAGVGDFQVFGSQYAMRIWLDPAKLNSYQMTPGDVKTAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQSAEQFKNILLRVNADGSQVRLKDVADVALGGQDYSINAQFNGKPASGIAIKLATGANALDTAKSIRATLSTLEPFFPQGMKIVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIALVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVLVALVLTPALCATMLKPIEKGDHGEHKRGFFGWFNRAFLSTTHGYERGVKSILSHRVPYLLMYVLILGGMVYLFTRIPTAFLPDEDQGVLFAQVQTPAGSSAERTQVVVDSMREYLLDKESSSVASVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGAENSVFALAQRAQQHFFSFKDAMVFAFAPPAVLELGNAVGFDIFLQDQAGVGHDVLMQARNQFLGLAAQNPVLQRVRPNGLNDEPQYKLLIDDEKASALGISLADINSTISIAWGSNYVNDFIDRGRVKKVYLQGRPNARMSPEDLDKWYVRNSAGEMVPFSAFATGEWSYGSPKLARYNGVPAMEVLGEPAPGRSTGEAMAAVEDIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVVVSTLFKDPASREQESTEKGH,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,98.77,gnl|BL_ORD_ID|133|hsp_num:0,153,,,6,3111,tetracycline
967,tcs_072017_12,NODE_99_length_17194_cov_12.833557_5 # 3337 # 4983 # -1 # ID=99_5;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.685,NODE_99_length_17194_cov_12.833557_5,3337,4983,-,Strict,400,410.2,ArnT,41.91,3005053,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGAAGCGCCTGGCCTACCCGTCGCTGCTCGCCGCCCTGGTGCTGTGCATCCTGTTGCCGACGGCCTTCCACGGCCTGTGGATTCCCGATGAATCGCGCAACGCGCAGATCGCCCAGGCCATGCTGCAGAGCGGCGACTGGGTGTCCCCGCACCTGCTCGGCCTGCGCTATTTCGAGAAGCCCACCGGCGGCTACTGGCTGACCGCAATCAGCCAGGCGGTGTTCGGCCAGAACCTGTTCGGCGTGCGCGCCGGCTCCGCGCTGGTGACGGCGCTGAGCACCCTGCTGGTGATCCTGGTGGCGCGCCGGCTGTGGAACGATCCGCGCCGGACCTGGGCCGCGGGCGCGCTGTACCTGAGTTTCGGGCTGATCGCGGGCCAGGCCGGCTATGCCAACCTCGACCCGCAGTTCACCCTGTGCGTGAACCTCAGCCTCGGCGCGCTGTGGTTCGCCTTCGACGCCAGCACCGCACGGGGGCGCTTCGCCGCCTGGAGCCTGCTCGGCGCAGCCTGCGCCTTCGGCCTGATGACCAAGGGCTTCCTCGCCTTCCTGCTGCCGGTGATCGTCGGCGTGCCCTACGCGCTGCTGCAGAAGCGTGTGGGCGACCTACTGCGCTACGGGCCGCTGGCGGTGCTGGTGGCGGTGCTGGTCAGCGCGCCCTGGGCACTGCTGATCCACGCCCGCGAACCGGAGTTCTGGGACTTCTTCTTCTGGAACGAACACATCCGCCGCTTCGCCGCCGAAGACGCCCAGCATGGCCGGCCGATCTGGTTCTTCGTGCCGCTGCTGTTCGCCAGCGCGCTGCCCTGGGCGGTGCTGATCTTCCCGGCGCTGCGCAACGGGGTGAAAGGCTGGCGCGAATCGAAGCTGTTGTACCTGCTGCTGTGGTTCGCCATGCCCTTCCTGTTCTTCAGCCTGTCCAAGGGCAAGCTGCCGACCTACATCATGCCCTGCTTCGCCCCGCTGGCCCTGCTGATGGCCGACGCCATCGGCCGCGCCCTGCAACAGGGCAAGCCGCTCGCCCTGAAACTCAACGGCGCGCTCAACCTGCTGCTGGGCAGCAGCGCGCTGGCCGGCCTGCTGTTCCTGCAGGCGCGCCACCCGCAGTACCACGACGAACTGCCCAGCGTGCTGATGGTCGCCCTGGTCTGCGTCGTCTGGCTGCTCACAGGACTGCTGCAACTGCTGCAGCCCACTCGCTACTGGGCCGCCCCGGCCTTCGCCGCCTGGCTGCTGGTGGCGCTGGTGCCCAACGCGATGCCGAACAAGATGGTCAACAGCAAGATGCCTGACCAGTTCATCGCCGAGCACCTGGAGCAGCTCAAGGGCGCGCGCAGCCTGCTGAGCAACGACCTGGGCGCCGCCACTGCCCTGGCCTGGCGCACCCAGCGCAGCGACATCACCCTGTTCAACACCGAAGGCGAGCTGAAGTTCGGCCTGGGTTACCCCGAAGGCCAGGGCCGCAGCATCGCGTCCAAGGACATCCATGCCTGGCTCGAACGCAACCGCGCCGCGGGCACCATCGGCGTGGTCATGCGCGTCAACAGCGCCAGCGACGAAGCGGAACTGGCGATGCTGCCCAGCGACGCCATCAGCTACCGGCAGAACCACCTGGTGGTCCTGCTGATCCCGCAGGCCTCGCCATGA,MKRLAYPSLLAALVLCILLPTAFHGLWIPDESRNAQIAQAMLQSGDWVSPHLLGLRYFEKPTGGYWLTAISQAVFGQNLFGVRAGSALVTALSTLLVILVARRLWNDPRRTWAAGALYLSFGLIAGQAGYANLDPQFTLCVNLSLGALWFAFDASTARGRFAAWSLLGAACAFGLMTKGFLAFLLPVIVGVPYALLQKRVGDLLRYGPLAVLVAVLVSAPWALLIHAREPEFWDFFFWNEHIRRFAAEDAQHGRPIWFFVPLLFASALPWAVLIFPALRNGVKGWRESKLLYLLLWFAMPFLFFSLSKGKLPTYIMPCFAPLALLMADAIGRALQQGKPLALKLNGALNLLLGSSALAGLLFLQARHPQYHDELPSVLMVALVCVVWLLTGLLQLLQPTRYWAAPAFAAWLLVALVPNAMPNKMVNSKMPDQFIAEHLEQLKGARSLLSNDLGAATALAWRTQRSDITLFNTEGELKFGLGYPEGQGRSIASKDIHAWLERNRAAGTIGVVMRVNSASDEAELAMLPSDAISYRQNHLVVLLIPQASP,MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ,99.46,gnl|BL_ORD_ID|2805|hsp_num:0,3795,,,0,1653,colistin A; colistin B
968,tcs_072017_12,NODE_107_length_16272_cov_11.483716_2 # 1744 # 4944 # 1 # ID=107_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.652,NODE_107_length_16272_cov_11.483716_2,1744,4944,+,Strict,750,1334.3,adeF,65.48,3000777,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACTTTTCGCAATTCTTCATCCAGCGGCCGATCTTCGCCGCCGTGCTCTCGCTGATCATCCTGATCGGCGGGGCCATCTCGCTGTTCCAGCTACCGATCAGCGAATACCCCGAAGTGGTGCCGCCCACCGTGGTGGTGCGCGCCAACTTCCCCGGCGCCAACCCCAAGGTGATCGGTGAAACCGTCGCCGCACCGCTGGAGCAGGCCATCACCGGCGTCGAGAACATGCTCTACATGTCCTCGCAGTCCACCGCCGACGGCAAGATGACCCTGACCATCACCTTCGCCCTGGGCACCGACCTGGACAACGCGCAGGTGCAGGTGCAGAACCGTGTGACCCGTACGCAGCCCAAGCTGCCCGAGGAAGTCACGCGGATCGGCATCACCGTCGACAAGGCCTCGCCCGACCTGACCATGGTCGTGCACCTCACCTCGCCGGATAACCGCTACGACATGCTCTACCTGTCCAACTACGCCATCCTCAACATCAAGGATGAGCTGGCGCGCCTGGACGGTGTGGGCGACGTTCAACTGTTCGGCATGGGCGACTACTCCCTGCGCGTCTGGCTGGACCCGAACAAGGTCGCCTCGCGCAACCTGACCGCCACCGATGTGGTCGCCGCGATCCGCGAGCAGAACCGCCAGGTCGCCGCCGGCGCCCTGGGCGCCCCGCCCTCGCCGAGCGACACCAGCTTCCAGTTGTCGATCAACACCCAGGGTCGCCTGGTCACCGAGGAAGAGTTCGAGAACATCATCATCCGCAGCGGCCCGGACGGCGAGATCACCCGTCTGAAGGACATCGCCCGCGTCGAGCTCGGCTCCAGCCAGTACGCCCTGCGCTCGCTGCTGGACAACCAGCCGGCGGTCGCCATCCCGATCTTCCAGCGTCCGGGCTCCAACGCCATCGCCATCTCCAACCTGGTGCGCGAGAAGATGGCCGAGCTGAAGAAGGACTTCCCGCAGGGCGTGGACTACTCCATCGTTTATGACCCAACCATCTTCGTTCGCGGCTCCATCGAGGCCGTGGTGCACACCCTGTTCGAAGCCCTGATCCTGGTGGTGCTGGTGGTCGTGCTGTTCCTGCAGACCTGGCGCGCCTCGATCATCCCGCTGGCCGCCGTGCCGGTATCGCTGATCGGTACCTTCGCGGTGATGCACGCCTTCGGCTTCTCGCTCAACGCGCTGTCGCTGTTCGGCCTGGTACTGGCCATCGGCATCGTGGTGGACGACGCCATCGTGGTGGTAGAGAACGTCGAGCGGAACATCGGGCTGGGCCTCACGCCTGTGGAGGCGACCAAGCGCGCCATGAAGGAAGTGACCGGGCCGATCATCGCCACCGCGCTGGTGCTGTGCGCCGTGTTCATCCCGACGGCGTTCATCTCCGGCCTCACCGGGCAGTTCTACCGGCAGTTCGCGCTGACCATCGCGATCTCCACGGTGATCTCCGCGTTCAACTCGCTGACCCTGTCGCCGGCGCTGTCCGCCGTGCTGCTCAAGGGGCACCACGAGCCCAAGGACCGCTTCTCGGTGCTACTGGACAAGCTGCTGGGCGGCTGGCTGTTCCGTCCGTTCAACCGCTTCTTCGACCGCGCCAGCCATGGCTATGTCGGCACCGTCACCCGCGTGCTGCGTGGCAGCTCCATCGCGCTGCTGCTGTATGCCGGGTTGATCGGCCTGACCTACCTGGGCTTCTCCAGCACCCCCACCGGCTTCGTGCCGCAGCAGGACAAGCAGTACCTGGTGGCCTTCGCGCAACTGCCCGACGCCGCCACCCTGGACCGCACCGAAGCGGTGATCAAGCGCATGTCGGAAATCGCCGGCAAGCACCCGGGCATCGAGCACACCGTGTCCTTCCCGGGCCTGTCGATCAACGGCTTCACCAACAGCCCCAACAGCGGCATCGTCTTCACCCCGCTCAAGGACTTCAGCGAGCGCAAGGGCCCGGGCATGTCGGCCAACGAGATCGCCGCCGAGCTGAACAAGCAGTTCGCGGACATCCAGGACGCCTACATCGCGATCTTCCCGCCGCCGCCGGTACAGGGGCTGGGGACCATCGGCGGCTTCCGCCTGCAGATCGAGGACCGCGGCAACGCCGGTTACGAGGAGCTCTACGCGCAGACCCAGAACATCCTCAACAAGGCCCGCGCGCTGCCGGAGCTCAACCCCATGTCGGTGTTCACCAGCTACCAGGTGAACGTGCCGCAGGTGGATGCCGCCATCGACCGCGAGAAGGCCAAGACCCACGGGGTTGCGATCAGCGACATCTTCGACACCCTGCAGGTCTACCTGGGCTCGCTGTACGCGAACGACTTCAACCGCTTCGGCCGCACCTACCAGGTGAACGTCCAGGGCGAGCAGCAGTTCCGTCTCGAACCCGAGCAGATCGGCCAGCTGAAGGTGCGCAACAACCTGGGTGAAATGGTCCCGCTGGCCACCTTCATCAAGATCAGCGACACCGCAGGTCCCGACCGCGTGATGCACTACAACGGCTTCATCACCGCCGAGATCAACGGCGCCGCCGCACCGGGCTACAGCTCCGGCCAGGCCGAGGCTGCCATCGAGCGCCTGCTCAAGCAGGAACTGCCCAATGGCATGACCTACGAATGGACCGAGCTGACCTACCAGCAGATCCTCGCCGGCAACTCCGCGGTGTACGTGTTCCCGCTCTGCGTGCTGCTCGCCTTCCTCGTGCTGGCCGCGCTGTACGAAAGCTGGGGCCTGCCGCTGGCGGTAATTCTGATCGTGCCGATGACCCTGCTGTCGGCCATCGCGGGCGTGATCCTGTCCGGTGGCGACAACAACATCTTCACCCAGATCGGCCTGATCGTACTGGTGGGCCTGGCGTGCAAGAACGCGATCCTCATCGTCGAGTTCGCCAAGGACAAGCAGGACGAAGGCATGGACCGCCTGAGCGCGGTGCTGGAAGCCTGCCGCCTGCGTCTGCGACCGATCCTGATGACCTCCATCGCCTTCATCATGGGCGTGGTGCCCCTGGTGCTGTCGTCCGGCGCCGGCGCCGAAATGCGCCACGCCATGGGGGTCGCGGTGTTCTCCGGGATGCTCGGCGTGACCTTCTTCGGCCTGCTGCTGACCCCGGTCTTCTATGTGCTGATCCGCCGCTTCATGGAAGCGCGTGAAGCGAAGAAACAGGCGCACCAAGCGCGCATCGCCCAGAACCACGAGGCCCACCAGGCATGA,MNFSQFFIQRPIFAAVLSLIILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVAAPLEQAITGVENMLYMSSQSTADGKMTLTITFALGTDLDNAQVQVQNRVTRTQPKLPEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLDGVGDVQLFGMGDYSLRVWLDPNKVASRNLTATDVVAAIREQNRQVAAGALGAPPSPSDTSFQLSINTQGRLVTEEEFENIIIRSGPDGEITRLKDIARVELGSSQYALRSLLDNQPAVAIPIFQRPGSNAIAISNLVREKMAELKKDFPQGVDYSIVYDPTIFVRGSIEAVVHTLFEALILVVLVVVLFLQTWRASIIPLAAVPVSLIGTFAVMHAFGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLTPVEATKRAMKEVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALSAVLLKGHHEPKDRFSVLLDKLLGGWLFRPFNRFFDRASHGYVGTVTRVLRGSSIALLLYAGLIGLTYLGFSSTPTGFVPQQDKQYLVAFAQLPDAATLDRTEAVIKRMSEIAGKHPGIEHTVSFPGLSINGFTNSPNSGIVFTPLKDFSERKGPGMSANEIAAELNKQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNAGYEELYAQTQNILNKARALPELNPMSVFTSYQVNVPQVDAAIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQGEQQFRLEPEQIGQLKVRNNLGEMVPLATFIKISDTAGPDRVMHYNGFITAEINGAAAPGYSSGQAEAAIERLLKQELPNGMTYEWTELTYQQILAGNSAVYVFPLCVLLAFLVLAALYESWGLPLAVILIVPMTLLSAIAGVILSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQDEGMDRLSAVLEACRLRLRPILMTSIAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGMLGVTFFGLLLTPVFYVLIRRFMEAREAKKQAHQARIAQNHEAHQA,MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH,100.66,gnl|BL_ORD_ID|133|hsp_num:0,153,,,0,3174,tetracycline
969,tcs_072017_12,NODE_142_length_13559_cov_12.952328_12 # 10174 # 11268 # 1 # ID=142_12;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.668,NODE_142_length_13559_cov_12.952328_12,10174,11268,+,Strict,250,258.5,vanG,38.23,3002909,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,glycopeptide resistance gene cluster; Van ligase,ATGGGCAAGGTGCGCGTTGGGGTGATTTTCGGTGGGCGTTCGGCGGAGCACGAGGTGTCCCTGCAATCGGCGAAAAACATCGTCGACGCGCTGGACCGCGAGCGTTTCGAACCGGTGCTGATCGGCATCGACAAGGAAGGCCGCTGGCACCTCAACGATGCCTCCGACTACCTGCTCAACCAGGAGAACCCGGCGCTGATCGCCCTCAACCGCTCCAACCGCGAGCTGGCCGTGGTGCCGGGCAAGGCCGAGCAGCAGCTGGTGGAAACCGGCAGCCGCCAGTTGCTCGACCATGTCGATGTGATCTTCCCCATCGTTCACGGCACCCAGGGCGAGGACGGCTGCCTGCAGGGCCTGTTGCGCATGGCCGACATCCCCTTCGTCGGCTCCGACGTGCTGGGCTCGGCCATCTGCATGGACAAGGACGTGAGCAAGCGCCTGCTGCGCGACGCCGGCCTCGCCATCACGCCCTTCCTCACCCTGACCCGCGCCAGCGCCGCGCGCACGCCCTTCGCCGAGGCACAGCGCAAGCTCGGCCTGCCGCTGTTCATCAAACCGGCGAACATGGGCTCCTCGGTGGGTGTGAGCAAGGTCGAGGACGAAGCGCAGTACGACGAAGCGGTTCGCCTGGCGCTGGCCTTCGACGACAAGGTGCTGGTGGAGGCCGCCGTGAAGGGCCGCGAGATTGAGTGCGCGGTACTGGGCAACGAGCAGCCGATCGCCAGCGGCTGCGGCGAGATCGTCGTGGGCAGCGGCTTCTATTCCTACGACAGCAAATACATCGACGAGGACGCGGCCAAGGTCGTGGTGCCCGCCGATATCCCCGCCGAGGCCAGCGAGCGCATCCGCCAGCTCGCCGTGGAAGCCTTCCTCGCCCTGGAGTGCTCGGGGCTGGCGCGGGTCGATGTGTTCCTCACCGACAGCGGCGAGGTGCTGATCAACGAGTTGAACTCGCTGCCCGGCTTTACCCGCATCAGCATGTATCCCAAGCTCTGGCAGGCCGCCGGGATGACCTACAGCGAACTGGTCAGCCGCCTGATCGACCTGGCCCTCGAGCGCCACGCCGCCCGCCGGAACCTGCAGACCAACCGCTGA,MGKVRVGVIFGGRSAEHEVSLQSAKNIVDALDRERFEPVLIGIDKEGRWHLNDASDYLLNQENPALIALNRSNRELAVVPGKAEQQLVETGSRQLLDHVDVIFPIVHGTQGEDGCLQGLLRMADIPFVGSDVLGSAICMDKDVSKRLLRDAGLAITPFLTLTRASAARTPFAEAQRKLGLPLFIKPANMGSSVGVSKVEDEAQYDEAVRLALAFDDKVLVEAAVKGREIECAVLGNEQPIASGCGEIVVGSGFYSYDSKYIDEDAAKVVVPADIPAEASERIRQLAVEAFLALECSGLARVDVFLTDSGEVLINELNSLPGFTRISMYPKLWQAAGMTYSELVSRLIDLALERHAARRNLQTNR,MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE,104.30,gnl|BL_ORD_ID|1066|hsp_num:0,1157,,,0,1047,vancomycin
970,tcs_072017_12,NODE_364_length_5704_cov_18.415154_6 # 5299 # 5703 # 1 # ID=364_6;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.681,NODE_364_length_5704_cov_18.415154_6,5299,5703,+,Strict,200,214.5,Pseudomonas aeruginosa soxR,80.92,3004107,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAAGAATCTTCTTCCTGTTCGATGCACCGCGAGCTGAGCGTCGGCGAGCTGGCCAGGCGCGCCGGCGTGGCCGTGTCCGCGCTGCACTTCTACGAGGCCAAGGGGCTGATTTCCAGCTCGCGCAATGCCGGCAACCAGCGCCGTTACGCCCGCGACACGCTGCGCCGGGTGGCGGTGATCAAGGTGGCGCAACGGGTTGGCATCCCCCTGGGCGAGATCGCCGAGGCGCTGGGCTCGCTGCCCACCGGGCACAACCCGACGGCAGCGGACTGGGCGCGGCTGTCGGCGCGCTGGCGGGACGACCTGAACGAGCGGATCGAGAAATTGCTGCTGCTGCGCGATCAGCTCGATGGCTGTATTGGCTGTGGGTGCCTGTCGATGGAGGCCTGCCCGCTGCGCAAT,MKESSSCSMHRELSVGELARRAGVAVSALHFYEAKGLISSSRNAGNQRRYARDTLRRVAVIKVAQRVGIPLGEIAEALGSLPTGHNPTAADWARLSARWRDDLNERIEKLLLLRDQLDGCIGCGCLSMEACPLRN,MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG,86.54,gnl|BL_ORD_ID|2401|hsp_num:0,2775,,,6,396,tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
971,tcs_072017_12,NODE_452_length_4153_cov_12.306014_3 # 1113 # 1781 # -1 # ID=452_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.650,NODE_452_length_4153_cov_12.306014_3,1113,1781,-,Strict,200,204.1,vanX gene in vanO cluster,47.24,3002954,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanX; glycopeptide resistance gene cluster,ATGAATCGGGCAGGCGCACGGTTCACGCTGCTGCTCTGCCTGCTCGTCAGCCCGGCATTACGCGCCGATCAGCCGGCGCAGGACGGCTTCGTCTATCTCGACCAGGTGCTGAAATCAGCGCGCTATGACGTGCGCTACGCCGGCAGCGACAACTTCGTCGGCGAGCCCATCGACGGCTACCAGAAGGCGCGGATCATCCTCACCCGCCAGGCAGCCACCGCCTTGGCCGCGGTGGAAAAGGACCTCGCCCTCAGCGGTCTGGCGTTGAAAATCTTCGATGGCTATCGCCCGCAGCGCGCGGTGGACGACTTCCGCCGCTGGGCTACCGACCCGCAGGACCTGCGGCAGAAGGCCCGCTATTACCCCGATCTGGACAAGCCCGCGCTGTTCCGCGACGGCTACATCGCCCAGCACTCCGGACATTCGCGCGGCAGTACGGTCGACCTCACGCTGGTCAAGGCACAGTCAGGAGAGGAGTTGGACATGGGCAGCCCGTTCGACTTCTTCGGGCCGATTTCCCATCACGGCACGGCGCTGGTCACGGTGCAGCAGACACGCAACCGCGAAACCCTGCGCCACGGCTTCGAACCGTACAGCGCGGAATGGTGGCACTACACCCTGAAAGCCGAGCCGTTTCCCACGACCTACTTCGACTTCCCGGTGCAGTGA,MNRAGARFTLLLCLLVSPALRADQPAQDGFVYLDQVLKSARYDVRYAGSDNFVGEPIDGYQKARIILTRQAATALAAVEKDLALSGLALKIFDGYRPQRAVDDFRRWATDPQDLRQKARYYPDLDKPALFRDGYIAQHSGHSRGSTVDLTLVKAQSGEELDMGSPFDFFGPISHHGTALVTVQQTRNRETLRHGFEPYSAEWWHYTLKAEPFPTTYFDFPVQ,MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT,109.90,gnl|BL_ORD_ID|1667|hsp_num:0,1699,,,6,603,vancomycin
972,tcs_072017_12,NODE_685_length_1432_cov_12.116892_2 # 1061 # 1393 # 1 # ID=685_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.661,NODE_685_length_1432_cov_12.116892_2,1061,1393,+,Strict,75,76.6,qacG,36.63,3007015,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGCCCGGCTATCTCTACCTCGCCATCGCCATCGTTGCCGAAGTCATCGCCACCGCCTCGCTGAAGTCGGTGAAGGGCCTGTCCACGCCGCTGCCGCTGGTGCTGGTGATCGTCGGCTACGGCATTTCCTTCTGGATGCTGACCCTGGTGGTGCGCAGCATCCCGGTGGGGATCGCCTACGCCATCTGGGCAGGGCTGGGCATCGTGCTGGTCAGCGTGGCGGCGCTGGTGCTCTACCAGCAGAAGCTCGATACCGCCGCCCTGCTCGGCATGGGCCTGATCGTCAGCGGGGTCGTGGTGATCCAGCTGTTCTCCGGCAACGCCGGCCACTGA,MPGYLYLAIAIVAEVIATASLKSVKGLSTPLPLVLVIVGYGISFWMLTLVVRSIPVGIAYAIWAGLGIVLVSVAALVLYQQKLDTAALLGMGLIVSGVVVIQLFSGNAGH,MHYLYLFISIATEIIGTSFLKTSEGFTKLWPTLGTLLSFGICFYFLSLTIKFLPLNITYATWAGLGLVLTTIISVIVFKENVNLISIISIGLIVIGVVLLNVFGESH,102.80,gnl|BL_ORD_ID|4669|hsp_num:0,5731,,,6,309,benzalkonium chloride
1944,tcs_502,NODE_3_length_41194_cov_7.485097_33 # 36680 # 38113 # 1 # ID=3_33;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.685,NODE_3_length_41194_cov_7.485097_33,36680,38113,+,Perfect,900,918.7,basS,100.0,3003583,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,ATGTCCCGTGCCGCCGTCCCCTCCGTCCGCCGGCGCCTGCTGGTCAACCTGCTGGTCGGCTTCGTGCTGTGCTGGCTGAGCGTGGCGGCGCTGACCTACCACCTCTCGCTGAAGCAGGTGAACCGCCTGTTCGACGACGACATGGTGGACTTCGGCGAAGCCGCCCTGCGCCTGCTCGACCTTGCCACCGAAGACCAGGCCGGCGAGGACGGCTCCATCACCGAGATCATCGAACGCAGCCGCGAAGCGATCCAGGGTCTGCCCCTGCTGCGCCGCGAAAGCGCCCTCGGCTACGCCCTGTGGCGCGACGGCCAGCCGCTGCTGTCGAGCCTCAACCTGCCGCCGGAGATCACGGCCCAGGGCCCCGGCTTCAGCACCGTGGAAGCCCAGGGCACCCACTGGCGGGTGCTCCAGCTGAATATCGACGGCTTCCAGATCTGGATCAGCGAAAACCTGATCTACCGCCAGCACACCATGAACCTGCTGCTGTTCTACTCGCTGTTCCCACTGCTGCTGGCGCTGCCGTTGCTCGGCGGCCTGGTCTGGTTCGGCGTTGCCCGCGGCCTGGCGCCGCTACGCGAAGTGCAGGCCGAGGTCCAGCAGCGCTCCGCGCGACACCTGCAGCCGATCGCGGTGGAAGCGGTGCCGCTGGAGATCCGCGGCCTCATCGACGAACTCAACCTCCTGCTGGAGCGTCTGCGCACCGCCCTCGAGGCCGAACGCCGACTGACCAGCGACGCCGCCCATGAAATCCGCACGCCACTGGCCAGCCTGCGCACCCATGCCCAGGTCGCGCTGCGTTCGGAAGACCCCAAGGCCCACGCCCGCGGCCTGCTGCAAGTCAGTCGCAGCGTCGAGCGGATCAGCACCTTGATGGAGCAGATCCTGCTCCTCGCCCGCCTCGACGGCGACGCCCTGCTGGAGCAATTCCACCCGGTCAACCTCGCCACCCTGGCCGAAGACGTACTCTCCGAACTGGCGCGCCAGGCCATCGACAAGGACATCGAGCTGTCGTTGCACCAGGAGACCGTGCACGTGATGGGCATCGACCTGTGGCTGAAGGCGATGGTCGGCAACCTGGTGGGCAACGCCCTGCGCTACACACCGGCCGGGGGCCAGGTCGAGATCCGCGTCGAGAATCGCGCCCAGCACGCCGTGCTGCGGGTGCGCGACAACGGCCCCGGGGTCGCCCTGGAAGAGCAGCAGGCGATCTTCACCCGCTTCTACCGCAGCCCCGCCACCAGCAGCGGCGAGGGCAGCGGCCTGGGCCTGCCGATCGTCAAGCGCATCGTCGAACTGCACTTCGGCAGTATCGGCCTGGGCAAGGGACTGGAGGGCAAAGGGCTGGAAGTGCAGGTGTTCCTGCCGAAGACCCAGCCGGACGCGACGCGGCCGCCGGCCAGAGGTCCGGACAGCGGGCGGTCACATATCTGA,MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI,MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI,100.00,gnl|BL_ORD_ID|2353|hsp_num:0,249,,,0,1431,polymyxin B
1945,tcs_502,NODE_6_length_35814_cov_6.577002_4 # 2519 # 3967 # -1 # ID=6_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.687,NODE_6_length_35814_cov_6.577002_4,2519,3967,-,Strict,850,914.4,OpmH,99.79,3003682,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGCGCAGACTCTCCCTGGCGGCCGCCGTGGCCGCTGCTACCGGTGTCGCCTGGGCCGCCCAGCCGACCCCGCTGCCGACCAAGACCGACCTGATCAGCGTCTACAAGGAAGCCGTCGACAACAACGCCGACCTCGCCGCCGCCCAGGCCGACTACCTGGCGCGCAAGGAAGTGGTGCCCCAGGCCCGCGCCGGCCTGCTGCCGCAACTCGGCGCCGGCGCCCGCGTCGGAGACACCCGGATCGCATTCGACGAGCGTCCGGCGACCGTCAAGCGCAACAGCCAGGTCGTCCAGGCCACCCTCAGCCAGCCGTTGTTCCGCGCCGACCGCTGGTTCCAGTGGCAGGCCGCCAAGGAAACCAGCGACCAGGCCCGGCTGGAATTCTCCGCGACCCAGCAGGACCTGATCCTGCGCAGCGCCGAGACCTACTTCACGGTGCTCCGCGCCCAGGACAACCTGGCCACCAGCAAGGCCGAGGAAGCCGCCTTCAAGCGCCAGCTGGACCAGGCCAACGAGCGCTTCGACGTGGGCCTTTCCGACAAGACCGACGTGCTCGAGGCCCAGGCCAGCTACGACACCGCCCGCGCCAACCGGTTGATCGCCGAACAGCGCGTGGACGATGCCTTCCAGGCCCTGGTGACCCTGACCAACCGCGACTACAGCGCCATCGAGGGCATGCGCCACACCCTGCCGGTGGTGCCGCCGGCGCCGAACGACGCCAAGGCCTGGGTCGACACCGCGGTGCAGCAGAACCTGCGCCTGCTGGCCAGCAACTACGCGGTCAACGCCGCCGAGGAAACCCTCCGCCAGCGCAAGGCCGGGCACCTGCCGACCCTCGATGCCGTGGCCCAGTACCAGAAGGGCGACAACGACGCCCTCGGCTTCGCCAACAGCGCCGCCAATCCGCTGGTGCACTATGGCAAGTATGTCGACGAGCGCAGCATTGGCCTGGAACTGAACATCCCGATCTACAGCGGCGGCCTGACCTCCTCCCAGGTCCGCGAGTCCTACCAGCGCCTCAACCAGAGCGAGCAATCCCGCGAAGGCCAGCGCCGCCAGGTGGTGCAGGACACCCGCAACCTGCACCGCGCGGTGAATACCGACGTCGAGCAGGTCCAGGCGCGGCGCCAGGCGATCATCTCCAACCAGAGTTCGCTGGAAGCCACCGAGATCGGCTACCAGGTCGGCACCCGCAACATCGTCGACGTGCTCAACGCCCAGCGCCAGCTGTACGCCGCCGTGCGCGACTACAACAACAGCCGCTACGACTACATCCTCGATACCCTGCGCCTGAAGCAGGCGGCCGGCACCCTCAGCCCGGCCGACCTGGAGGCGCTCAGCGCCTACCTGAAGCAGGACTACGATCCGGACAAGGACTTCCTCCCGCCGGACCTGGCCAAGGCCGCCTCCGAGCAGTTACAGAGCAAGCCGCGCCAGCAGTACTAG,MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAASEQLQSKPRQQY,MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY,100.00,gnl|BL_ORD_ID|1998|hsp_num:0,2195,,,0,1446,triclosan
1946,tcs_502,NODE_28_length_22311_cov_6.456288_16 # 20551 # 21258 # 1 # ID=28_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.638,NODE_28_length_22311_cov_6.456288_16,20551,21258,+,Perfect,400,472.2,ParR,100.0,3005068,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr),ATGGACTGCCCTACCCTCAGCAAGGTATTGCTCGTCGAAGACGACCAGAAGCTCGCCCGCCTGATCGCCAGTTTCCTTTCCCAGCATGGTTTCGAAGTGCGCCAGGTGCATCGCGGTGATGCCGCGTTCGCCGCCTTCCTCGACTTCAAACCGCAAGTGGTGGTTCTCGACCTCATGCTCCCCGGACAGAATGGTCTGCAGGTGTGCCGGGAGATCCGCCGGGTCGCGAACCTGCCGATCCTCATACTCACCGCCCAGGAGGACGATCTCGATCACATCCTCGGCCTGGAGTCCGGCGCCGACGACTACGTGATCAAGCCGATCGAGCCACCGGTGCTGCTCGCCCGCCTGCGCGCCCTGATGCGCCGGCACGCGCCCCTTCCCGCCTCCCCGGAAAGCCTGACATTCGGCAAGCTGAACATCGACCGACGGCGGCGCGAAGCGGAACTCGAAGGCCTCGGCATCGAACTGACCACGATGGAGTTCGAGCTGCTCTGGCTGCTGGCCAGCCAGGCAGGGGAAATACTCTCCCGCGACGAGATCCTCAACCAGATCCGCGGCATCGGCTTCGACGGCCTGAACCGCAGCGTCGACGTCTGCATCAGCAAGCTGCGCAATAAACTGAAGGACAATCCGCGCGAGCCGGTCCGGATCAAGACCGTCTGGGGCAAGGGCTACCTGTTCAACCCGCTGGGCTGGGAGCTCTGA,MDCPTLSKVLLVEDDQKLARLIASFLSQHGFEVRQVHRGDAAFAAFLDFKPQVVVLDLMLPGQNGLQVCREIRRVANLPILILTAQEDDLDHILGLESGADDYVIKPIEPPVLLARLRALMRRHAPLPASPESLTFGKLNIDRRRREAELEGLGIELTTMEFELLWLLASQAGEILSRDEILNQIRGIGFDGLNRSVDVCISKLRNKLKDNPREPVRIKTVWGKGYLFNPLGWEL,MDCPTLSKVLLVEDDQKLARLIASFLSQHGFEVRQVHRGDAAFAAFLDFKPQVVVLDLMLPGQNGLQVCREIRRVANLPILILTAQEDDLDHILGLESGADDYVIKPIEPPVLLARLRALMRRHAPLPASPESLTFGKLNIDRRRREAELEGLGIELTTMEFELLWLLASQAGEILSRDEILNQIRGIGFDGLNRSVDVCISKLRNKLKDNPREPVRIKTVWGKGYLFNPLGWEL,100.00,gnl|BL_ORD_ID|2813|hsp_num:0,3806,,,0,705,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
1947,tcs_502,NODE_28_length_22311_cov_6.456288_17 # 21259 # 22311 # 1 # ID=28_17;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.649,NODE_28_length_22311_cov_6.456288_17 ,21259,22311,+,Strict,800,666.8,ParS,100.0,3005067,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr),ATGCTGCGCCTGTTCCTGCGCCTCTACCTGCTACTGGCCCTGGGGTTCGCCGCCGCGATCTTCGTGGTCGACCATGTCATCGACGCGTTCTACGACAGCATCGTCGAGAACTATCACCGCGACGCCGTTCGCGGCCAGGCCTATTCGCTGGTGGAAAAGCTGGCCCCGCTGGACCAGGCCGGACGCCAGCGACAGCTCGAAGACTGGCGTCCCCACTACGGGCTCGAGCTGAGCCTGACGGATGCCAGGCAGGCGAAGCTGACGCAGGAAGAGCAGGCCCTCCTCGACAAGAACCTGCTGGTGGTACGCGAGGACTTCACGGAATTCATCAGCCGCATCGACGCGGGCCCGCAGCTGCTCGACATCAAACTGCCGCCGGAACCCTCGCTGACCCCACTATTCACCGTGCTGGCCTACATCCTGCTCGGCGTGCTGGTCGGCATCGCCCTGCTGGTATGGGTCCGCCCGCACTGGCGCGACCTCGAGACCCTGCGCCTGGCCGCGCAACGCTTCGGCGACGGCGACCTGTCATCGCGCACGCGCATTTTCCGACGCTCCGACATCCGCACCCTGGCCCAGCACTTCAACCAGATGGCCGACCGCATCGAAAGCCTGATCAGCAACCAGCGTGAACTGACCAACGCGGTATCCCACGAATTGCGCACGCCGATCTCCCGCCTGTCCTTCGAACTCGAGCAATTGAACAAGCAGGTCGACGCCGAAGTACGCCACGACCTGATAGAGGACATGCGCGCCGATCTCGGCGAACTGGAGGAAATGGTCTCCGAACTGCTGACCTACGCCCGCCTGGAGCACGGCAACGTCGGGAGCCACCGGGAAATCGTCGACGCCGCGAGCTGGCTGGATAGCGTCGTCGCCGACGTCGCCCTGGAAGCCGAAGCCGCCGGAGTCACCTGCGAGATCAGCGCCTGCCAGGTCGAACAGATCCGCATCGAGCCTCGCTTCATGGCGCGCGCAGTGATCAACCTGCTGCGCAACGCCATTCGCCACGCACACTCGCGCGTCGAAATCGCCCTCCTCGATCAAGGCGAC,MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGD,MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR,82.01,gnl|BL_ORD_ID|2812|hsp_num:0,3805,True,loose hit with at least 95 percent identity pushed strict,0,1053,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
1948,tcs_502,NODE_32_length_21094_cov_7.120152_8 # 10419 # 11225 # -1 # ID=32_8;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.710,NODE_32_length_21094_cov_7.120152_8,10419,11225,-,Strict,500,543.9,APH(3')-IIb,99.25,3002645,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic inactivation,APH(3'),ATGCATGATGCAGCCACCTCCATGCCGCCGCAGGCTCCCTCAACCTGGGCCGACTACCTTGCCGGCTACCGCTGGCGAGGGCAGGGCGAAGGATGTTCCGCGGCCACGGTCCACCGCCTGGAGGCTGCGCGGCGGCCGACCCTGTTCGTCAAGCAGGAAGTGCTGTCCGCACATGCCGAGCTGCCCGCCGAAATCGCCCGCCTGCGCTGGCTGCACGGTGCCGGCATCGATTGCCCGCAGGTGCTGAACGAAACCCAGAGCGACGGCCGGCAATGGCTGCTGATGAGCGCAGTGCCGGGGGACACGCTGTCCGCGCTGGCGCAGCGCGGCGAGCTGGAGCCCGAGCGCCTGGTGCGCCTGGTGGCCGCCGCCCTGCGCCGGCTGCACGATCTCGATCCGGCCGCCTGTCCCTTCGACCATCGCCTGGAACGGCGTCTGGACACCGTGCGCCAGCGGGTCGAGGCCGGGCTGGTGGACGAGGCGGACTTCGACGACGACCATCGCGGTCGCAGCGCCACGGAGCTGTACCGCCTGCTGCTCGACCGGCGTCCGGCGGTCGAAGACCTGGTGGTCGCCCATGGCGACGCCTGCCTGCCAAATCTGCTGGCGGAGGGGCGGCGCTTCAGCGGCTTCATCGATTGCGGGCGGCTCGGCGTCGCCGACCGGCACCAGGACCTGGCCCTGGCCGCGCGGGACATCGAGGCCGAACTCGGCGCGGCCTGGGCCGAGGCCTTCCTCGTCGAATACGGCGGCGATATCGACGGCGAACGGCTGGCGTACTTCAGGCTATTGGACGAGTTCTTCTAG,MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAELPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRLVAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAWAEAFLVEYGGDIDGERLAYFRLLDEFF,MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAELPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRLVAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAWAEAFLVEYGGDIDGERLAYFRLLDEFF,100.00,gnl|BL_ORD_ID|873|hsp_num:0,954,,,0,804,neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
1949,tcs_502,NODE_33_length_21022_cov_5.201782_12 # 10009 # 10479 # 1 # ID=33_12;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.694,NODE_33_length_21022_cov_5.201782_12,10009,10479,+,Strict,200,309.7,Pseudomonas aeruginosa soxR,99.36,3004107,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic target alteration; antibiotic efflux,ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGAATTCCTGCGCATCTCGTGAACTGAGCGTCGGCGAACTGGCCAGGCGTGCCGGCGTGGCGGTCTCCGCCCTGCATTTCTACGAAACCAAGGGGCTGATCAGCAGCCAGCGCAACGCCGGCAACCAGCGGCGCTTCAGTCGCGAGACGCTACGCCGGGTGGTGGTGATCAAGGTCGCCCAGCGGGTCGGCATTCCCCTCGCGGAGATCGCTCGCGCCCTGCAGACCCTGCCGGCGGGGCGTAGCCCTACCGCGGCGGACTGGGCGCGCCTGTCGGCGCAGTGGAAGGAGGATCTCACCGAGCGCATCGACAAGCTGCTGCTGTTGCGCGACCAACTGGACGGCTGCATCGGTTGCGGCTGCCTGTCGCTCCAGGCCTGCCCGTTGCGCAACCCCGGCGACCAGCTTTCCGCCGAGGGGCCGGGAGCGCACTGGCTGGACGCCGAGGGCCGCGAGCACGACGGCTAG,MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPTAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG,MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG,100.00,gnl|BL_ORD_ID|2401|hsp_num:0,2775,,,0,468,tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
1950,tcs_502,NODE_44_length_19018_cov_5.934910_13 # 10709 # 10894 # -1 # ID=44_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.559,NODE_44_length_19018_cov_5.934910_13,10709,10894,-,Perfect,100,118.2,rsmA,100.0,3005069,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCTGATTCTGACTCGTCGGGTCGGAGAGACCCTGATGGTAGGTGACGACGTCACCGTGACGGTACTGGGTGTCAAAGGGAACCAGGTGCGCATCGGCGTCAACGCGCCGAAGGAAGTCGCCGTACACCGGGAGGAAATTTACCAGCGCATCCAGAAAGAGAAAGATCAAGAGCCAAACCATTAA,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH,100.00,gnl|BL_ORD_ID|2814|hsp_num:0,3807,,,0,183,trimethoprim; chloramphenicol
1951,tcs_502,NODE_45_length_18539_cov_6.165478_1 # 1 # 723 # -1 # ID=45_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.697,NODE_45_length_18539_cov_6.165478_1 ,1,723,-,Strict,800,452.6,OprN,100.0,3000805,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGATTCACGCGCAGTCGATCCGGAGCGGGCTCGCGTCCGCCCTGGGTCTGTTCAGTCTGCTGGCGCTCAGCGCCTGCACGGTGGGTCCGGACTACCGGACCCCCGACACCGCGGCGGCGAAGATCGACGCCACGGCGAGCAAGCCCTACGACCGCAGCCGCTTCGAAAGCCTGTGGTGGAAACAGTTCGACGATCCGACCCTGAACCAGTTGGTCGAACAGTCGCTGAGCGGCAACCGCGACCTGCGCGTGGCCTTCGCCCGCCTGCGCGCCGCCCGCGCCCTGCGCGACGACGTGGCCAACGATCGCTTCCCGGTGGTCACCAGCCGCGCCAGCGCCGACATCGGCAAGGGCCAGCAACCGGGAGTGACCGAGGACCGGGTCAACAGCGAGCGCTACGACCTTGGCCTGGATAGCGCCTGGGAGCTTGACCTGTTCGGGCGCATCCGCCGTCAGCTGGAGTCCAGCGACGCCCTCAGCGAAGCAGCCGAGGCCGACCTGCAGCAACTGCAGGTCAGCCTGATCGCCGAGCTGGTGGACGCCTACGGCCAGCTGCGCGGCGCGCAACTGCGCGAGAAGATTGCCCTGAGCAACCTGGAGAACCAGAAGGAGTCGCGCCAGCTCACCGAGCAACTGCGCGACGCCGGGGTCGGTGCCGAACTCGACGTACTGCGCGCCGATGCGCGCCTGGCGGCCACCGCCGCCAGCGTGCCGCAACTGCAG,MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQ,MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA,51.06,gnl|BL_ORD_ID|293|hsp_num:0,172,True,loose hit with at least 95 percent identity pushed strict,0,723,ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
1952,tcs_502,NODE_45_length_18539_cov_6.165478_2 # 720 # 3908 # -1 # ID=45_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.657,NODE_45_length_18539_cov_6.165478_2,720,3908,-,Perfect,2110,2017.3,MexF,100.0,3000804,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAATTTCTCCCAATTCTTCATCCAGCGGCCGATCTTCGCCGCGGTGCTGTCGCTGCTGATCCTGATTGGCGGCGCCATCTCCCTGTTCCAGCTACCCATCAGCGAATACCCGGAAGTGGTGCCGCCGACCGTCGTGGTCCGCGCCAACTTCCCCGGCGCCAACCCGAAAGTCATCGGCGAGACCGTCGCCTCTCCCCTTGAACAGGCGATCACCGGGGTGGAGAACATGCTCTACATGTCCTCCCAGTCGACCTCCGACGGCAAGCTGACCCTGACCATCACCTTCGCCCTCGGCACCGACCTGGACAACGCCCAGGTGCAGGTGCAGAACCGCGTCACCCGGACCGAGCCGAAGCTCCCGGAAGAAGTGACCCGGCTCGGCATCACCGTCGACAAGGCCTCGCCCGACCTGACCATGGTCGTGCACCTGACCTCGCCGGATAACCGCTACGACATGCTCTACCTGTCGAACTACGCGGTGCTCAACGTGAAGGACGAACTGGCCCGCCTCGACGGCGTCGGCGACGTCCAGTTGTTCGGCCTCGGTGACTATTCGCTGCGCGTCTGGCTGGATCCGAACAAGGTCGCCTCGCGCAACCTCACCGCCACCGACGTGGTCAACGCCATCCGCGAGCAGAACCGCCAGGTCGCCGCCGGCACCCTGGGCGCGCCGCCGGCGCCGAGCGACACCAGCTTCCAGTTGTCGATCAACACCCAGGGTCGCCTGGTCACCGAGGAAGAGTTCGAGAACATCATCATCCGCGCCGGCGCCAACGGCGAGATCACCCGTCTGCGCGACATCGCCCGGGTCGAGCTGGGCTCCAACCAGTACGCCCTGCGTTCGCTGCTGAACAACAAGCCGGCGGTGGCGATCCCGATCTTCCAGCGTCCCGGCTCGAACGCCATCGAGATCTCCAACCTGGTGCGGGAGAAGATGGCCGAGCTGAAGCACAGCTTCCCGCAGGGCATGGACTACTCCATCGTCTACGACCCGACCATCTTCGTCCGCGGCTCCATCGAGGCGGTGGTGCACACCCTGTTCGAAGCCCTGGTGCTGGTGGTGCTGGTGGTGATCCTGTTCCTGCAGACCTGGCGCGCCTCGATCATCCCGCTGGCCGCGGTGCCGGTGTCGCTGATCGGCACCTTCGCGGTGATGCACATGCTCGGCTTCTCGCTCAACGCGCTGTCGCTGTTCGGCCTGGTGCTGGCCATCGGCATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGCAACATCGGCCTCGGCCTCAAGCCGGTGGAAGCCACCAAGCGTGCCATGCGCGAAGTGACCGGGCCGATCATCGCCACGGCGCTGGTGCTCTGCGCGGTGTTCATCCCGACCGCGTTCATCTCCGGCCTCACCGGGCAGTTCTACCGCCAGTTCGCCCTGACCATCGCGATCTCCACGGTGATCTCGGCGTTCAACTCGCTGACCCTGTCGCCAGCGCTGGCGGCGGTCCTGCTCAAGGGCCACCACGAGCCGAAGGACCGCTTCTCGGTGTTCCTCGACAAGCTCCTCGGCAGTTGGCTGTTCCGTCCGTTCAACCGTTTCTTCGACCGCGCCAGCCATGGCTACGTCGGCACGGTGAACCGGGTCCTGCGCGGCAGCTCGATCGCCCTGCTGGTCTACGGCGGGCTGATGGTGCTGACCTACTTCGGCTTCTCCAGCACGCCGACCGGTTTCGTCCCGCAGCAGGACAAGCAGTACCTGGTGGCCTTCGCCCAGTTGCCCGACGCGGCCAGCCTGGACCGTACCGAGGCGGTGATCAAGCAGATGTCCGAGATCGCCCTGGCGCAGCCCGGCGTGGCGGACTCGGTGGCCTTCCCCGGCCTGTCGATCAACGGCTTCACCAACAGCCCGAACAGCGGCATCGTGTTCACCCCGCTGAAGCCGTTCGACGAGCGCAAGGACCCGAGCCAGTCGGCCGGTGCCATCGCCGCCGCGCTGAACGCCAAGTACGCCGACATCCAGGACGCCTACATCGCGATCTTCCCGCCGCCGCCGGTACAGGGGCTGGGGACCATCGGCGGCTTCCGCCTGCAGATCGAGGACCGTGGCAACCAGGGCTACGAGGAGCTGTTCAAGCAGACCCAGAACATCATCACCAAGGCCCGTGCGCTGCCTGAGCTGGAACCCAGCTCGGTGTTCTCCAGCTACCAGGTCAACGTGCCGCAGATCGACGCCGACATCGACCGCGAGAAGGCCAAGACCCACGGCGTGGCGATCAGCGACATCTTCGACACCCTGCAGGTCTACCTCGGCTCGCTGTACGCGAACGACTTCAACCGCTTCGGCCGTACCTATCAGGTCAACGTCCAGGCCGAGCAGCAGTTCCGCCTCGAACCCGAGCAGATCGGCCAGCTGAAGGTGCGCAACAACCTCGGCGAGATGGTCCCGCTGGCGTCCTTCATCAAGGTCAGCGACACCTCCGGTCCGGACCGTGTGATGCACTACAACGGCTTCATCACCGCCGAACTCAACGGCGCCCCGGCCGCGGGCTACAGCTCCGGCCAGGCGCAGGCGGCGATCGAGAAGCTGCTGAAGGAGGAACTGCCCAACGGCATGACCTACGAGTGGACCGAGCTGACCTACCAGCAGATCCTCGCCGGCAATACCGCGCTGTTCGTCTTCCCGCTCTGCGTGCTGCTGGCCTTCCTCGTGCTGGCCGCCCAGTACGAGAGCTGGAGCCTGCCGCTGGCGGTGATCCTGATCGTGCCGATGACCCTGCTGTCGGCGATCACCGGGGTGATCCTGGCCGGCAGCGACAACAACATCTTTACCCAGATCGGCCTGATCGTTCTGGTGGGGCTGGCGTGCAAGAACGCGATCCTGATCGTCGAGTTCGCCAAGGACAAGCAGGAGGAAGGCATGGACCGCGTCGCCGCGGTGCTGGAAGCCTGCCGCCTGCGCCTGCGGCCGATCCTGATGACGTCCATCGCCTTCATCATGGGCGTGGTGCCGCTGGTGATCTCCACCGGCGCCGGCGCCGAGATGCGCCATGCGATGGGCGTGGCGGTGTTCTCCGGGATGATCGGGGTGACCTTCTTCGGCCTGCTGCTGACGCCGGTGTTCTACGTCCTCATCCGCCGCTTCGTGGAGAACCGCGAAGCGCGCCGCGCCGCCAACGACAAAGGCCTGCCAGAGGTGCATGCATGA,MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA,MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA,100.00,gnl|BL_ORD_ID|2356|hsp_num:0,1300,,,0,3186,ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
1953,tcs_502,NODE_45_length_18539_cov_6.165478_3 # 3930 # 5174 # -1 # ID=45_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.692,NODE_45_length_18539_cov_6.165478_3,3930,5174,-,Perfect,750,786.6,MexE,100.0,3000803,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGAACAGTCATCCCACTTCTCCTGGCGCTACCCCCTCGCACTCGCGGCCGTACTGGTCCTGAGCGCCTGCGGCAAGGCCCCGGAAACCACCCAAGGCATGGCGGCGCCCAAGGTCAGCGTCGCCGAAGTCATCGAACAACCGCTGAACGAGTGGGACGAATTCACCGGCCGCCTGGAGGCCCCGGAGTCGGTGGAGCTGCGCCCGCGGGTGTCGGGCTACATCGACCGCGTGGCCTTCCATGAAGGCGCACTGGTGAAGAAAGGCGACCTGCTGTTCCAGATCGACCCGCGCCCGTTCGAGGCCGAGGTCAAGCGCCTCGAAGCCCAGCTGCAACAGGCCCGCGCGGCCCAGGCGCGGAGCGTCAACGAAGCCCAGCGCGGCGAACGCCTGCGCGCCAGCAACGCGATCTCCGCGGAACTCGCCGACGCCCGCACCACCGCCGCCCAGGAAGCCAAGGCGGCGGTCGCCGCGACCCAGGCGCAACTGGACGCGGCGCGCCTGAACCTGAGCTTCACCCGGATCACCGCGCCGATCGACGGTCGCGTCAGCCGCGCCGAGGTCACCGCCGGCAACCTGGTCAACTCCGGGGAAACCCTGCTCACCACCCTGGTCAGCACCGACAAGGTCTACGCCTACTTCGACGCCGACGAACGCGTGTTCCTCAAGTACGTCGAGCTGGCCCGCCAGGCCGGTCGCGACACGCGCAGCGAGAGCCCGGTCTACCTCGGCCTGAGCAGCGAGGACGGCAACCCGCACCTGGGCCGGCTGGACTTCCTCGACAACCAGGTCAACCCGCGTACCGGCACCATCCGCGGCCGCGCCGTGTTCGACAACGCCAAGGGCGAGTTCACCCCGGGCCTCTACGTGCGCCTGAAGCTGGTCGGCAGCAAGACCTACGCCGCCACCCTGATCAAGGACGAAGCGGTCGGCACCGACCTGGGCAAGAAGTTCGTGCTGGTCCTGGATGGCGACAACAAGACCGTCTACCGCACCGTCGAGATGGGACCGAAGCTGGAGGGCCTGCGCATCGTCCGCAGCGGCCTGAGCAAGGGCGACCGGATCGTCGTGAATGGCCTGCAGCGGGTCCGCCCGGGCATGCAGGTGGATCCGCAGAAGGTCGAGATGGCCAGCGCCGACACCCTGGCCACCCTCGCGCGCCTGCGGCAGTCGGTCGGCGACAGCGAACCACCGAAGGTGGCGGCGTCCAAGGACAACGCCACTCGCAACGAGCCGCGCGGCTGA,MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG,MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG,100.00,gnl|BL_ORD_ID|1036|hsp_num:0,1067,,,0,1242,ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
1954,tcs_502,NODE_63_length_15627_cov_7.444544_5 # 3959 # 4297 # -1 # ID=63_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.608,NODE_63_length_15627_cov_7.444544_5,3959,4297,-,Perfect,200,218.0,YajC,100.0,3005040,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCTTTCTAATTCCCGCTGCCTACGCCGACGCAGCCGCTCCGGCAGCCGCTGGCCCGGCCGGCACCGGTTTCGAGTGGGTCTTCCTGGTTGGTTTCCTGGTCATCTTCTACCTGATGATCTGGCGTCCCCAGGCCAAGCGCGCCAAGGAACACAAGAACCTGCTGGGCAACCTGCAAAAAGGTGACGAAGTCGTCACTTCCGGTGGTATCGCCGGCAAGGTGACCAAGGTCGCCGACGATTTCGTCGTCGTCGAGGTTTCCGACAACGTCGAGCTGAAGTTCCAGAAGGCCGCGATTGCCGCGACCCTGCCGAAAGGCACCCTGAAAGCGATCTGA,MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI,100.00,gnl|BL_ORD_ID|2793|hsp_num:0,3783,,,0,336,vancomycin; tigecycline; tetracycline; linezolid; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
1955,tcs_502,NODE_64_length_15611_cov_6.713259_4 # 5799 # 6863 # 1 # ID=64_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.718,NODE_64_length_15611_cov_6.713259_4,5700,6864,+,Perfect,600,657.5,MexC,100.0,3000800,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTGATTTGCGTGCAATAGGAAGGATCGGGGCGTTGGCTATGGCCATCGCGTTGGCGGGTTGTGGGCCGGCGGAAGAGCGACAGGAGGCCGCCGAAATGGTGTTGCCGGTGGAGGTCCTGACGGTGCAGGCCGAGCCCCTGGCGCTGAGTTCGGAACTGCCTGGGCGGATCGAACCGGTGCGGGTCGCCGAGGTGCGCGCGCGGGTGGCCGGCATCGTCGTGCGGAAGCGCTTCGAGGAGGGCGCCGACGTCAAGGCTGGCGACCTGCTGTTCCAGATCGATCCGGCACCGCTGAAGGCTGCGGTGTCGCGCGCCGAAGGTGAGCTGGCGCGGAACCGCGCGGTGCTGTTCGAGGCGCAGGCGCGGGTGCGTCGCTACGAGCCGCTGGTGAAGATCCAGGCGGTCAGCCAGCAGGACTTCGATACCGCCACCGCCGACCTGCGCAGCGCCGAGGCGGCGACCCGCTCGGCCCAGGCCGACCTGGAGACCGCGCGCCTGAACCTCGGCTACGCCTCGGTCACTGCGCCGATCTCCGGGCGCATCGGCCGCGCGCTGGTGACCGAGGGCGCGCTGGTCGGGCAGGGCGAGGCGACGCTGATGGCGCGCATCCAGCAGCTCGATCCGATCTATGCGGATTTCACCCAGACCGCGGCCGAGGCCCTGCGCCTGCGCGACGCCCTGAAGAAAGGCACCTTGGCCGCCGGCGACAGCCAGGCGCTGACCCTGCGCGTCGAAGGGACGCCCTACGAGCGCCAGGGCGCGTTGCAGTTCGCCGACGTGGCGGTGGATCGCGGTACCGGCCAGATCGCCCTGCGCGGCAAGTTCGCCAACCCCGACGGGGTCCTGCTGCCGGGCATGTACGTGCGCGTACGTACGCCCCAGGGCATCGACAACCAGGCGATCCTGGTGCCGCAACGGGCCGTGCACCGCTCCAGCGACGGCAGCGCCCAGGTGATGGTGGTGGGCGCCGACGAGCGCGCCGAGTCGCGCAGCGTCGGTACCGGCGTCATGCAGGGTTCGCGCTGGCAGATCACCGAGGGCCTGGAGCCGGGTGACCGGGTCATAGTCGGCGGCCTGGCTGCGGTGCAGCCGGGGGTGAAGATCGTGCCGAAGCCGGATGGTGCCCAGGCGCAAGCCCAGTCACCTGCGCCGCAACAGTAA,MADLRAIGRIGALAMAIALAGCGPAEERQEAAEMVLPVEVLTVQAEPLALSSELPGRIEPVRVAEVRARVAGIVVRKRFEEGADVKAGDLLFQIDPAPLKAAVSRAEGELARNRAVLFEAQARVRRYEPLVKIQAVSQQDFDTATADLRSAEAATRSAQADLETARLNLGYASVTAPISGRIGRALVTEGALVGQGEATLMARIQQLDPIYADFTQTAAEALRLRDALKKGTLAAGDSQALTLRVEGTPYERQGALQFADVAVDRGTGQIALRGKFANPDGVLLPGMYVRVRTPQGIDNQAILVPQRAVHRSSDGSAQVMVVGADERAESRSVGTGVMQGSRWQITEGLEPGDRVIVGGLAAVQPGVKIVPKPDGAQAQAQSPAPQQ,MADLRAIGRIGALAMAIALAGCGPAEERQEAAEMVLPVEVLTVQAEPLALSSELPGRIEPVRVAEVRARVAGIVVRKRFEEGADVKAGDLLFQIDPAPLKAAVSRAEGELARNRAVLFEAQARVRRYEPLVKIQAVSQQDFDTATADLRSAEAATRSAQADLETARLNLGYASVTAPISGRIGRALVTEGALVGQGEATLMARIQQLDPIYADFTQTAAEALRLRDALKKGTLAAGDSQALTLRVEGTPYERQGALQFADVAVDRGTGQIALRGKFANPDGVLLPGMYVRVRTPQGIDNQAILVPQRAVHRSSDGSAQVMVVGADERAESRSVGTGVMQGSRWQITEGLEPGDRVIVGGLAAVQPGVKIVPKPDGAQAQAQSPAPQQ,91.47,gnl|BL_ORD_ID|742|hsp_num:0,805,True,"possible complete gene, missing n-terminus",99,1161,erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
1956,tcs_502,NODE_64_length_15611_cov_6.713259_5 # 6891 # 10022 # 1 # ID=64_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.656,NODE_64_length_15611_cov_6.713259_5,6891,10022,+,Strict,1800,1843.6,MexD,95.43,3000801,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTCCGAATTCTTCATCAAGCGGCCGAACTTCGCCTGGGTGGTGGCCCTGTTCATCTCCCTGGCCGGCCTGCTGGTCATTTCCAAATTGCCGGTAGCGCAGTACCCCAATGTCGCGCCGCCACAGATCACCATCACCGCCACCTATCCCGGCGCCTCGGCGAAGGTGCTGGTGGACTCCGTCACCAGTGTGCTCGAGGAGTCGCTGAACGGCGCCAAGGGCCTGCTCTACTTCGAGTCGACCAACAACTCCAACGGCACCGCCGAGATCGTCGTCACCTTCGAGCCGGGCACCGATCCGGACCTGGCCCAGGTGGACGTGCAGAACCGCCTGAAGAAAGCCGAGGCGCGCATGCCGCAGGCGGTGCTGACCCAGGGCCTGCAGGTCGAGCAGACCAGCGCCGGTTTCCTGCTGATCTATGCGCTCAGCTACAAGGAAGGCGCTCAGCGCAGCGACACCACCGCCCTCGGCGACTACGCCGCGCGCAATATCAACAACGAGCTGCGGCGCCTGCCGGGCGTCGGCAAGCTGCAATTCTTCTCTTCCGAGGCGGCCATGCGGGTCTGGATCGATCCGCAGAAGCTGGTGGGCTTCGGCCTCTCCATCGACGACGTGAGCAATGCCATCCGCGGGCAGAACGTGCAGGTGCCGGCCGGCGCCTTCGGCAGCGCACCGGGCAGTTCCGCGCAGGAGCTGACGGCGACCCTGGCGGTGAAGGGCACCCTGGACGATCCGCAGGAGTTCGGCCAGGTAGTGCTGCGCGCCAACCAGGACGGCTCGCTGGTCCGGCTCGCCGATGTCGCGCGCCTGGAACTCGGCAAGGAGAGCTACAACATTTCCTCGCGACTGAACGGCACGCCCACCGTGGGCGGGGCGATCCAGCTGTCGCCCGGGGCCAACGCGATCCAGACCGCTACCCTGGTGAAACAGCGTCTCGCCGAACTGTCGGCGTTCTTCCCCGAGGACATGCAGTACAGCGTGCCCTACGACACCTCGCGCTTCGTCGACGTGGCCATCGAGAAGGTGATCCACACCCTGATCGAAGCGATGGTCCTGGTGTTCCTGGTGATGTTCCTGTTCCTGCAGAACGTCCGCTACACCCTGATCCCGTCCATCGTGGTGCCGGTGTGCCTGCTGGGTACGCTGATGGTGATGTACCTGCTGGGGTTCTCGGTGAACATGATGACCATGTTCGGCATGGTCCTGGCGATCGGCATCCTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGATCATGGCGGAGGAGGGGATTTCCCCGGCCGAGGCCACGGTCAAGGCGATGAAGCAGGTATCCGGCGCCATCGTCGGCATCACCCTGGTGCTCTCGGCGGTGTTCCTGCCGCTGGCTTTCATGGCCGGTTCGGTGGGGGTGATCTACCAGCAGTTCTCGGTGTCGCTGGCGGTCTCGATCCTGTTCTCCGGCTTCCTCGCCCTGACCTTCACCCCGGCGCTGTGCGCCACGCTGCTCAAGCCCATTCCCGAAGGGCACCACGAGAAGCGCGGCTTCTTCGGCGCCTTCAACCGTGGCTTCGCCCGCGTCACCGAGCGCTATTCGCTGCTCAACTCGAAGCTGGTGGCGCGCGCCGGACGCTTCATGCTGGTGTACGCCGGCCTGGTGGCCATGCTCGGCTACTTCTACCTGCGCCTGCCGGAAGCCTTCGTGCCGGCGGAAGACCTCGGCTACATGGTGGTCGACGTGCAACTGCCGCCTGGTGCTTCGCGCGTGCGCACCGATGCCACCGGCGAGGAGCTCGAGCGCTTCCTCAAGTCCCGCGAGGCGGTGGCTTCGGTGTTCCTGATCTCGGGCTTCAGCTTCTCCGGCCAGGGCGACAATGCCGCGCTGGCCTTCCCGACCTTCAAGGACTGGTCCGAGCGAGGCGCCGAGCAGTCGGCCGCCGCCGAGATCGCCGCGCTGAACGAGCATTTCGCGCTGCCCGACGATGGCACGGTCATGGCCGTGTCGCCGCCACCGATCAACGGTCTGGGTAACTCCGGCGGCTTCGCATTGCGCCTGATGGACCGTAGCGGGGTCGGCCGCGAAGCGCTGCTGCAGGCTCGCGATACTCTTCTTGGCGAGATCCAGACCAACCCGAAATTCCTTTACGCGATGATGGAAGGACTGGCCGAAGCGCCGCAACTGCGCCTGTTGATCGACCGGGAGAAGGCCCGCGCCCTGGGGGTGAGCTTCGAGACCATCAGCGGCACGCTGTCCGCTGCCTTCGGCTCGGAGGTGATCAACGACTTCACCAATGCGGGGCGCCAACAGCGGGTGGTGATCCAGGCCGAACAGGGCAACCGGATGACCCCGGAAAGCGTGCTCGAGCTATACGTGCCTAACGCTGCTGGCAACCTGGTACCGCTCAGCGCCTTCGTCAGCGTGAAATGGGAAGAGGGACCGGTGCAATTGGTGCGCTATAACGGCTACCCGTCGATCCGCATCGTCGGTGACGCCGCGCCCGGCTTCAGCACCGGCGAAGCCATGGCGGAAATGGAGCGCCTGGCCGCGCAGCTGCCGGCCGGCATCGGCTACGAGTGGACCGGCCTGTCCTATCAGGAGAAGGTCTCCGCCGGGCAGGCCACCAGCCTGTTCGCCCTCGCCATCCTGGTGGTGTTCCTGTTGCTGGTGGCGCTCTACGAGAGCTGGTCGATCCCGCTGTCGGTGATGCTGATCGTGCCGATCGGCGCCATCGGCGCGGTGCTCGCGGTGATGGTCAGCGGTATGTCCAACGACGTGTATTTCAAGGTCGGCCTGATCACCATCATCGGTCTTTCGGCGAAGAACGCGATTCTCATCGTCGAGTTCGCCAAGGAACTCTGGGAGCAGGGGCATAGCCTGCGCGACGCCGCCATCGAGGCCGCGCGCCTGCGCTTCCGGCCGATCATCATGACTTCCATGGCGTTCATCCTCGGCGTGATACCCCTGGCCCTGGCCAGCGGTGCCGGCGCGGCGAGCCAGCGTGCCATCGGCACCGGAGTGATCGGCGGGATGCTCAGCGCCACCTTCCTCGGCGTGCTGTTCGTACCTATCTGTTTCGTCTGGCTGCTGTCGCTGCTGCGCAGCAAGCCGGCACCCATCGAACAGGCCGCTTCGGCCGGGGAGTGA,MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANQDGSLVRLADVARLELGKESYNISSRLNGTPTVGGAIQLSPGANAIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLQNVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLAAQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE,MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE,100.00,gnl|BL_ORD_ID|1480|hsp_num:0,1523,,,0,3129,erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
1957,tcs_502,NODE_64_length_15611_cov_6.713259_6 # 10028 # 11467 # 1 # ID=64_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.697,NODE_64_length_15611_cov_6.713259_6,10028,11467,+,Strict,850,879.4,OprJ,99.16,3000802,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCGCAAACCTGCTTTCGGCGTATCGGCGCTGCTGATCGCCCTGACCCTCGGTGCCTGCTCCATGGCGCCGACCTACGAACGTCCCGCCGCGCCGGTGGCCGACAGCTGGAGCGGCGCCGCCGCCCAGCGCCAGGGCGCGGCGATCGACACGCTGGATTGGAAGAGTTTCATCGTCGATGCCGAACTACGCCGCCTGGTGGGCGTGGCCCTGGATAACAACCGCTCGCTGCGTCAGACCCTCCTGGATATCGAGGCGGCCCGCGCGCAGTACCGAATCCAGCGCGCCGACCGGGTTCCGGGCCTGAATGCCGCTGCCACCGGCAACCGCCAGCGGCAGCCGGCCGACCTGTCCGCCGGCAATCGCTCGGAAGTGGCCAGCAGCTACCAGGTCGGGCTGGCCCTGCCGGAGTACGAACTGGACCTCTTCGGTCGGGTCAAGAGCCTGACCGACGCAGCCCTGCAACAGTACCTGGCCAGCGAGGAGGCAGCGCGCGCGGCACGGATCGCCCTGGTCGCCGAGGTCAGCCAGGCCTACCTGAGCTATGACGGCGCCCTGCGGCGCCTGGCGCTGACCCGTCAGACCCTGGTCAGCCGCGAGTATTCCTTCGCCCTGATCGACCAGCGCCGCGCGGCCGGCGCCGCCACCGCGCTGGACTACCAGGAAGCCCTTGGCCTGGTGGAGCAGGCGCGCGCCGAGCAGGAGCGCAACCTGCGGCAGAAACAGCAGGCATTCAACGCGCTGGTGTTGCTGCTGGGTAGCGACGATGCCGCGCAGGCGATTCCGCGGAGTCCGGGGCAGCGGCCGAAGCTGCTGCAGGACATCGCTCCCGGCACGCCGTCCGAGCTGATCGAGCGACGCCCGGACATCCTTGCCGCCGAACATCGTTTGCGGGCGCGCAACGCGGATATCGGCGCGGCGCGCGCGGCGTTCTTCCCGCGCATCAGCCTGACCGGCAGCTTCGGCACCTCCAGCGCGGAAATGTCCGGCCTGTTCGATGGCGGCTCGCGCTCCTGGAGCTTCCTGCCGACGCTGACGCTGCCGATCTTCGATGGCGGGCGCAACCGTGCCAACCTGAGCCTGGCCGAGGCGCGCAAGGATTCGGCGGTGGCCGCCTACGAGGGGACCATCCAGACCGCTTTCCGCGAGGTCGCCGACGCCCTGGCGGCCAGCGATACCCTGCGTCGCGAAGAGAAGGCCCTGCGCGCCCTGGCGAACAGCAGCAACGAAGCCCTGAAGCTGGCCAAGGCACGCTACGAGAGTGGCGTCGACAACCACCTGCGCTACCTCGATGCGCAGCGCAGCAGCTTCCTCAACGAGATCGCCTTCATCGACGGCAGCACCCAGCGGCAGATCGCCCTGGTCGACCTGTTCCGCGCGCTCGGCGGAGGCTGGGACGAGGGACGGAGCCTGGTGGTACATCGAGGCGGCAGGAGTTGA,MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVGVALDNNRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS,MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS,100.00,gnl|BL_ORD_ID|743|hsp_num:0,704,,,0,1437,erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
1958,tcs_502,NODE_67_length_15394_cov_7.535373_8 # 7502 # 8653 # 1 # ID=67_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.666,NODE_67_length_15394_cov_7.535373_8,7502,8653,+,Perfect,650,717.2,MexA,100.0,3000377,protein homolog model,n/a,n/a,,antibiotic efflux,,ATGCAACGAACGCCAGCCATGCGTGTACTGGTTCCGGCCCTGCTGGTCGCGATTTCGGCCCTTTCCGGGTGCGGAAAAAGCGAGGCGCCGCCGCCGGCGCAAACGCCGGAGGTCGGGATCGTGACCCTGGAAGCGCAGACGGTGACCCTGAATACCGAGCTGCCGGGCCGGACCAATGCGTTCCGCATCGCCGAGGTGCGTCCCCAGGTGAACGGCATCATCCTCAAGCGCCTGTTCAAGGAAGGCAGCGACGTCAAGGCCGGGCAGCAGCTCTACCAGATCGACCCCGCCACCTACGAGGCCGACTACCAGAGCGCCCAGGCCAACCTGGCTTCGACCCAGGAGCAGGCCCAGCGCTACAAGCTGCTGGTCGCCGACCAGGCCGTGAGCAAGCAGCAGTACGCCGACGCCAATGCCGCCTACCTGCAGTCCAAGGCGGCGGTGGAGCAGGCGCGGATCAACCTGCGCTACACCAAGGTGCTGTCGCCGATCTCCGGCCGCATCGGCCGTTCCGCGGTGACCGAAGGCGCCCTGGTGACCAACGGCCAGGCCAACGCGATGGCCACCGTGCAACAGCTCGACCCGATCTACGTCGACGTCACCCAGCCGTCCACCGCCCTGCTGCGCCTGCGCCGCGAACTGGCCAGCGGCCAGTTGGAGCGCGCCGGCGACAACGCGGCGAAGGTCTCCCTGAAGCTGGAGGACGGTAGCCAATACCCGCTGGAAGGTCGCCTCGAATTCTCCGAGGTTTCCGTCGACGAAGGCACCGGCTCGGTCACCATCCGCGCCGTGTTCCCCAACCCGAACAACGAGCTGCTGCCCGGCATGTTCGTTCACGCGCAGTTGCAGGAAGGCGTCAAGCAGAAGGCCATCCTCGCTCCGCAGCAAGGCGTGACCCGCGACCTCAAGGGCCAGGCTACCGCGCTGGTGGTGAACGCGCAGAACAAGGTCGAGCTGCGGGTGATCAAGGCCGACCGGGTGATCGGCGACAAATGGCTGGTTACCGAAGGCCTGAACGCCGGCGACAAGATCATTACCGAAGGCCTGCAGTTCGTGCAGCCGGGTGTCGAGGTGAAGACCGTGCCGGCGAAGAATGTCGCGTCCGCGCAGAAGGCCGACGCCGCTCCGGCGAAAACCGACAGCAAGGGCTGA,MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG,MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG,100.00,gnl|BL_ORD_ID|437|hsp_num:0,440,,,0,1149,
1959,tcs_502,NODE_67_length_15394_cov_7.535373_9 # 8669 # 11809 # 1 # ID=67_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.645,NODE_67_length_15394_cov_7.535373_9,8669,11809,+,Strict,1950,1985.3,MexB,99.9,3000378,protein homolog model,n/a,n/a,,antibiotic efflux,,ATGTCGAAGTTTTTCATTGATAGGCCCATTTTCGCGTGGGTGATCGCCTTGGTGATCATGCTCGCGGGCGGCCTGTCGATCCTCAGTCTGCCGGTCAACCAGTACCCGGCCATCGCCCCGCCGGCCATCGCCGTGCAGGTGAGCTACCCGGGCGCCTCGGCCGAGACGGTGCAGGACACCGTGGTCCAGGTGATCGAGCAGCAGATGAACGGGATCGACAATCTGCGCTACATCTCCTCGGAGAGTAACTCCGACGGCAGCATGACCATCACCGTGACCTTCGAACAGGGCACCGACCCCGACATCGCCCAGGTCCAGGTGCAGAACAAGCTGCAACTGGCCACCCCGCTACTGCCGCAGGAAGTGCAGCGCCAGGGGATCCGGGTGACCAAGGCGGTGAAGAACTTCCTCATGGTGGTCGGTGTGGTTTCCACCGACGGCAGCATGACCAAGGAAGACCTGTCGAACTACATTGTTTCCAACATCCAGGATCCGCTCTCGCGGACCAAGGGCGTCGGTGACTTCCAGGTGTTCGGCTCGCAGTACTCGATGCGCATCTGGCTCGACCCGGCCAAGCTGAACAGCTACCAGCTGACCCCCGGCGACGTGAGCAGCGCGATCCAGGCGCAGAACGTGCAGATTTCCTCCGGCCAGCTCGGCGGCTTGCCGGCGGTCAAGGGCCAGCAGCTCAACGCCACCATCATCGGCAAGACCCGCCTGCAGACCGCGGAGCAATTCGAGAACATCCTGCTCAAGGTCAATCCCGACGGTTCCCAGGTGCGCCTGAAGGACGTCGCCGATGTAGGCCTGGGCGGCCAGGACTACAGCATCAACGCGCAGTTCAACGGCAGCCCGGCGTCCGGTATCGCGATCAAGCTGGCCACCGGCGCCAACGCGCTGGATACCGCCAAGGCGATCCGCCAGACCATCGCCAACCTGGAACCGTTCATGCCGCAGGGCATGAAGGTGGTCTACCCGTACGACACCACCCCGGTGGTCTCGGCCTCGATCCATGAGGTAGTGAAGACCCTCGGCGAGGCGATCCTCCTCGTGTTCCTGGTGATGTACCTGTTCCTGCAGAACTTCCGCGCCACGCTGATCCCGACCATCGCCGTACCGGTGGTGCTGCTGGGGACCTTCGGCGTGCTCGCCGCGTTCGGCTTCTCGATCAACACCCTGACCATGTTCGGCATGGTGCTGGCCATCGGCTTGCTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGGGTGATGGCCGAGGAAGGCCTGTCGCCAAGGGAGGCGGCGCGCAAGTCCATGGGCCAGATCCAGGGCGCGCTGGTCGGTATCGCCATGGTGCTCTCGGCGGTATTCCTGCCGATGGCGTTCTTCGGCGGCTCCACCGGGGTGATCTACCGGCAGTTCTCCATCACCATCGTGTCGGCCATGGCCCTCTCGGTGATCGTGGCGCTGATCCTCACCCCGGCGCTCTGCGCGACCATGCTCAAGCCGATCGAGAAAGGCGACCATGGCGAGCACAAGGGCGGCTTCTTCGGCTGGTTCAACCGGATGTTCCTTTCCACCACCCACGGCTACGAGCGGGGCGTGGCGTCGATCCTCAAGCATCGCGCGCCGTACCTGCTGATCTACGTGGTGATCGTGGCCGGGATGATCTGGATGTTCACCCGCATTCCCACCGCGTTCCTCCCCGACGAGGACCAGGGCGTACTGTTCGCCCAGGTACAGACCCCGCCGGGCTCCAGTGCCGAGCGTACCCAGGTGGTGGTGGACTCGATGCGCGAATACCTGCTGGAGAAGGAAAGCTCTTCGGTCAGCTCGGTGTTCACCGTGACCGGCTTCAACTTCGCCGGCCGCGGCCAGAGTTCGGGCATGGCGTTCATCATGCTCAAGCCCTGGGAAGAGCGTCCCGGTGGCGAGAACAGCGTGTTCGAACTGGCCAAGCGCGCGCAGATGCACTTCTTCAGCTTCAAGGACGCGATGGTGTTCGCCTTCGCGCCGCCGTCGGTACTGGAACTGGGTAACGCCACCGGCTTCGACCTGTTCCTCCAGGACCAGGCGGGTGTCGGCCACGAAGTCCTGCTCCAGGCGCGCAACAAGTTCCTCATGCTCGCCGCGCAGAACCCGGCGCTGCAACGCGTGCGCCCCAACGGCATGAGCGACGAACCGCAGTACAAGCTGGAGATCGACGACGAGAAGGCCAGCGCCCTCGGCGTGTCCCTTGCCGACATCAACAGCACCGTGTCCATCGCCTGGGGTTCCAGCTACGTCAACGACTTCATCGACCGTGGCCGGGTCAAGCGGGTCTACCTGCAGGGCAGGCCGGACGCGCGGATGAACCCGGACGACCTGAGCAAGTGGTACGTGCGCAACGACAAGGGCGAGATGGTGCCGTTCAACGCCTTCGCCACCGGCAAGTGGGAATACGGTTCGCCGAAGCTGGAGCGCTACAATGGCGTGCCGGCGATGGAGATCCTCGGCGAGCCGGCGCCCGGCCTGAGTTCCGGTGACGCCATGGCGGCGGTCGAGGAGATCGTCAAGCAATTGCCGAAAGGCGTTGGCTACTCCTGGACCGGCCTGTCCTACGAGGAGCGCTTGTCCGGCTCGCAGGCGCCGGCGCTGTATGCGCTGTCGCTGCTGGTGGTGTTCCTCTGCCTGGCGGCCCTGTACGAAAGCTGGTCGATTCCGTTCTCGGTGATGCTGGTGGTGCCGTTGGGCGTGATCGGCGCGCTGCTGGCGACGTCCATGCGCGGCCTGTCCAACGACGTGTTCTTCCAGGTGGGCCTGTTGACGACCATCGGCCTGTCGGCGAAGAACGCCATTCTCATCGTGGAGTTCGCCAAGGAGCTGCACGAGCAGGGCAAGGGCATCGTCGAGGCGGCCATCGAAGCCTGCCGCATGCGTCTGCGGCCGATCGTGATGACCTCCCTGGCGTTCATCCTCGGCGTGGTCCCGCTGGCGATCTCCACCGGCGCCGGCTCGGGCAGCCAGCATGCGATCGGTACCGGCGTGATCGGCGGCATGGTCACTGCGACCGTCCTGGCGATCTTCTGGGTACCGCTGTTCTACGTGGCGGTCAGCACGCTGTTCAAGGACGAGGCGTCCAAGCAGCAAGCGTCCGTCGAAAAGGGGCAATGA,MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ,MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ,100.00,gnl|BL_ORD_ID|1784|hsp_num:0,1925,,,0,3138,
1960,tcs_502,NODE_67_length_15394_cov_7.535373_10 # 11811 # 13268 # 1 # ID=67_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.687,NODE_67_length_15394_cov_7.535373_10,11811,13268,+,Perfect,850,917.5,OprM,100.0,3000379,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAACGGTCCTTCCTTTCCCTGGCGGTAGCCGCTGTCGTTCTGTCCGGCTGCTCGCTGATCCCCGACTACCAGCGCCCCGAGGCGCCGGTAGCCGCGGCCTACCCGCAAGGGCAGGCCTACGGGCAGAACACCGGCGCGGCGGCCGTTCCGGCCGCCGACATCGGCTGGCGCGAGTTCTTCCGCGACCCGCAGTTGCAGCAACTGATCGGCGTGGCGCTGGAAAACAACCGCGACCTGCGGGTCGCCGCGCTGAACGTCGAGGCCTTCCGGGCGCAGTACCGCATCCAGCGGGCCGACCTGTTCCCGCGGATCGGCGTGGACGGTAGCGGCACCCGCCAGCGTTTGCCGGGCGACCTGTCGACCACCGGCAGTCCGGCGATTTCCAGCCAGTACGGGGTGACCCTGGGCACTACCGCCTGGGAACTCGATCTCTTCGGCCGCCTGCGCAGCCTGCGCGACCAGGCCCTGGAGCAGTACCTGGCGACCGAACAGGCGCAGCGCAGCGCGCAGACCACCCTGGTGGCCAGCGTGGCGACCGCCTACCTGACGCTGAAGGCCGACCAGGCGCAGTTGCAGCTGACCAAGGACACCCTGGGCACCTACCAGAAGAGTTTCGACCTGACCCAGCGCAGCTACGACGTCGGCGTCGCCTCCGCGCTCGACCTGCGCCAGGCGCAGACCGCCGTGGAAGGCGCCCGCGCGACCCTGGCGCAGTACACCCGCCTGGTAGCCCAGGACCAGAATGCGCTGGTCCTGCTGCTGGGCTCCGGGATCCCGGCGAACCTGCCGCAAGGCCTGGGCCTGGACCAGACCCTGCTGACCGAAGTGCCGGCGGGTCTGCCGTCGGACCTGCTGCAACGGCGCCCGGACATCCTCGAGGCCGAGCACCAGCTCATGGCTGCCAACGCCAGCATCGGCGCCGCGCGCGCGGCGTTCTTCCCGAGCATCAGCCTGACCGCCAACGCCGGCACCATGAGCCGCCAACTGTCCGGCCTGTTCGACGCCGGTTCGGGTTCCTGGTTGTTCCAGCCGTCGATCAACCTGCCGATCTTCACCGCCGGCAGCCTGCGTGCCAGCCTGGACTACGCGAAGATCCAGAAGGACATCAACGTCGCGCAGTACGAGAAGGCGATCCAGACGGCGTTCCAGGAAGTCGCCGACGGCCTGGCCGCGCGCGGTACCTTCACCGAGCAGTTGCAGGCGCAGCGCGATCTGGTCAAGGCCAGCGACGAGTACTACCAGCTCGCCGACAAGCGCTATCGCACGGGGGTGGACAACTACCTGACCCTGCTCGACGCGCAACGCTCGCTGTTCACCGCGCAGCAGCAACTGATCACCGACCGCCTCAATCAGCTGACCAGCGAGGTCAACCTGTACAAGGCCCTCGGCGGCGGCTGGAACCAGCAGACCGTGACCCAGCAGCAGACCGCGAAGAAGGAAGATCCCCAGGCCTGA,MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA,MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA,100.00,gnl|BL_ORD_ID|2358|hsp_num:0,1305,,,0,1455,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; azithromycin; chloramphenicol; thiamphenicol; norfloxacin; ofloxacin; gentamicin
1961,tcs_502,NODE_97_length_13273_cov_6.826185_1 # 3 # 257 # 1 # ID=97_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.725,NODE_97_length_13273_cov_6.826185_1 ,3,257,+,Strict,650,166.0,TriA,100.0,3003679,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GCGCTGTCCAAGGTCGGCGAGCAGCCGGCGGTCTGGTTGCTCGACCAGCAAGGCAAGGCGCGTCTGCAACCGGTGCGGGTGGCACGCTACGCCAGCGAGAAGGTGGTCATCGACGGTGGCCTGGAGGCGGGCCAGACGGTGGTCACGGTGGGCGGCCAACTGCTCCATCCGGGCCAGGTGGTCGAGGTGGCCCAGCCGCCGCAGCCGACCCAGAGCACCGCCAGCCGCGACGCCGTGGGCGGAGGCCAGCCATGA,ALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP,MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP,21.93,gnl|BL_ORD_ID|1995|hsp_num:0,2192,True,loose hit with at least 95 percent identity pushed strict,897,1149,triclosan
1962,tcs_502,NODE_97_length_13273_cov_6.826185_2 # 254 # 1324 # 1 # ID=97_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.709,NODE_97_length_13273_cov_6.826185_2,254,1324,+,Strict,600,666.8,TriB,99.72,3003680,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGCCGTTTTCCCTCGCCGGCCTGTTCGGCTTCGCCCTGCTCCTCTCCGGCTGCGGCGACGAGCCGCCGCCGGCACCGCCGCGGCCGGTGCTGACGGTGACCGTGAAGACCCTGAAGAACGACGACCTCGGTCGCTTCGCCGGGAGCATCCAGGCGCGCTACGAGAGCGTGCTCGGCTTCCGCACCAACGGACGGATCGCCTCGCGCCTGTTCGACGTCGGTGACTTCGTCGGCAAGGGCGCGCTGCTGGCGACCCTCGACCCCACCGACCAGCAGAACCAGTTGCGCGCCAGCCAGGGCGACCTGGCCAGCGCCGAGGCACAGTTGATCGACGCCCAGGCCAATGCCCGGCGCCAGGAAGAACTGTTCGCCCGCAGCGTCACCGCCCAGGCGCGCCTGGACGATGCGCGGACCCGCCTGAAGACCAGCCAGGCCAGCTTCGACCAGGCCAAAGCGACGGTGCAGCAGGCCAGGGACCAGCTTTCCTACACGCGCCTGGTGACCGATTTCGACGGCGTCATCACCACCTGGCACGCCGAGGCCGGGCAAGTGGTCAGCGCCGGCCAGGCGGTGGTCACCCTGGCCCGGCCCGAAGTGCGCGAGGCGGTCTTCGACCTGCCCACCGAGGTCGCCGAGAGCCTGCCGGCCGACGCGCGCTTCCTGGTCAGCGCCCAGCTCGACCCGCAGGCCAGGACCACCGGCAGCATCCGCGAGCTGGGTCCGCAGGCCGACGCCTCGACCCGCACCCGTCGCGTGCGCCTGAGCCTGGCGCAGACGCCGGAGGCGTTTCGCCTCGGTTCGACCATCCAGGTCCAGCTGAGCAGCGCCGGTAGCGTGCGCAGCGTGCTGCCGGCCAGCGTGCTGCTGGAGCGCGACGGCAAGACCCAGGTCTGGGTCGTCGATGGGAAACAGTCCAGCGTGGCCCTGCGCGAGGTACAGGTGCTCAGCCGCGACGAACGCCAGGTGGTGATCGGACAGGGCCTGGCCGACGGCGACCGGGTGGTCCGCGCCGGAGTCAACAGCCTCAAGCCCGGCCAGAAGATCAAACTCGACGAGGATGCGCGATGA,MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKATVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR,MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR,100.00,gnl|BL_ORD_ID|1996|hsp_num:0,2193,,,0,1068,triclosan
1963,tcs_502,NODE_97_length_13273_cov_6.826185_3 # 1321 # 4659 # 1 # ID=97_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.653,NODE_97_length_13273_cov_6.826185_3 ,1321,4659,+,Strict,1900,1887.5,TriC,99.0,3003681,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGGGCGGTTTCAACCTGTCGGACTGGGCCCTGCGCCACCAGTCCCTGGTCTGGTACCTGATGGCGGTATCGCTGGTGATGGGCGTGTTCTCCTACCTCAACCTGGGGCGCGAGGAGGATCCCTCGTTCGCCATCAAGACCATGGTCATCCAGACCCGCTGGCCGGGCGCCACGGTGGACGACACCCTGGAGCAGGTCACCGACCGCATCGAGAAGAAGCTCGAGGAGCTGGACTCGCTGGATTACGTGAAGAGCTACACGCGACCCGGCGAATCGACGGTCTTCGTCTACCTCAAGGACACCACCAAGGCCGGCGACATCCCGGATATCTGGTACCAGGTGCGCAAGAAGATATCCGACATCCTGGTGATGGGCGTGTTCTCCTACCTCAACCTGGGGCGCGAGGAGGATCCCTCGTTCGCCATCAAGACCATGGTCATCCAGACCCGCTGGCCGGGCGCCACGGTGGACGACACCCTGGAGCAGGTCACCGACCGCATCGAGAAGAAGCTCGAGGAGCTGGACTCGCTGGATTACGTGAAGAGCTACACGCGACCCGGCGAATCGACGGTCTTCGTCTACCTCAAGGACACCACCAAGGCCGGCGACATCCCGGATATCTGGTACCAGGTGCGCAAGAAGATATCCGACATCCAGGGCGAATTCCCCCAGGGCATCCAGGGACCGGGTTTCAACGACGAGTTCGGCGACGTGTTCGGCAGCGTCTACGCCTTCACCGCCGACGGCCTGGACTTCCGCCAGCTGCGCGACTACGTGGAGAAGGTGCGCCTGGACATCCGCTCGGTGAAAGACCTGGGCAAGGTGCAGATGATCGGTGCGCAGAACGAGGTCATCTACCTCAACTTCTCTACCCGCAAGCTGGCCGCCCTCGGTCTCGACCAGCGCCAGGTCGTGCAGAGCCTGCAGGCGCAGAACGCGGTGACCCCGTCCGGCGTGGTCGAGGCCGGCCCCGAGCGCATCTCGGTGCGCACCTCCGGCAACTTCCGTTCGGAAAAGGACCTGCAGGCGGTCAACCTGCGGGTCAACGATCGTTTCTACCGGCTGTCCGACCTGGCCAGCATCAGCCGCGATTTCGTCGACCCGCCGACCTCGCTGTTCCGCTACAAGGGCGAGCCGGCCATCGGCCTGGCGGTGGCGATGAAGGAGGGCGGCAATATCCTCGAGTTCGGCGAGGCGCTCAATGCGCGCATGCAGGAGATCACCGGCGAACTGCCGGTTGGTGTCGGCGTGCACCAGGTGTCGAACCAGGCCCAGGTGGTGAAGAAGGCGGTCGGCGGTTTCACCCGGGCGCTGTTCGAGGCGGTGGTGATCGTCCTCATCGTCAGCTTCGTCAGCCTCGGCCTGCGCGCCGGGCTGGTGGTGGCCTGCTCGATCCCGCTGGTGCTGGCGATGGTCTTCGTGTTCATGGAATACACCGACATCACCATGCAGCGGGTTTCCCTCGGCGCGCTGATCATCGCCCTCGGCCTGCTGGTGGACGATGCCATGATCACCGTGGAGATGATGATCACGCGCCTCGAACTGGGCGACTCGCTACACGACTCGGCGACCTACGCCTACACCTCGACGGCCTTCCCGATGCTCACCGGGACCCTGGTGACGGTGGCCGGCTTCGTACCCATCGGGCTCAACGCCAGCTCCGCTGGCGAGTACACCTTCACCCTGTTCGCAGTGATCGCCGTGGCGCTGCTGCTGTCGTGGATCGTCGCGGTGCTGTTCGCCCCGGTGATCGCCGTGCACATCCTGCCGAAGACTCTCAAGCACAAGTCGGAGCAGAAGAAGGGCCGCATCGCCGAGCGTTTCGACAGCCTGCTGCACCTGGCGATGCGCCGGCGCTGGACGACCATCTTCCTCACCGCGCTGCTGTTCGGCGTGTCGCTGTTCCTGATGAAGTTCGTCCAGCACCAGTTCTTCCCGTCTTCCGACCGTCCGGAACTGCTGGTCGACCTCAACCTGCCGCAAAACAGCAGCATCCACGAGACCAGGGCGGTGATGGACCGCCTGGAAGCGACGCTGAAGGACGACGAGGACATCGACCACTGGAGCGCCTACGTCGGCGAAGGCGCGATCCGCTTCTACCTGCCGCTGGACCAGCAGTTGCAGAACAACTTCTATGGCCAGCTGGTGATCGTCACCAAGGACCTGGAGGCCCGCGAGCGCGTCGCCGCACGCCTGCGCGATCGCTTGCGCAAGGACTACGTCGGCATCAGCACCTACGTGCAGCCGCTGGAGATGGGGCCGCCGGTGGGACGGCCGATCCAGTACCGGGTCAGCGGACCGCAGATCGACAAGGTCCGCGAGTACGCCATGGGCCTGGCCGGCGTGCTCGACGGCAACCCGAACATCGGCGATATCGTCTACGACTGGAACGAGCCCGGGAAGATGCTCAAGATCGACATCGCCCAGGACAAGGCGCGCCAGCTCGGGCTTTCCTCCGAGGACGTGGCGCAGATCATGAACAGCGTGGTGACCGGCAGCGCGGTGACCCAGGTGCGCGACGACATCTACCTGGTGAACGTCATCGGCCGCGCCGAGGATAGCGAGCGCGGCTCGCTGGAGACCCTGGAGAGCCTGCAGATCGTCACGCCCAGCGGCACCTCGATCCCGCTCAAGGCGTTCGCCAAGGTCAGCTACGAGCTGGAGCAGCCGCTGGTGTGGCGCCGCGACCGCAAGCCGACGATCACGGTGAAGGCGTCGCTGCGCGGCGAGATCCAGCCCACCGACCTGGTCGCCCGGCTGGCGCCGGAGGTCAAGCGCTTCGCCGACGGCCTGCCGGCGAACTACCGGATCGAAGTGGGCGGCACGGTGGAGGAGAGCGGCAAGGCCGAGGGCCCGATCGCCAAGGTGGTGCCGCTGATGCTGTTCCTCATGGCGACCTTCCTGATGATCCAGTTGCAGAGCGTGCAGAAGCTGTTCCTGGTGGCCAGCGTCGCGCCGCTGGGGCTGATCGGGGTGGTCGCGGCGTTGCTGCCGACCGGCACGCCGATGGGCTTCGTGGCGATCCTCGGGATTCTCGCGCTGATCGGCATCATCATCCGCAACTCGGTGATCCTGGTGACCCAGATCGATGCCTTCGAGAAAGACGGCAAGACGCCCTGGGAAGCCGTGCTGGAAGCCACCCACCACCGCACCCGGCCGATCCTGCTGACGGCGGCGGCGGCCAGCCTGGGGATGATCCCCATCGCCCGCGAAGTGTTCTGGGGGCCGATGGCCTATGCGATGATCGGCGGCATCGTCGCCGCCACGCTGCTCACGCTGATCTTCCTGCCGGCGCTGTACGTCGCCTGGTACCGGATTCCGGAACCGGGACGCTGA,MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDILVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR,MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR,109.56,gnl|BL_ORD_ID|1997|hsp_num:0,2194,True,loose hit with at least 95 percent identity pushed strict,51,3045,triclosan
1964,tcs_502,NODE_122_length_11677_cov_5.070828_1 # 3 # 674 # -1 # ID=122_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692,NODE_122_length_11677_cov_5.070828_1 ,3,674,-,Strict,800,427.6,MuxA,100.0,3004073,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACTCCAACGACCGGTAAATCCAAGTTCCGTACCCTGCGCCCGTGGCTGATCACCGCCCTGGCCTTCGCCGCCGTGATCGGCCTGGTGATGTGGCTGGCGGCGCCCGCCTCGGCGCCGTCCTCCGACGGGCGACCCGGTCGCGGCGGCAAGCCGGGCGCCGCGCTGCCCAAGGCCAACGCGCTCACCGTCGGCGTGGCCAGGGTGGAGCAGGGCGACCTGGCGCTGCATTTCAACGCGCTTGGCACCGTCACCGCCTTCAACACGGTGAACGTCAAGCCGCGGGTCAACGGCGAGCTGGTCAAGGTGCTGTTCCAGGAGGGGCAGGAGGTCAAGGCCGGCGACCTGCTGGCGGTGGTCGACCCGCGCACCTACAAGGCGGCGCTGGCCCAGGCCGAGGGCACGCTGATGCAGAACCAGGCGCAACTGAAGAACGCCGAGATCGACCTGCAGCGCTACAAGGGGCTGTACGCCGAGGACTCGATCGCCAAGCAGACCCTGGATACCCAGGAAGCCCAGGTCCGCCAGTTGCAGGGCACCATCCGTACCAACCAGGGCCAGGTCGACGACGCCCGCCTCAACCTGACCTTCACCGAGGTCCGCGCACCGATTTCCGGGCGCCTCGGTCTGCGCCAGGTGGACATCGGCAACCTGGTCACCAGCGGCGATACC,MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDT,MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE,52.58,gnl|BL_ORD_ID|2242|hsp_num:0,2717,True,loose hit with at least 95 percent identity pushed strict,0,672,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1965,tcs_502,NODE_127_length_11388_cov_6.234968_12 # 9623 # 10300 # 1 # ID=127_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.701,NODE_127_length_11388_cov_6.234968_12,9623,10300,+,Perfect,400,444.9,Pseudomonas aeruginosa CpxR,100.0,3004054,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGCGAACTGCTGTTGATCGACGATGACCGGGAGCTCTGCGAGCTGCTCGGTACCTGGCTGGTCCAGGAAGGTTTCTCCGTGCGTGCCAGCCACGACGGCGCCCAGGCCCGTCGCGCCCTCGCCGAGCAGACGCCGGATGCCGTGGTGCTCGACGTGATGCTGCCGGACGGCAGCGGCCTGGAACTGCTCAAGCAACTGCGCGGCGACCATCCCGACCTGCCGGTGCTGATGCTGTCCGCCCGCGGCGAGCCGCTGGACCGCATCCTGGGTCTGGAACTGGGCGCCGACGACTACCTGGCCAAGCCCTGCGACCCGCGCGAACTCACCGCACGGCTGCGCGCCGTGCTGCGGCGAACCCACCCGGCGCAGCCCAGCGCGCAGATGCAACTGGGCGACCTGTCGCTGAACCTGACGCGCGGCGTGGCGCAGATCGACGGCCAGGAGATCAGCCTGACCCTTTCCGAAAGCCGCATCCTCGAAGCGCTCCTGCGCCAGCCCGGCGAGCCGCTGGACAAGCAGGCCCTGGCGCAACTGGCGCTGGGCCGCAAGCTGACCCTCTACGACCGCAGCCTGGACATGCACGTCAGCAACCTGCGCAAGAAGCTCGGCAGCCACCCCGACGGCAGCCCGCGCATCCTCGCCCTGCGCGGCCGCGGCTACTACTACAGCCACTGA,MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH,MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH,100.00,gnl|BL_ORD_ID|2301|hsp_num:0,2685,,,0,675,neomycin; erythromycin; amikacin; ciprofloxacin; kanamycin A; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole; gentamicin
1966,tcs_502,NODE_139_length_10802_cov_5.861227_3 # 1917 # 3074 # 1 # ID=139_3;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.702,NODE_139_length_10802_cov_5.861227_3,1917,3074,+,Strict,650,695.7,mexM,98.44,3003704,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGGCGTTGCGCAGTAGTGGGGGACGGGTCCTGGTGGGCGTGCTGGCGGCGGGCCTGGTCGCCTTCGGCGGTTGGGCATGGCTCGGCGGCGACGCCGGGGCGAAGGCGGCGCCCGCGCCGGCCAGGGTCCCGGTGAACGTGGCGCGGGTGGAGCGGCGCGACGTCGAGCAACAGGTCAGCGGCATCGGCACGGTGACTTCGTTGCACAACGTGGTGATCCGCACCCAGATCGACGGCCAGTTGACCCGCCTGCTGGTGAGCGAAGGGCAGATGGTCGAGGCGGGCGAGTTGCTGGCGACCATCGATGACCGCGCCGTCGTCGCCGCGCTGGAGCAGGCGCAGGCCTCCAGGGCGAGCAACCAGGCCCAGCTGAAATCCGCCGAGCAGGACCTGCAACGCTACCGCAGCCTGTATGCCGAGCGTGCGGTGTCACGCCAACTGCTGGACCAGCAGCAGGCGACGGTCGACCAGTTGCGCGCGACCCTGAAGGCCAACGATGCCACCATCAACGCCGAGCGGGTGCGCCTGTCCTACACCCGGATCACCTCGCCGGTATCCGGCAAGGTCGGTATCCGCAACGTCGATGTCGGCAACCTGGTGCGGGTCGGCGACAGTCTCGGCCTGTTCAGCGTGACCCAGATCGCACCGATCTCCGTAGTCTTCTCCCTGCAACAGGAACAGTTGCCCCAGTTGCAGGCGCTGCTCGGCGGCGAGGCGGCGGTGCGCGCCTACAGCCGCGACGGCGGGAGCGCGCTGGGCGAGGGCCGGTTGCTGACCATCGACAACCAGATCGACAGTTCCACCGGTACCATCCGCGTGCGCGCCTCCTTCGATAACCGCCAGGCCCGGCTCTGGCCCGGGCAGTTCGTCGCGGTGAGCCTGCACACCGGGGTCCGGCGCGACCAGTTGGTGCTGTCGAGCAAGGCGGTGCGCCGCGGCCTGGAGGGTAATTTCGTCTACCGGGTCGCCGCCGACCGGGTCGAGGCGGTGCCAGTGCGGGTGCTCCAGGACATCGACGGCCTCAGTGTGGTGGAAGGCCTGGCCAGCGGTGACCAGGTGGTGGTGGACGGCCACTCGCGGCTGATGCCCGGCGCCCTGGTCGATATCCAGGAGCCGCGCCCGAGCCTGGCTCAGGCGGCGGAGCGGCAGCCGTGA,MQALRSSGGRVLVGVLAAGLVAFGGWAWLGGDAGAKAAPAPARVPVNVARVERRDVEQQVSGIGTVTSLHNVVIRTQIDGQLTRLLVSEGQMVEAGELLATIDDRAVVAALEQAQASRASNQAQLKSAEQDLQRYRSLYAERAVSRQLLDQQQATVDQLRATLKANDATINAERVRLSYTRITSPVSGKVGIRNVDVGNLVRVGDSLGLFSVTQIAPISVVFSLQQEQLPQLQALLGGEAAVRAYSRDGGSALGEGRLLTIDNQIDSSTGTIRVRASFDNRQARLWPGQFVAVSLHTGVRRDQLVLSSKAVRRGLEGNFVYRVAADRVEAVPVRVLQDIDGLSVVEGLASGDQVVVDGHSRLMPGALVDIQEPRPSLAQAAERQP,MQALRSGGGRVLVGVLAAGLVAFGGWAWLGGDAGAKAAPAPARVPVIVARVERRDVEQQVSGIGTVTSLHNVVIRTQIDGQLTRLLVSEGQMVEAGELLATIDDRAVVAALEQAQASRASNQAQLKSAEQDLQRYRSLYAERAVSRQLLDQQQATVDQLRATLKANDATINAERVRLSYTRITSPVSGKVGIRNVDVGNLVRVGDSLGLFSVTQIAPISVVFSLQQEQLLQLQALLGGEAAVRAYSRDGGSALGEGRLLTIDNQIDSSTGTIRVRASFDNRQARLWPGQFVAVSLHTGVRRDQLVLSSKAVRRGLEGNFVYRVADDRVEAVPVRVLQDIDGLSVVEGLASGDQVVVDGHSRLMPGALVDIQEPRPSLAQATERRP,100.00,gnl|BL_ORD_ID|2014|hsp_num:0,2216,,,0,1155,chloramphenicol; thiamphenicol
1967,tcs_502,NODE_139_length_10802_cov_5.861227_4 # 3071 # 6181 # 1 # ID=139_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.679,NODE_139_length_10802_cov_5.861227_4,3071,6181,+,Strict,1900,1913.3,mexN,99.61,3003705,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGACGCCGCGCGCCGGGATTTCCGGCTGGTGCGTACGGCACCCGATCGCCACCGCGCTGCTGACCCTGGCCTCGCTGCTGCTGGGGCTGCTGGCGTTCCTCCGGCTCGGTGTGGCGCCGTTGCCGGAGGCGGACTTCCCGACCATCCAGATCAACGCCTTGCTGCCCGGCGGTAGCCCGGAAACCATGGCCTCGTCGGTGGCCACCCCCTTGGAAGTGCAGTTCAGCGCGATTCCCGGGATCACCGAGATGACTTCCAGCAGCGCCCTGGGCACCACCACCCTGACCCTGCAGTTCAGCCTCGACAAGAGCATCGACGTCGCCGCCCAGGAGGTCCAGGCGGCGATCAACGCCGCGGCGGGGCGGCTGCCGGTGGACATGCCGAACCTGCCGACCTGGCGCAAGGTCAACCCGGCGGACAGCCCGATCATGATCCTGCGGGTCAACTCGGAGATGATGCCGCTGATCGAACTCAGCGATTACGCCGAGACCATCCTCGCCCGCCAGCTCAGCCAGGTGAACGGCGTGGGGCAGATCTTCGTGGTCGGCCAGCAGCGCCCGGCGATCCGCATCCAGGCCCAGCCGGAGAAGCTCGCCGCCTACCAGCTGACCCTGGCCGACCTGCGCCAGTCGTTGCAGTCGGCCAGCGTCAACCTGGCCAAGGGCGCGCTCTACGGCGAGGGGCGGGTGTCGACCCTCGCGGCCAACGACCAGTTGTTCAACGCCAGCGACTATGACGACCTGGTGGTCGCCTACCGCCAGGGCGCGCCGGTGTTCCTCAAGGACGTGGCGCGGATCGTCTCGGCGCCCGAGGACGACTACGTGCAGGCCTGGCCGAACGGGGTGCCCGGGGTGGCACTGGTGATCCTCCGCCAGCCTGGGGCGAACATCGTCGATACCGCCGACGCGATCCAGGCCGCATTGCCGCGCCTGCGCGAGATGCTCCCGGCGACCATCGAGGTAGACGTGCTCAACGATCGCACCCGGACCATCCGCTCGTCGCTGCACGAGGTCGAACTGACCCTGCTGCTGACCATTGGCCTGGTGGTGCTGGTGATGGGCCTGTTCCTCCGCCAGCTGTCGGCGACCCTGATCGTCGCCACGGTGCTGGCGGTGTCCCTGAGCGCCAGCTTCGCGGCGATGTACGTGCTCGGTTTCACCCTCAACAACCTGACCCTGGTGGCGCTGATCATCGCCGTCGGCTTCATCGTCGACGACGCCATCGTGGTCGTGGAGAACATCCACCGACACCTGGAAGCGGGCGCCTCGAAGGTCGAGGCGGCGCTCAAGGGCGCGGCGGAGATCGGCTTTACCGTGATTTCCATCAGCTTCTCGCTGATCGCCGCGTTCATTCCCCTGCTGTTCATGGGCGGGATCGTCGGCCGGCTGTTCCGCGAATTCGCGGTCAGCGTGACGGTGGCGATCCTGATCTCGGTGCTCGCTTCGCTGACCCTGGCGCCGATGCTGGCTTCGCGCTTCATGCCGGCATTGCGGCATGCCGACGCGCCGAGAAAGGGCTTCGCCGAATGGCTGACCGGCGGCTACGAACGCGGCCTGCGCTGGGCGCTCGGGCACCAGCGGCTGATGCTGGTCGGCTTCGCCTTTACCGTGCTGGTGGCGGTGGCCGGCTACGTCGGGATTCCCAAGGGTTTCTTCCCCTTGCAGGACACCGCCTTCGTCTTCGGCACGAGCCAGGCTGCCGAGGATATCTCCTACGACGACATGGTCGCCAAGCACCGGCAACTGGCCGAGATCATCGCCAGCGACCCGGCGGTGCAGAGCTACAACCATGCGGTGGGCGTCACCGGCGGTAGCCAGAGCCTGGCCAACGGACGTTTCTGGATCGTCCTCAAGGACCGTGGCGAGCGCGATGTCTCGGTCGGCGAGTTCATCGACCGGCTGCGCCCGCAACTGGCGAAGGTGCCGGGAATCATGCTCTACCTGCGCGCGGCGCAGGACATCAACCTCAGTTCCGGACCCTCGCGGACCCAGTACCAGTACGCCCTGCGCAGCAGCGACAGCACCCAGCTGGCGCTCTGGGCGCAACGCCTCACCGAGCGCCTGAAGCAGGTGCCGGGGCTGATGGATGTGTCCAACGACCTGCAGGTCGGCGCCAGCGTCACCGCGCTGGACATCGACCGGGTGGCCGCGGCGCGTTTCGGCCTCAGCGCCGAGGATGTCAGCCAGACCCTCTACGACGCCTTCGGCCAGCGCCAGGTCGGCGAGTACCAGACCGAGGTCAACCAGTACAAGGTGGTCCTCGAACTCGATGCGCGCCAGCGCGGCCGCGCGGAAAGCCTGGACTGGTTCTACCTGCGCTCGCCGCTGAGCGGCGAGATGGTCCCGCTGTCGGCCATCGCCAAGGTCGCGGCGCCGCGCTCCGGGCCGCTGCAGATCAACCACAACGGCATGTTCCCGGCGGTCAACCTGTCCTTCAACCTGGCTGCCGGGGTGTCCCTCGGCGAGGCGGTGCAGGCGGTGCAGCGCGCCCAGGAGGAGATCGGCATGCCCTCGACCATTATCGGCGTGTTCCAGGGCGCGGCGCAGGCCTTCCAGAGCTCGCTGGCCTCGCAACCGCTGCTGATCCTCGCCGCGCTGATCGCGGTGTACATCATCCTCGGCGTGCTCTACGAGAGTTTCGTACATCCGCTGACGATCCTCTCGACCCTGCCCTCGGCGGGGATCGGCGCGGTGTTCCTGCTCTGGGCCTGGGGCCAGGACTTCTCGATCATGGCGCTGATCGGCATCGTGCTGCTGATCGGCATCGTCAAGAAGAACGGCATCCTCATGGTCGACTTCGCCATCGTCGCCCAGCGCGAGCAGGGCATGAACGCGGAGCAGGCGATCTACCAGGCCTGCCTGACCCGTTTCCGGCCGATCATGATGACCACCCTGGCCGCGCTGCTGGGCGCGATACCCCTGATGATCGGCTTCGGCACCGGTTCCGAGCTGCGCCAGCCTCTGGGCATCGCGGTGGTCGGCGGGCTGCTGGTGAGCCAGGTGCTGACCCTGTTCAGCACGCCGGTGGTATACCTGGCCCTGGAGCGGCTGTTCCACCGGCGCGGGACGACGACCTCGGACGGCGGAACCGCTGGGGCGACGGCGACATGA,MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVLASLTLAPMLASRFMPALRHADAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVFGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMNAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT,MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT,100.00,gnl|BL_ORD_ID|2015|hsp_num:0,2217,,,0,3108,chloramphenicol; thiamphenicol
1968,tcs_502,NODE_178_length_9627_cov_6.697958_5 # 4569 # 5699 # 1 # ID=178_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.667,NODE_178_length_9627_cov_6.697958_5,4569,5699,+,Strict,650,699.9,MexV,99.73,3003030,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTTGCTCCGCCGCATGTTGATCATGCTCGCCGCGGTGATCGCCGTGGTGGCGATTCTCGCCGGCTACAAGGTCTACTCCATCCGTCAGCAGATCGCCCTTTTCAGCGCACCGAAACCGCCGATCAGCGTGACCGCCAGCCTGGCCGAAAAGCGTCCCTGGCAGAGCCGCCTGCCAGCCATCGGCAGCCTCAAGGCATTCCAGGGCGTGACCCTCACCGCCGAAGTCTCCGGCACGGTACGCGACGTACTGTTCCTTTCCGGCGACCAGGTGAAGCTGGACCAACCGCTGATCCAGTTGGAAAGCGACGTCGAGGAAGCCACCCTGCGCACTGCCGAGGCCGATCTCGGCCTGGCCAGGGCCGAGTACCAGCGCGGCCGCGAACTGATCGGCAGCAAGGCCATCTCGAAAAGCGAATTCGATCGTCTCGCCGCGCAGTGGGCCAAGACCAGCGCCACCGTCGCCGAGCTGAAGGCGGCGCTGGCGAAGAAGCGCGTGCTCGCGCCCTTCGCCGGGACCATCGGCATCCGCCAGGTGGACGTCGGCGACTACGTCTCGCCCGGGACGCCGATCGCCACCTTGCAGGACCTTTCCACCCTGCTCCTGGATTTCCACCTGCCCGAGCAGGACTTCCCCCTGCTCAGCCGCGGCCAACTGGTGAAGGTCCGGGTCGCCGCCTACCCCGCCCAGGTGTTCGACGCCGAGATCGCCGCCATCAACCCCAAGGTCGACAACGAGACCCGCAACCTGCAGGTCCGCGCTGCCCTGGAGAACCCGGACGGCAAGCTGCTGCCGGGCATGTTCGCCAACCTCGAGGTGATGTTGCCTGGCGAGGAACAACGCGTCGTGGTCCCGGAGACGGCGATCACCTTCACCCTCTACGGCGACTCGATCTACGTCGTCGGGCAGAAGAAGGACGAGCAGGGCCAGGTGTCGAAGGATGACAAGGGCCAGCCGCAACGGGTCGTCGAGCGCCGCTTCGTCAGGATCGGCGAACGCCGCGAAGGCCTGGCGGTGGTGCTCGAAGGCCTGGAGGGCGGCGAGCAGGTAGTGACTTCCGGGCAACTGAAGCTCGACAACGGCGCCGCGGTGGCCATCGTCGCCGAGCGGGACCTCCAGCAAGAGCACTGA,MLLRRMLIMLAAVIAVVAILAGYKVYSIRQQIALFSAPKPPISVTASLAEKRPWQSRLPAIGSLKAFQGVTLTAEVSGTVRDVLFLSGDQVKLDQPLIQLESDVEEATLRTAEADLGLARAEYQRGRELIGSKAISKSEFDRLAAQWAKTSATVAELKAALAKKRVLAPFAGTIGIRQVDVGDYVSPGTPIATLQDLSTLLLDFHLPEQDFPLLSRGQLVKVRVAAYPAQVFDAEIAAINPKVDNETRNLQVRAALENPDGKLLPGMFANLEVMLPGEEQRVVVPETAITFTLYGDSIYVVGQKKDEQGQVSKDDKGQPQRVVERRFVRIGERREGLAVVLEGLEGGEQVVTSGQLKLDNGAAVAIVAERDLQQEH,MLLRRMLIMLAAVIAVVAILAGYKVYSIRQQIALFSAPKPPISVTASLAEKRPWQSRLPAIGSLKAFQGVTLTAEVSGTVRDVLFLSGDQVKLDQPLIQLESDVEEATLRTAEADLGLARAEYQRGRELIGSKAISKSEFDRLAAQWAKTSATVAELKAALAKKRVLAPFAGTIGIRQVDVGDYVSPGTPIATLQDLSTLLLDFHLPEQDFPLLSRGQLVKVRVAAYPAQVFDAEIAAINPKVDNETRNLQVRAALENPDGKLLPGMFANLEVMLPGEEQRVVVPETAITFTLYGDSIYVVGQKKDEQGQVSKDDKGQPQQVVERRFVRIGERREGLAVVLEGLEGGEQVVTSGQLKLDNGAAVAIVAERDLQQEH,100.00,gnl|BL_ORD_ID|2011|hsp_num:0,2207,,,0,1128,erythromycin; acriflavine; tetracycline; chloramphenicol
1969,tcs_502,NODE_178_length_9627_cov_6.697958_6 # 5750 # 8806 # 1 # ID=178_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.645,NODE_178_length_9627_cov_6.697958_6,5750,8806,+,Strict,1900,1904.8,MexW,99.9,3003031,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTTTTACCGATCCGTTCATCCGTCGTCCGGTCCTGGCGAGCGTGGTCAGCCTGCTGATCGTCCTGCTCGGCATGCAGGCCTTCAGCAAGCTGGTGATCCGCGAGTATCCGCAAATGGAGAACGCGCTGATCACGGTGACCACGCTCTACGCCGGCGCCAACGCGGAAACCATCCAGGGCTACATCACCCAGCCGCTGCAGCAGAGCCTGGCCAGCGCCGAAGGCATCGACTACATGACCTCGGTGAGCCGGCAGAACTATTCGACCATCTCCATCTACGCGCGGATCGGCGCCAATACCGATCGCCTGGTCACCGAGCTGCTGGCCAAGTCCAACGAAGTGAAGAGCCAGCTGCCGCCGGACGCCGAGGACCCGGTGCTGCAGAAGGAGGCCGCGGACGCCTCGGCGCTGATGTACATCAGCTTCTACAGCGAGCAGATGAACAACCCGCAGATCACCGACTACCTGTCGCGGGTGATCCAGCCCAAGCTGGCGACCCTGCCCGGTATCGCCGAGGCGGAGATCCTCGGCAACCAGGTGTTCGCCATGCGCCTGTGGCTGGACCCGGTGAAGATGGCCGCGTTCGGCGTCACCGCCGGCGAGATCAACCAGGCGGTGCAGCAGTACAACTTCCTCGCCGCCGCCGGCGAGGTGAAGGGCCAGTTGGTGGTCACCAGCGTCAATGCTTCCACCGACCTCAAGTCGCCCCAGGCCTTCGCCGCCATCCCGGTGAAGACCGACGGCGACCGCCGGGTGCTGATGGGTGATGTCGCACGGGTCGAGCTGGGCGCCGCCAGCTACGACGCGATCAGTTCGTTCAATGGGATTCCCTCGGTCTACATCGGCATCAAGGGCACGCCCAGCGCCAACCCGCTGGACGTGATCAAGGAAGTGCGGGCGAAGATGCCCGAACTGGAAGAGCAATTGCCGCCCAACCTCAAGGTGTCCATCGCCTACGACGCCACGCGCTTCATTCAGGCCTCCATCGATGAAGTGGTGAAGACCCTCGGCGAGGCGGTGCTGATCGTCATCGTGGTGGTGTTCCTGTTCCTCGGCGCGTTCCGTTCGGTACTGATCCCGGTGGTGACCATTCCGCTGTCGATGATCGGCGTATTGTTCTTCATGCAGGCCATGGGCTACTCGATCAACCTGCTGACCCTGCTGGCGATGGTCCTGGCCATCGGCCTGGTGGTGGACGACGCGATCGTGGTGGTGGAAAACATCCACCGCCACATCGAGGAGGGCAAGCCGCCCTTCGAGGCTGCCCTGGAGGGCGCGCGGGAGATCGCCGTACCGGTGGTCAGCATGACCATCACCCTCGCCGCGGTCTACGCGCCGATCGGCTTCCTCACCGGCCTCACCGGCGCCCTGTTCAAGGAGTTCGCCTTCACCCTGGCCGGCGCGGTGATCATTTCCGGGATCGTCGCCCTGACCCTGTCGCCGATGATGTGCTCGCGCCTGTTGCGCCACGAGGAGAATCCCTCGGGCCTGGCGCATCGCCTCGACCTGATCTTCGAGGGCCTGAAGCAACGCTACCAGCGCGCCCTCCACGGCACCCTGGACACCCGTCCGGTGGTCCTGGTGTTCGCCGTGCTGGTACTGGCGCTGATCCCGGTACTGCTGATGTTCACCAAGAAGGAGCTGGCGCCGGAAGAGGACCAGGGCATCGTGTTCCTCATGACCAACTCGCCGCAAACCGCCAACCTCGACTACCTGAATCACTACACCGCCGAGTTCGAAGGCATCTTCCGCAGCTTCCCGGAGTATTACTCGGCGTTCCAGATCAACGGCTACAACGGCGTCCAGGCCGGCATCGGCGGCATGCTGCTCAAGCCCTGGGACGAACGCGAAAAGAGCCAGATGGAATTGCTCCATGCGGTGCAGGCGAAGCTCAACGAGATTCCCGGCGTGCAGATCTTCGCCTTCAACCTGCCGTCGCTACCGGGCACCGGCGAGGGCCTGCCATTCCAGTTCGTGCTCAACACCGCCAACGACTACGAGTCGCTGCTGCAAGTGGCGCAACGGGTGAAGCAGCGCGCCAGCGAGTCCGGCAAGTTCGCCTTCCTCGATCTCGACCTGGCGTTCGACAAACCCGAGCTGGTGGTCGACATCGACCGCGAGAAGGCCGCGCAGATGGGCGTCTCCATGCAGGACCTGGGGGTGGCGCTGGCCAGCCTGCTCGGCGAGGGCGAGATCAACCGCTTCACCATCGACGGGCGCAGCTACAAGGTCATCGCCCAGGTCGAACGCCCCTATCGCGACAATCCCGGCTGGCTCGGCAGCTACTACGTGAAGAGCCGCAACGGCCAACTGGTCGCCCTCTCGACCCTGATCGAGACCCACGAACGGGCACGGCCACGGCAACTGAACCAGTTCCAGCAGCTCAACTCGGCGATCATCTCCGGCTTCCCCATCGTCAGCATGGGCGAGGCCATCGAGACGGTTCAGCAGATCGCCCGCGAGGAAGCCCCGCGTGGCTTCGCCGTCGACTACGCCGGCGCTTCCCGGCAATACGTGCAGGAAGGCAGCGCATTGCTGGTCACCTTCGGACTGGCCCTGGCGATCATCTTCCTGGTCCTCGCCGCACAGTTCGAAAGCTTCCGCGATCCGCTGGTGATCATGGTCACCGTGCCGCTGTCGATCTGCGGTGCGCTGATACCGCTGTTCCTCGGCGTGTCGAGCCTGAACATCTATACCCAGGTCGGCCTGGTGACACTGATCGGCCTGATCAGCAAACACGGCATCCTGATCGTCGAGTTCGCCAACCAGTTGCGCCACGAACAGGGGCTGGGGCGTCGCGAGGCCATCGAGCAGGCCGCCGCGATCCGCCTGCGGCCAGTACTGATGACCACCGCGGCTATGGTGCTCGGGGTGATCCCGCTGATCCTCGCCACCGGCGCCGGGGCGGTCAGTCGCTTCGACATCGGCATCGTGATCGCGACCGGCATGTCGGTGGGCACCCTCTTCACCCTGTTCGTCCTGCCGTGCATCTACACCCTGGTGGCCAGGCCGGATGCCCCGCCAGGCGTGACGCAAGCGGCAAACGCACACTGA,MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNHYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH,MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH,100.00,gnl|BL_ORD_ID|2012|hsp_num:0,2208,,,0,3054,erythromycin; acriflavine; tetracycline; chloramphenicol
1970,tcs_502,NODE_222_length_8200_cov_5.678987_3 # 1553 # 2374 # 1 # ID=222_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.661,NODE_222_length_8200_cov_5.678987_3,1553,2374,+,Strict,50,142.9,vanW gene in vanG cluster,31.58,3002965,protein homolog model,n/a,n/a,glycopeptide antibiotic,antibiotic target alteration,vanW; glycopeptide resistance gene cluster,ATGCGCAAACCCCTATCGCTCTACCACCCCTGGCTCTACTGGCTGCGGGTCTGGCAACGACGTCTCTGGCGGCACTGCCGCTGGCGTCTTGGCGGCCGTCGCTACGTGCGGTTGCCATCGATCGACGAGCGCCTGCCGTACCGCTACATCAAGCACACCTCGAAGTTGATCCGCCGCCTCGGCGACAGCGACCTCGCCCTGCAACGCAACAAGGTGGTCAACCTGCGCCTGGCGGTGGACTGCATGAACGGCGTGAGCATCGGCCCCGGCGAGTACTTCTCGTTCTGCCGGCTGGTCGGTCGGCCCAGCGCCCGGCGTGGCTTCGTCGAAGGTATGGAGTTGTCCTTCGGCGAGGCGCGCAGCGGAATCGGCGGCGGCATCTGCCAACTGAGCAACCTGATCCACTGGATGGCCCTGCATTCCCCGCTGCGCGTGGTGGAGCGGGCCAACCACAGCTTCGACCCGTTTCCCGACGAGGGACGGATCCTGCCGTTCGGCTCGGGCGCGGCGATCTTCTACAACTTCATCGACCTGGTGCTGCACAATCCGACGGCGGATACCTTCCAGCTGCGCTTCCATATCGCCGCCCACCAACTGGAAGGCGAACTGCTGTGCAGCGCGCCGCGCCCTGTGCGCTACCACGTCTATGAGAGGGCCCAGCGCTTTGTCCGCGACGGCGATGCGGTGCTGAGGCTCAACGAGATCTGGCGCGACATCCGGGAAAAGGGCCAGGCCGGCACCCTGCTGGCCAGCGAGTGCCTGTACCGCAACCGGGTGCGCGTGAAGTATCCGGTGGAAGAGGCCCGCCTGTCCCGAGATTGA,MRKPLSLYHPWLYWLRVWQRRLWRHCRWRLGGRRYVRLPSIDERLPYRYIKHTSKLIRRLGDSDLALQRNKVVNLRLAVDCMNGVSIGPGEYFSFCRLVGRPSARRGFVEGMELSFGEARSGIGGGICQLSNLIHWMALHSPLRVVERANHSFDPFPDEGRILPFGSGAAIFYNFIDLVLHNPTADTFQLRFHIAAHQLEGELLCSAPRPVRYHVYERAQRFVRDGDAVLRLNEIWRDIREKGQAGTLLASECLYRNRVRVKYPVEEARLSRD,MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV,97.15,gnl|BL_ORD_ID|4756|hsp_num:0,1622,,,27,816,vancomycin
1971,tcs_502,NODE_224_length_8091_cov_6.335277_8 # 7070 # 8089 # 1 # ID=224_8;partial=01;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.685,NODE_224_length_8091_cov_6.335277_8,7070,8089,+,Strict,500,687.6,PDC-639,99.41,3008986,protein homolog model,n/a,n/a,monobactam; carbapenem; cephalosporin,antibiotic inactivation,PDC beta-lactamase,ATGCGCGATACCAGATTCCCCTGCCTGTGCGGCATCGCCGCTTCCACACTGCTGTTCGCCACCACCCCGGCCATTGCCGGCGAGGCCCCGGCGGATCGCCTGAAGGCACTGGTCGACGCCGCCGTACAACCGGTGATGAAGGCCAATGACATTCCGGGCCTGGCCGTAGCCATCAGCCTGAAAGGAGAACCGCATTACTTCAGCTATGGGCTGGCCTCGAAAGAGGACGGCCGCCGGGTGACGCCGGAGACCCTGTTCGAGATCGGCTCGGTGAGCAAGACCTTCACCGCCACCCTCGCCGGCTATGCCCTGGCCCAGGACAAGATGCGTCTCGACGACCGCGCCAGCCAGCACTGGCCGGCACTGCAGGGCAGCCGCTTCGACGGCATCAGCCTGCTCGACCTCGCGACCTATACCGCCGGCGGCTTGCCGCTGCAGTTCCCCGACTCGGTGCAGAAGGACCAGGCACAGATCCGCGACTACTACCGCCAGTGGCAGCCGACCTACGCGCCGGGCAGCCAGCGCCGCTATTCCAACCCGAGCATCGGCCTGTTCGGCTATCTCGCCGCGCGCAGCCTGGGCCAGCCGTTCGAACGGCTCATGGAGCAGCAAGTGTTCCCGGCACTGGGCCTCGAACAGACCCACCTCGACGTGCCCGAGGCGGCGCTGGCGCAGTACGCCCAGGGCTACGGCAAGGACGACCGCCCGCTACGGGTCGGTCCCGGCCCGCTGGATGCCGAAGGCTACGGGGTGAAGACCAGCGCGGCCGACCTGCTGCGCTTCGTCGATGCCAACCTGCATCCGGAGCGCCTGGACAGGCCCTGGGCGCAGGCGCTCGATGCCACCCATCGCGGTTACTACAAGGTCGGCGACATGACCCAGGGCCTGTGCTGGGAAGCCTACGACTGGCCGATCTCCCTGAAGCGCCTGCAGGCCGGCAACTCGACGCCGATGGCGCTGCAACCGCACAGGATCGCCAGGCTGCCCGCGCCACAGGCGCTGGAGGGCCAGCGCCTGCTG,MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLCWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL,MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWEQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR,85.64,gnl|BL_ORD_ID|6178|hsp_num:0,8404,,,0,1020,
1972,tcs_502,NODE_255_length_7455_cov_6.250741_4 # 3186 # 4343 # 1 # ID=255_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.695,NODE_255_length_7455_cov_6.250741_4,3186,4343,+,Strict,650,724.9,mexP,99.74,3003698,protein homolog model,n/a,n/a,macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAATCTCAGACACTTCATCCGCATCACCGCGACGCTAGGTGTCGCGGCCCTTATCGCTGGCTGCGGGGAGTCGGCGCCGCCGGGGGCGGCGAGCGCCCCGCCAAGCGTTCCCGTCGCCGAGGTGGTGGTTCGCCCGGTGACACCCTACGCCGAGTTCACCGGCTCGCTGACCGCTGTCGAGCAGGTAGAACTGCGGCCGCGCGTCGCCGGCTACATCCAGGACGTTACGGTGCCGGAAGGCCGCCTGGTGGAGAAGGGCCAGCAACTGTTCCTCATCGACCCGCGCGTGTTCAAGGCGGCGCAGGATGCCGCCAGGGCACGCCTGCGCGAGGCCGAGGCCGCGGCGTTGCTGGCGCGCACCGAACACGAGCGAGCCGAGCTGCTGTATGCGCGGAAGGTCGTCGCCCGGGAGCGGCTCGACAGCGCCATCGCCTCGCGCAATGCCAGCAAGGCCCAGGTCGATGCGGCCAGGGCCGCCCTCGACGCGGCGCAACTGGATCTCGGCTTCACGCGGGTGACGGCACCGATCGGCGGGCGTGTCGGGCATATCCAGGTCACCGAGGGCAACTACGTCACCAATGGCGTCACCGCGCTGACCAGCATCGTTTCGGTCGATCCGCTGTACGTGTACTTCGATGTCGACGAGCGCACCTACCTGCAGGCCCTGGCGCCGACCCGCGGCAGGGAAGGCGAGCAGGCCCCCAGGGTCAAGGTGGCGCTGCTCACCGACGAGTCCTATGGACGAAGCAGTCGCCTCGATTTCCTCGCCAACGCCGCCGACCGCGGGACCGGCACGGTCCGGGTTCGGGCGGTGGTGGACAACCCGGACGGGCAACTGACGCCGGGGCTGTTCGCCAAGGTCAGGCTGGAGACCGGCAAGCCTCGCGCGCAGGTGCTGGTCGCCGACCATTCCATCGGCACCGACCAGGGCAGGCGCTATGTGCTGGTCGTCGACGAAGGCAACAAGACCCAGTACCGGCCGGTGGAACTCGGCCCGATGGTCGACGGCCTGCGGGTCGTCCGCCAGGGCCTGCAGCCGGGCGAGCGCATCGTCGTCAAGGGCCTGGTGCGGCCGGACATGCAGATCACGCCGCTCCTTGCGGAAATCGATGGCACGCCCGTCGACCTGTCGAAGACCGTGGGGGCCGCACAATGA,MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPLLAEIDGTPVDLSKTVGAAQ,MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGAAQ,100.00,gnl|BL_ORD_ID|2002|hsp_num:0,2211,,,0,1155,erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
1973,tcs_502,NODE_315_length_6389_cov_5.743553_5 # 2990 # 4486 # -1 # ID=315_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.697,NODE_315_length_6389_cov_5.743553_5,2990,4486,-,Perfect,850,944.1,OpmB,100.0,3004072,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAACACACCCCCTCGTTGCTCGCCCTGGCCCTGGTCGCCGCCCTCGGCGGCTGCGCCATCGGCCCCGACTACCAGCGACCGGACCTGGCGGTGCCCGCCGAATTCAAGGAAGCCGAAGGCTGGCGCCGCGCCGAGCCGCGCGACGTGTTCCAGCGCGGCGCCTGGTGGGAGCTGTACGGCGACCAGACCCTGAACGACCTGCAGATGCACCTGGAACGTTCCAACCAGACCCTGGCCCAGTCGGTGGCGCAGTTCCGCCAGGCCGAGGCGCTGGTGCGCGGCGCGCGGGCGGCGTTCTTCCCGTCGATCACCGGCAACGTGGGCAAGACCCGCAGCGGCCAGGGCGGCGGCGACAGCACCGTGTTGCTGCCGGGAGGCTCGACGGTGAGCAGCGGCGGCTCTGGCGCGATCAGCACCAGCTACTCGACCAACCTCAGTGTCAGCTGGGAGGTCGACCTCTGGGGCAAGCTGCGCCGGCAACTGGAGGCCAACCAGGCGAGCCTGCATGCCAGCGCCGCCGACCTCGCCGCGGTGCGCCTCAGCCAGCAGTCGCAACTGGCGCAGAACTACCTGCAACTGCGGGTGATGGACGAACAGATCCGCCTGCTCAACGACACGGTGACGGCCTACGAGCGTTCGCTGAAGGTGGCCGAGAACAAATACCGCGCCGGCATCGTCACCAGGGCCGACGTGGCCCAGGCCCGCACCCAGCTGAAAAGCACCCAGGCCCAGGCCATCGACCTGAAGTACCAGCGTGCCCAGCTGGAGCACGCCATCGCCGTGCTGGTCGGCCTGCCGCCGGCGCAATTCAACCTGCCGCCGGTGGCGAGCGTGCCGAAGCTGCCGGACCTGCCGGCAGTGGTGCCGTCGCAATTGCTCGAGCGGCGGCCGGACATCGCCTCGGCGGAACGCAAGGTGATTTCCGCCAACGCCCAGATCGGCGTGGCCAAGGCCGCCTATTTCCCCGACCTCACCCTGAGCGCCGCCGGCGGCTACCGCAGCGGCAGCCTGAGCAACTGGATCAGCACGCCGAACCGCTTCTGGTCGATCGGCCCGCAGTTCGCCATGACCCTGTTCGACGGCGGCCTGATCGGCTCCCAGGTGGACCAGGCCGAGGCGACCTACGACCAGACCGTGGCGACCTACCGGCAGACCGTGCTCGACGGTTTCCGCGAGGTGGAGGACTACCTGGTGCAATTGAGCGTCCTCGACGAGGAGAGCGGGGTGCAGCGCGAAGCCCTGGAGTCGGCCCGCGAGGCACTGCGCCTGGCCGAGAACCAGTACAAGGCCGGCACCGTCGACTACACCGACGTGGTCACCAACCAGGCCACCGCGCTGAGCAACGAACGCACCGTGCTGACCCTGCTTGGCAGCCGCCTGACCGCCAGCGTCCAGTTGATCGCGGCAATGGGCGGCGGCTGGGACAGCGCCGACATCGAGCGGACCGACGAGCGGCTCGGCCGGGTCGAAGAGGGCCTGCCGCCTTCGCCCTGA,MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP,MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP,100.00,gnl|BL_ORD_ID|2314|hsp_num:0,2716,,,0,1494,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1974,tcs_502,NODE_315_length_6389_cov_5.743553_6 # 4483 # 6387 # -1 # ID=315_6;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.676,NODE_315_length_6389_cov_5.743553_6 ,4483,6387,-,Strict,1900,1202.2,MuxC,100.0,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GACGACGCCATCGTGGTGGTGGAGAACATCGCCCGACGCATCGAGGAGGGCGATCCGCCGATCCAGGCGGCGATCACCGGCGCCCGCCAGGTCGGTTTCACCGTGCTGTCGATGACGCTCTCGCTGGTCGCGGTGTTCATCCCGCTGCTGCTCATGGGCGGCCTCACCGGACGGCTGTTCCGCGAGTTCGCGGTGACTCTCTCGGCGGCGATCCTGGTGTCCCTGGTGGTATCCCTGACCCTCACGCCGATGCTCTGCGCGCGTCTGCTGCGTCCGCTGAAACGGCCCGAAGGCGCTTCCCTGGCGCGGCGCAGCGATCGCTTCTTCGCCGCCTTCATGCTGCGCTACCGCGCCAGCCTGGGCTGGGCGCTGGAGCACTCGCGGCTGATGGTGGTGATCATGCTGGCCTGCATCGCCATGAACCTCTGGTTGTTCGTGGTGGTGCCCAAGGGCTTCCTCCCGCAGCAGGACTCCGGGCGCCTGCGCGGCTACGCGGTGGCCGACCAGAGCATCTCGTTCCAGTCCCTGAGCGCGAAGATGGGCGAGTACCGCAAGATCCTCTCTTCCGATCCGGCGGTGGAAAACGTAGTCGGCTTCATCGGTGGCGGCCGTTGGCAGTCGAGCAACACCGGTTCGTTCTTCGTCACTCTCAAGCCGATCGGCGAGCGCGACCCGGTGGAGAAGGTCCTCACCCGGCTGCGCGAGCGGATCGCCAAGGTGCCCGGCGCGGCGCTCTATCTCAACGCCGGCCAGGACGTGCGCCTGGGCGGCCGCGACAGCAACGCGCAGTACGAATTCACCCTGCGCAGCGACGACCTGACCCTGCTCCGCGAATGGGCGCCGAAGGTCGAGGCGGCGATGCGCAAGCTGCCGCAGCTGGTGGACGTCAACAGCGACTCCCAGGACAAGGGCGTGCAGACCCGCCTGGTGATCGACCGCGACCGCGCGGCGACCCTGGGGATCAACGTGGAAATGGTCGACGCGGTGCTCAACGACTCTTTCGGCCAGCGCCAGGTGTCGACCATCTTCAACCCGCTGAACCAGTACCGGGTGGTGATGGAGGTCGACCAGCAGTACCAGCAGAGCCCGGAGATCCTCCGCCAGGTCCAGGTGATCGGCAACGACGGCCAGCGCGTGCCGCTGTCCGCGTTCAGCCACTACGAACCGAGCCGGGCACCGCTGGAGGTCAACCATCAGGGCCAGTTCGCCGCCACCACGCTGTCCTTCAACCTGGCACCGGGCGCGCAGATCGGCCCGACCCGCGAGGCCATCATGCAGGCCCTGGAGCCGCTGCACATCCCGGTGGACGTGCAGACCAGCTTCGAGGGCAACGCCGGCGCGGTGCAGGACACGCAGAACCAGATGCCCTGGCTGATCCTCCTGGCGCTGCTGGCGGTGTACATCGTCCTCGGCATCCTCTACGAGAGCTACGTGCACCCGCTGACCATCCTCTCGACCCTGCCTTCGGCCGGGGTCGGCGCGCTGCTCGCGCTGATCCTCTGCCGCAGCGAGCTGAGCCTGATCGCGCTGATCGGCATCATCCTGCTGATCGGCATCGTCAAGAAGAACGCGATCATGATGATCGACTTCGCCCTGGAGGCCGAGCGCAACCACGGCCTGAGCCCGCGCGAGGCGATCCTCGAGGCCTGCATGATGCGCTTCCGGCCGATCATGATGACCACCCTGGCCGCCTTGCTCGGCGCCTTGCCGCTGATCTTCGGCATCGGCGGCGACGCCGCGCTGCGCCGGCCGCTGGGCATCACCATCGTCGGCGGGCTGATCGGCAGCCAGTTGCTGACCCTGTACACCACCCCGGTGGTCTACCTCTATCTCGACCGCCTGCGCCACTGGGTCAACCAGAAACGCGGCGTACGCACGGACGGTGCGCTGGAGACACCCCTATGA,DDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,61.20,gnl|BL_ORD_ID|2370|hsp_num:0,2720,True,loose hit with at least 95 percent identity pushed strict,1206,3108,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1975,tcs_502,NODE_359_length_5887_cov_5.648856_6 # 5302 # 5886 # 1 # ID=359_6;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.697,NODE_359_length_5887_cov_5.648856_6 ,5302,5886,+,Strict,1200,396.0,arnA,100.0,3002985,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,ATGACCTCGAAAGCCGTCGTCTTCGCCTACCACGACATCGGTTGCACCGGTATCGAAGCCCTGCTCAATGCCGGCTACGAGATCGCCGCCGTCTTCACCCATGCCGACGACCCACGGGAAAACACCTTCTACGCCTCGGTCGCGCGCCTCTGTGCCGAGCGCGGCATTCCGCTGCACGCGCCCGAGGACGTGAACCATCCGCTGTGGCTGGAGCGCATCCGCCAACTGCGCCCGGACTTCCTGTTCTCCTTCTACTACCGCCGCCTGCTCGGCGCCGAGCTGCTCGCCTGCGCCGCACGCGGCGCCTACAACCTGCACGGTTCGCTGCTGCCGCGCTACCGCGGACGCGCCCCGGCGAACTGGGTGCTGGTCAACGGCGAAACGCAGACCGGGGTGACCCTGCATCGCATGATCGAGCGCGCCGACGCCGGGCCGATCCTCGCCCAGCAGGCCGTCGCCATCGACCCCGAGGACACCGCCCTGAGCCTGCACGGCAAGCTGCGCAAGGCCGCCGGTGCCCTGCTGCGCGACAGCCTGCCGCTGCTCGCCCTCGGCGTGCTGCCGGAAGTCGAGCAGGACGAGAGC,MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDES,MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA,29.46,gnl|BL_ORD_ID|1508|hsp_num:0,1643,True,loose hit with at least 95 percent identity pushed strict,0,585,polymyxin B
1976,tcs_502,NODE_361_length_5870_cov_7.483479_4 # 4942 # 5868 # -1 # ID=361_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.681,NODE_361_length_5870_cov_7.483479_4 ,4942,5868,-,Strict,800,614.8,cprS,100.0,3005064,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,GTGGTCCGCCAGCCACTGGCCGACGGCAAGACGCTCTACCTCTACGACAACGACGCCGCCGGCAGCATCGACACGCCGCTGTCCGACGCCATCATCGACGCCCGCGTCAGGCAGACCTGGATCGTCACCCTATCGGTCACCCTGCCTTCGCTGGCCGCCGTCGGCCTGCTGGTCTGGTTCATCGTCGCGCCGTTGCGCAAGCTGACGCGCTGGTCGATGACCCTCGACGACCTCGCCCCGGACAGCCAGCGGCCGCGCTTCAACTACCGCGAACTCAACGTGCTGGCGGATACCCTGTGGAACAGCGTGACCCGGATCAAGGACTTCAGCCAGCGCGAGGAGCGCTTCCTGCGCTACGCCAGCCATGAGCTGCGCACCCCGCTGGCGGTGATCGGCATGAACCTGGAGTTGCTCGACCAACCCGGCCGCGCGCCCTCCCCGCATGCCTTGCAACGCATCCGCCGCTCGGCGCTGGGCATGCAGCAGATGACCGAGACCCTGCTCTGGCTCAGCCGCGAGAGCGGCGAACTGCGCGACGACGGACACATCGAGGTCGGCCGCCTGCTGGAGGAACTGCTCGAGGAACAACAGGCGCTGAGCCAGCGCCGCGGCCTGACCTTCCACCTCGACGTGGAGCCACACAGCCTGCCGCAGACCCGCGCACGGATCATCATCGGCAACCTGCTGCGCAACGCCCTGCAGTACAGCGACGAGGGCGTGGTGGAAATCGTCGTGCGCGACCGCAGCCTGCTGATCAGCAACCCCATCGGTGCGGCCCAGGGCACGGAGGAGTCGATGGCGTTCGGTTATGGCCTGGGCCTCGACCTGGTCCAGCGCCTGTGCCAGAAGAGCGGCTGGCGCCTGCATTACAGCAGCGACGAGCAGCGCTTCCGCTGCGAGCTGCTGTTCCCCGCCACGCCGGACTGA,VVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD,MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD,71.46,gnl|BL_ORD_ID|2811|hsp_num:0,3804,True,loose hit with at least 95 percent identity pushed strict,369,1293,polymyxin B; colistin A; colistin B
1977,tcs_502,NODE_368_length_5790_cov_5.631661_1 # 1 # 78 # 1 # ID=368_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.718,NODE_368_length_5790_cov_5.631661_1 ,1,78,+,Strict,1800,54.3,mexY,100.0,3003033,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGGTCGGGCGCCTGTTCCGGTTGCGCAAGGCGCCGCGCACCGGCAACTCGCCCCAGATCCCCACGGAGCAAGCCTGA,VVGRLFRLRKAPRTGNSPQIPTEQA,MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA,2.39,gnl|BL_ORD_ID|1635|hsp_num:0,1786,True,loose hit with at least 95 percent identity pushed strict,3063,3138,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
1978,tcs_502,NODE_423_length_5220_cov_6.146793_1 # 3 # 2438 # -1 # ID=423_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.686,NODE_423_length_5220_cov_6.146793_1 ,3,2438,-,Strict,1800,1481.8,mexY,98.86,3003033,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCTCGTTTCTTCATTGACCGGCCGGTCTTCGCCTGGGTGATCTCCCTGCTGATCGTGCTCGCCGGGGTCCTGGCGATCCGCTTCCTGCCGGTCGCCCAGTACCCGGACATCGCGCCGCCGGTGGTCAACGTCAGCGCCAGCTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCGGTGACCGCGATCATCGAGCGCGAGATGAACGGCGCGCCCGGCCTGCTCTACACCAAGGCCACCAGCAGCACCGGCCAGGCCTCGCTGACCCTGACCTTCCGCCAGGGCGTGAACGCCGACCTCGCCGCGGTGGAAGTGCAGAACCGCCTGAAGATCGTCGAGTCGCGCCTGCCCGAATCGGTGCGGCGCGACGGCATCTACGTGGAGAAGGCGGCGGACAGCATCCAGCTGATCGTTACCCTTACCTCCTCCAGCGGCCGCTACGACGCCATGGAGCTGGGCGAGATCGCCTCGTCCAACGTGTTGCAGGCGCTGCGCCGGGTGGAGGGCGTGGGCAAGGTCGAGACCTGGGGCGCCGAGTACGCCATGCGCATCTGGCCCGACCCGGCCAAGCTGACCTCGATGAACCTCAGCGCCAGCGACCTGGTCAACGCCGTGCGCCGGCACAACGCCCGCCTCACCGTGGGCGACATCGGCAACCTCGGGGTCCCCGACTCGGCGCCGATCAGCGCCACGGTGAAGGTCGACGACACCCTGGTGACGCCCGAGCAGTTCGGCGAGATTCCGCTGCGCATCCGCGCCGACGGCGGCGCGATCCGCCTGCGCGACGTGGCCCGCGTCGAGTTCGGCCAGAGCGAGTACGGCTTCGTCTCGCGGGTCAACCAGATGACCGCCACCGGCCTGGCGGTGAAGATGGCGCCCGGCTCCAACGCGGTGGCCACCGCCAAGCGCATCCGCGCCACCCTCGACGAGCTGTCGCGCTACTTCCCGGAGGGCGTGAGCTACAACATCCCCTATGACACCTCGGCGTTCGTCGAGATCTCGATCAGGAAGGTGGTCAGCACCCTGCTCGAGGCGATGCTGCTGGTGTTCGCCGTGATGTACCTGTTCATGCAGAACTTCCGCGCCACCCTGATCCCGACACTGGTGGTGCCGGTGGCCCTGCTGGGCACCTTCACGGTGATGCTCGGCCTGGGCTTCTCGATCAACGTGCTGACCATGTTCGGCATGGTCCTGGCGATCGGCATCCTGGTGGACGACGCGATCATCGTGGTGGAGAACGTCGAGCGGCTGATGGCCGAGGAAGGCCTGTCGCCGCACGACGCCACGGTCAAGGCGATGCGCCAGATCAGCGGGGCCATCGTCGGCATCACCGTGGTGCTGGTCTCGGTGTTCGTGCCGATGGCGTTCTTCAGCGGCGCGGTGGGCAACATCTACCGCCAGTTCGCGGTGACCCTGGCGGTCTCCATCGGCTTCTCGGCGTTCCTCGCGCTGTCGCTGACCCCGGCCCTGTGCGCCACCCTGCTGCGCCCGATCGACGCCGACCACCATGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCCTGCGCCTGACCGGACGCTACCGCAACGCGGTGGCCGGCATCCTCGCCCGGCCGATCCGCTGGATGCTGGTCTACGCCCTGGTCATCGGCGTGGTCGCCCTGCTCTTCGTGCGCCTGCCGCAGGCGTTCCTGCCGGAAGAGGACCAGGGCGACTTCATGATCATGGTGATGCAGCCCGAAGGCACGCCGATGGCGGAGACCATGGCCAACGTCGGCGACGTCGAGCGCTACCTGGCGGAGCACGAACCGGTGGCCTACGCCTATGCGGTCGGCGGCTTCAGCCTGTACGGCGACGGCACCAGCTCGGCGATGATCTTCGCCACCCTGAAGGACTGGTCGGAACGCCGGGAGGCCAGCCAGCACGTCGGCGCCATCGTCGAGCGCATCAACCAGCGCTTCGCCGGCCTGCCCAACCGTACGGTGTATGCGATGAACTCGCCGCCGCTGCCGGACCTGGGTTCCACCAGCGGCTTCGACTTCCGCCTGCAGGACCGTGGCGGGGTTGGCTACGAGGCCCTGGTCAAGGCCCGCGACCAGTTGCTGGCGCGCGCCGCCGAGGACCCGCGCCTGGCCAACGTGATGTTCGCCGGCCAGGGCGAGGCGCCGCAGATCCGCCTGGACATCGACCGGCGCAAGGCGGAGACCCTCGGCGTGAGCATGGACGAGATCAACACCACCCTGGCGGTGATGTTCGGCTCGGACTACATCGGCGACTTCATGCACGGCAGCCAGGTGCGCAAGGTGGTGGTCCAGGCCGACGGCGCCAAGCGCCTGGGCATCGACGACATCGGCCGGCTTCACGTGCGCAACGAGCAGGGCGAGATGGTGCCGCTGGCGACGTTCGCCAAGGCCGCCTGGACCCTCGGCCCGCCGCAACTGACCCGC,MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSASYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNADLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYALVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADGAKRLGIDDIGRLHVRNEQGEMVPLATFAKAAWTLGPPQLTR,MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA,77.63,gnl|BL_ORD_ID|1635|hsp_num:0,1786,True,loose hit with at least 95 percent identity pushed strict,0,2376,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
1979,tcs_502,NODE_446_length_4975_cov_6.361706_5 # 2723 # 3511 # -1 # ID=446_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.648,NODE_446_length_4975_cov_6.361706_5,2723,3511,-,Perfect,300,542.7,OXA-50,100.0,3001796,protein homolog model,n/a,n/a,cephalosporin; penicillin beta-lactam,antibiotic inactivation,OXA beta-lactamase; OXA-50-like beta-lactamase,ATGCGCCCTCTCCTCTTCAGTGCCCTTCTCCTGCTTTCCGGGCATACCCAGGCCAGCGAATGGAACGACAGCCAGGCCGTGGACAAGCTATTCGGCGCGGCCGGGGTGAAAGGCACCTTCGTCCTCTACGATGTGCAGCGGCAGCGCTATGTTGGCCATGACCGGGAGCGCGCGGAAACCCGCTTCGTTCCCGCTTCCACCTACAAGGTGGCGAACAGCCTGATCGGCTTATCCACAGGGGCGGTTAGATCCGCCGACGAGGTTCTTCCCTATGGCGGCAAGCCCCAGCGCTTCAAGGCCTGGGAGCACGACATGAGCCTGCGCGACGCGATCAAGGCATCGAACGTACCGGTCTACCAGGAACTGGCGCGGCGCATCGGCCTGGAGCGGATGCGCGCCAATGTCTCGCGCCTGGGTTACGGCAACGCGGAAATCGGCCAGGTTGTGGATAACTTCTGGTTGGTGGGACCGCTGAAGATCAGCGCGATGGAACAGACCCGCTTTCTGCTCCGACTGGCGCAGGGAGAATTGCCATTCCCCGCCCCGGTGCAGTCCACCGTGCGCGCCATGACCCTGCTGGAAAGCGGCCCGGGCTGGGAGCTGCACGGCAAGACCGGCTGGTGCTTCGACTGCACGCCGGAACTCGGCTGGTGGGTGGGCTGGGTGAAGCGCAACGAGCGGCTCTACGGCTTCGCCCTGAACATCGACATGCCCGGCGGCGAGGCCGACATCGGCAAGCGCGTCGAACTGGGCAAGGCCAGTCTCAAGGCTCTCGGGATACTGCCCTGA,MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAETRFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFPAPVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGGEADIGKRVELGKASLKALGILP,MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAETRFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFPAPVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGGEADIGKRVELGKASLKALGILP,100.00,gnl|BL_ORD_ID|1772|hsp_num:0,1928,,,0,786,oxacillin; ampicillin; cefalotin
1980,tcs_502,NODE_455_length_4856_cov_6.310338_1 # 2 # 610 # 1 # ID=455_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.673,NODE_455_length_4856_cov_6.310338_1 ,2,610,+,Strict,800,379.0,MuxA,99.5,3004073,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ACGCCGCTGGTGGTGATCACCCAGGTCAAGCCGATCTCGGTGGTGTTCAGCCTGCCGCAGCAGCAGATCGGCACCGTCGTCGAGCAGATGAACGGCCCCGGCAAGCTGGCGGTCACCGCGCTGGACCGCAACCAGGACAAGGTTCTCGCCGAAGGCACCCTGACCACCCTGGACAACCAGATCGACACCACCACCGGCACGGTCAAGCTCAAGGCGCGCTTCGAGAACGCCGACGGCAAGCTGTTCCCCAACCAGTTCGTCAACGTGCGCCTGCTGGCGCAGACCCTCAAGGGCGTGCTGACCATTCCGGCCAACGCCGTGCAGCGCGGCACCAACGGTATCTATGTGTACGTGGTCGGCGCCGACAACAAGGTCAGCCAGCGCAGCGTCGCCATCGGCACCAGCGAGAACGAGCGGGTGGTGGTGGAAAGCGGCCTGAAGGCCGGCGAGCAGGTGGTGGTGGAAGGCACCGACCGCCTGCGCGACGGTATGGAAGTGCGTGTCGCCGAGGCCTCCCCGCAGGTCCTCGAGGGCGAGCCGCAGAAACCGCAGACTGGCCGCCCCAGCGGCCTCCAGGGCGACTCGGTGGGTAGCGGGAGCGCTGAATGA,TPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLAVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE,MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE,47.42,gnl|BL_ORD_ID|2242|hsp_num:0,2717,True,loose hit with at least 95 percent identity pushed strict,672,1278,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1981,tcs_502,NODE_455_length_4856_cov_6.310338_2 # 607 # 3738 # 1 # ID=455_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.678,NODE_455_length_4856_cov_6.310338_2,607,3738,+,Perfect,1900,1926.4,MuxB,100.0,3004074,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACCCGTCCCGCCCGTTCATCCTGCGGCCGGTCGCGACCACCCTGTTGATGGTGGCGATCCTGCTCTCGGGCCTGATCGCCTACCGCTTCCTGCCGATCTCGGCGTTGCCGGAAGTGGACTACCCGACCATCCAGGTGGTCACCCTGTACCCCGGCGCCAGCCCGGAGATCATGACCTCGTCGATCACCGCGCCGCTGGAGAACCAGCTCGGGCAGATTCCGGGGCTCAACGAGATGTCTTCCAGCAGTTCCGGCGGCGCCTCGGTGATCACCCTGCAATTCAGCCTGCAGAGCAACCTCGATGTCGCCGAGCAGGAAGTCCAGGCGGCGATCAACGCCGCGCAGAGCCTGCTGCCCAACGACCTGCCGAACCAGCCGGTGTTCAGCAAGGTGAATCCGGCGGACGCACCGATCCTGACCCTGGCGGTGATGTCCGACGGCATGCCGCTGCCGCAGATCCAGGACCTGGTGGATACCCGCCTGGCACAGAAGATCTCGCAGATCTCCGGGGTCGGCCTGGTCAGCATCAGCGGCGGCCAGCGCCCGGCGGTGCGGGTGCGCGCCAACCCGACGGCGCTGGCGGCGGCCGGGCTGAGCCTGGAGGACCTGCGCAGCACGGTGACCAGCAACAACCTCAACGGCCCCAAGGGCAGCTTCGACGGCCCGACCCGTGCCTCGACCCTGGACGCCAACGACCAGTTGCGCTCGGCCGACGCCTACCGCGACCTGATCATCGCCTACAAGAACGGCTCGCCGCTGCGCATCCGCGACGTCGCCAGCGTCGAGGACGACGCCGAGAACGTGCGCCTGGCCGCCTGGGCCAACAACCTGCCGGCGGTGGTGCTGAACATCCAACGCCAGCCGGGGGCCAACGTGATCGAGGTGGTCGACCGGATCAAGGCGCTGCTGCCGCAGCTGCAATCGACCCTGCCGGGCAATCTCGACGTGCAGGTGCTGACCGACCGCACCACCACCATCCGCGCCTCGGTCAAGGACGTGCAGTTCGAGCTGGCGCTGGCGGTGGCGCTGGTGGTGATGGTCACCTTCCTGTTCCTGCGCAACGTCTACGCCACCCTGATTCCCAGCTTCGCCGTGCCGCTGTCGCTGATCGGTACCTTCGGCGTGATGTACCTGTCCGGCTTCTCGATCAACAACCTGACCCTGATGGCGCTGACCATCGCCACCGGCTTCGTGGTCGACGACGCGATCGTCATGGTGGAGAACATCGCCCGCTACCTGGAGCAGGGCGACTCGCCGCTGGAAGCGGCGCTCAAGGGCTCGAAGCAGATCGGCTTCACCATCATCTCGCTGACCTTCTCGCTGATCGCCGTGCTGATCCCGCTGCTGTTCATGGGCGACGTCGCCGGGCGGCTGTTCCGCGAGTTCGCCATCACCCTGGCGGTGGCGATCCTGATTTCCGGCTTCGTCTCCCTGACCCTTACGCCGATGCTCAGCGCCAAGCTGCTGCGCCACATCGACGAGGACCAGCAGGGCCGCTTCGCGCGCGCCGCGGGGCGGGTCATCGATGGCCTGATCGCACAATACGCCAAGGCCCTGCGGGTGGTCCTGCGGCACCAGCCGCTGACCCTGCTGGTGGCCATCGCCACCCTGGCGCTGACCGCGCTGCTCTACCTGGCCATGCCCAAGGGCTTCTTCCCGGTGCAGGACACCGGGGTGATCCAGGGCGTCGCCGAAGCGCCGCAGTCGATCTCCTTCCAGGCCATGTCCGAGCGCCAGCGCGCCCTTGCCGAGGTGGTGCTGAAGGACCCGGCGGTGGCCAGCCTGTCCTCCTACATCGGCGTCGACGGCAGCAACCCGACCCTCAACACCGGCCGCCTGCTGATCAACCTCAAGCCGCACAGCGAGCGCGACGTCACCGCCAGCGAAGTGATCCAGCGCCTGCAGCCCGAACTCGACCACCTGCCCGGGATCAAGCTGTACATGCAGCCGGTGCAGGACCTGACCATCGAGGACCGGGTCGCCCGCACCCAGTACCAGTTCACCTTGCAGGACGCCGACCCGGACGTGCTCGCCGAGTGGGTGCCGAAGCTGGTGGCGCGGCTGCAGGAGTTGCCGCAGCTCGCCGACGTCGCCAGCGACTGGCAGGACAAGGGCTTGCAGGCCTACCTGAACATCGACCGCGACACCGCCTCGCGCCTCGGCGTGAAGCTCTCCGACATCGACAGCGTGCTCTACAACGCCTTCGGCCAGCGGCTGATCTCGACCATCTTCACCCAGGCCACCCAGTACCGCGTGGTGCTGGAGGTGGCGCCGCAGTTCCAGCTCGGCCCGCAGGCCCTGGAGCAGCTCTACGTGCCGTCCAGCGACGGCACCCAGGTGCGCCTGTCGAGCCTGGCGAAGGTGGAGGAGCGGCATACCCTGCTGGCGATCAACCATATCGCCCAGTTCCCCTCGGCGACCCTGTCGTTCAACCTGGCCAAGGGTTACTCCCTGGGCGAGGCGGTCGAGGCGATCCGTGGCGTCGAGGCCAGCCTGGAGCTGCCGCTGAGCATGCAGGGCAGCTTCCGCGGCGCGGCGCTGGCCTTCGAGGCCTCGCTGTCGAACACGCTGCTGCTGATCCTCGCCTCGGTGGTGACCATGTACATCGTCCTGGGCATCCTCTACGAGAGCTTCATCCATCCGGTGACCATCCTCTCGACCCTGCCCTCGGCCGGGGTCGGCGCGCTGCTGGCGCTGATGCTGGCGGGGCAGGAGATCGGCATCGTGGCGATCATCGGCATCATCCTGCTGATCGGCATCGTCAAGAAGAACGCGATCATGATGATCGACTTCGCCCTCGACGCCGAGCGCAACGAAGGCAAGCCGCCCCATGAGGCGATCTACCAGGCCTGCCTGCTGCGCTTCCGGCCGATCCTGATGACCACCATGGCCGCGCTGCTCGGCGCGCTGCCGCTGATGCTCGCCGGCGGCGCCGGCGCCGAGCTGCGCCAGCCGCTGGGCATCACCATGGTCGGTGGCCTGCTGCTGAGCCAGGTCCTGACCCTGTTCACCACCCCGGTGATCTATCTCTACTTCGACCGCCTGGCCCGTCGCTGGGCGGCCTGGCGCAAGCAGCGCGGGCTGGACCTGAACACCGAGGCCGGGTTCGACGGGGACGCCGGGCGATGA,MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR,MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR,100.00,gnl|BL_ORD_ID|2367|hsp_num:0,2718,,,0,3129,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1982,tcs_502,NODE_455_length_4856_cov_6.310338_3 # 3735 # 4856 # 1 # ID=455_3;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.688,NODE_455_length_4856_cov_6.310338_3 ,3735,4856,+,Strict,1900,689.9,MuxC,100.0,3004075,protein homolog model,n/a,n/a,macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAGTCTGTCCACGCCCTTCATCCGCCGCCCGGTCGCCACCACGCTGCTGACCCTGGCGTTGCTGCTGGCCGGCACCCTGTCGTTCGGCCTGCTGCCGGTGGCGCCGCTGCCCAACGTCGATTTTCCGGCCATCGTGGTCAGCGCCAGCCTGCCGGGCGCCAGCCCGGAAACCATGGCCTCGTCGGTGGCCACGCCGCTGGAGCGCTCGCTGGGACGGATCGCCGGGATCAGCGAGATGACCTCCAGCAGTTCGCTGGGCTCGACCACCGTGGTGCTCGTGTTCGACCTGGAGAAGGACATCGACGGCGCCGCCCGCGAGGTGCAGGCGGCGATCAACGGCGCGATGAGCCTGCTGCCCAGCGGTATGCCGAACAATCCCAGCTACCGCAAGGCCAACCCCTCGGACATGCCGATCATGGTCCTCACCCTGACCTCGGAGACCCAGAGTCGCGGCGAGATGTACGACCTCGCCTCGACCGTGCTGGCGCCCAAGCTGTCGCAGGTGCAGGGGGTAGGGCAGGTGAGCATCGGCGGCAGCTCGCTGCCGGCGGTGCGGGTCGACCTCAACCCGGATGCCATGAGCCAGTACGGGCTGTCCCTGGACAGCGTGCGCACGGCCATCGCCGCGGCCAACAGCAACGGCCCCAAGGGCGCCGTCGAGAAGGACGACAAGCATTGGCAGGTGGACGCCAACGACCAGTTGCGCAAGGCCCGCGAGTACGAGCCGCTGGTGATCCACTACAACGCCGACAACGGCGCCGCGGTGCGCCTCGGCGACGTGGCCAAGGTCAGCGACTCGGTGGAGGACGTGCGCAACGCCGGCTTTTCCGACGACCTGCCGGCGGTGCTGCTGATCGTCACCCGCCAGCCCGGCGCCAACATCATCGAGGCCACCGACGCCATCCACGCGCAACTGCCGGTGTTGCAGGAACTGCTCGGGCCGCAGGTCAAGCTGAACGTGATGGACGATCGCAGCCCGTCGATCCGTGCGTCGCTGGAAGAGGCCGAGCTGACCCTGCTGATCTCGGTGGCGCTGGTGATCCTGGTGGTCTTCCTGTTCCTGCGCAACGGCCGCGCCACGCTGATCCCCAGCCTGGCGGTGCCGGTCTCGCTGATCGGC,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIG,MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL,36.10,gnl|BL_ORD_ID|2370|hsp_num:0,2720,True,loose hit with at least 95 percent identity pushed strict,0,1122,erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
1983,tcs_502,NODE_480_length_4608_cov_5.791658_1 # 2 # 217 # 1 # ID=480_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.741,NODE_480_length_4608_cov_5.791658_1 ,2,217,+,Strict,900,144.8,PmpM,98.59,3004077,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,GGCATCGGCCTGCCGGTGGGCTACAGCCTCGGCCTCACCGACTGGTTCCAGGAACCCACCGGACCGCGCGGCCTGTGGCAGGGCCTGGTGGTGGGCCTGACCGGCGCGGCGATCATGCTCTGCATCCGCCTGGCGCGCAGCGCGCGGCGCTTCATCCGCCAGCACGAGCGCCTGCAGCGGGAGGACGCGACGGCCGCCTCAGTCCTTGGCCGGTAG,GIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDATAASVLGR,MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR,14.88,gnl|BL_ORD_ID|2382|hsp_num:0,2734,True,loose hit with at least 95 percent identity pushed strict,1218,1431,neomycin; benzalkonium chloride; chlorhexidine
1984,tcs_502,NODE_496_length_4459_cov_6.078330_1 # 3 # 845 # -1 # ID=496_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.705,NODE_496_length_4459_cov_6.078330_1 ,3,845,-,Strict,650,511.5,TriA,99.64,3003679,protein homolog model,n/a,n/a,disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGGCGCTGCCCGCCATCCTGTGCGCCGGCCTGCTTGTCGGTTGCGGCGCCGAGCCGCCCGCCGAGGAACACGTCCGTGTGCTGGCGCAGACGGTGAAGATGGCCGAGTTCGCCTCGGCCACCTCGATCACCGGCGACATCCAGGCACGGGTACAGGCCGACCAGTCGTTCCGTGTCGGCGGCAAGATCGTCGAGCGCCTGGTCGATGTCGGCGACCACGTCGCGGCTGGCCAGGTGCTGGCGCGGCTCGACCCGCAGGACCAGCGCAGCAACGTGGAGAACGCCCAGGCGGCGGTCGCCGCGCAGCAGGCGCAGTCGAAGCTCGCCGACCTCAACTACCAGCGGCAGAAGGCGCTGCTGCCCAAGGGCTACACCAGCCAGAGCGAGTACGACCAGGCGCTGGCCTCGGTGCGCAGCGCGCAGAGTTCGCTGAAGGCCGCCCAGGCGCAGTTGGCCAACGCCCGCGACCTGCTTTCCTATACCGAGCTGCGTGCCTCCGACGCCGGGGTCATCACTGCCCGCCAGGCCGAGGTCGGCCAGGTGGTGCAGGCCACCGTGCCGATCTTCACCCTGGCCCGCGACGGCGAGCGCGACGCGGTGTTCAACGTCTACGAGTCGTTGTTCAGCCACGATGTCGACGGCCAGCGGATCACCGTCAGCCTGCTCGGCAAGCCGGAAGTCACCGCCAGCGGCAAGGTCCGCGAGATCACCCCGACGGTGGACGAGCGCAGCGGTACGCTGAAGGTCAAGGTCGGCCTAGACTCGGTGCCGGCGGAAATGAGCCTCGGCAGCGTGGTCAACGCCAGCGTCGCCGCGCCGGCCGCGCACAGCGTGGTGCTGCCC,MALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAAHSVVLP,MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP,73.37,gnl|BL_ORD_ID|1995|hsp_num:0,2192,True,loose hit with at least 95 percent identity pushed strict,48,891,triclosan
1985,tcs_502,NODE_548_length_4033_cov_7.419081_2 # 608 # 3685 # -1 # ID=548_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.665,NODE_548_length_4033_cov_7.419081_2,608,3685,-,Strict,1900,1948.7,MexK,99.9,3003693,protein homolog model,n/a,n/a,macrolide antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTCCTTCAACCTTTCCGCCTGGGCGTTGCAGAATCGCCAGATCGTCCTGTACCTGATGATCCTGCTTGGCGCGGTCGGCGCGCTGTCCTACAGCAAGCTGGGGCAGAGCGAAGACCCGCCGTTCACCTTCAAGGCCATGGTGGTGCAGACCAACTGGCCGGGCGCCAGCGCCGAAGAGGTGGCCCGGCAGGTCACCGAGCGTATCGAGAAGAAGCTGATGGAAACCGGCGACTACGATCGCATCGTGTCCTTCTCCCGCCCCGGCGTCTCGCAGGTGACCTTCATGGCCCGCGAGGACATCCATTCCAGCGAGATCCCCGAACTCTGGTACCAGATCCGCAAGAAGATCAGCGACATTCGCGCCACCTTGCCGCAAAGCATCCAGGGCCCGTTCTTCAACGACGAGTTCGGCACCACCTACGGCAACATCTATGCGCTCACCGGCAAGGGCTTCGACTACGCGGTGATGAAGGACTATGCCGACCGCCTGCAACTGCAATTGCAGCGGATCAGGAACGTCGGCAAGGTCGAGCTGATCGGCCTGCAGGACGAGAAGATCTGGATCGACCTGTCCAACACCAAGCTGGCCACCCTCGGCCTGCCCCTGGCGGCGGTACAGAAGGCGCTGGAGGAACAGAACGCGGTGGCCTCCTCCGGGTTCTTCGAGACCGCCAGCGACCGCGTGCAGTTGCGCGTTTCCGGGCGTTTCGATTCGGTGGAGGAGATCCGCGACTTCCCCATCCGCGTCGGCGACCGCACCTTCCGCATCGGCGACGTGGCCGAGGTTCGCCGCGGCTTCAACGATCCGCCGGCGCCGCGCATGCGCTTCATGGGCGAGGACGCCATCGGCCTGGCGGTAGCGATGAAGCCGGGCGGCGACATCCTGGTGCTGGGCAAGGCCCTGGAAACCGAGTTCGCCCGCCTGCAGCAGTCGCTGCCGGCCGGACTGGAACTGCGCAAGGTGTCCGACCAGCCGGCGGCGGTACGTACCGGGGTCGGCGAGTTCATCCGGGTGCTGGCCGAGGCGCTGGTGATCGTCCTGCTGGTGAGCTTCTTCTCCCTCGGCCTGCGCACCGGCCTGGTGGTGGCGCTGTCGATCCCGCTGGTGCTGGCGATGACCTTCGCCGCCATGCATTACTTCGGCATCGGCCTGCACAAGATCTCCCTCGGCGCCCTGGTGCTGGCGCTGGGATTGCTGGTGGACGACGCGATCATCGCGGTGGAGATGATGGCGGTGAAGATGGAGCAGGGCTACGACCGTCTCAAGGCGGCCGCCTTCGCCTGGACCAGTACCGCCTTCCCGATGCTCACCGGCACCCTGATCACCGCCGCCGGCTTCCTGCCGATCGCCACCGCGCAGTCCGGCACCGGCGAATACACCCGCTCGCTGTTCCAGGTGGTGACCATCGCCCTGGTGGTCTCCTGGTTCGCCGCGGTGGTCTTCGTTCCCTACCTGGGGGCCAAGCTGCTGCCGGACCTGGCCAGGTTGCACGCGCAGAAGCACGGCGGCAGCGCCGATGGCTACGATCCCTATGCTACGGCCTTCTACCAGCGCTTCCGGCGTCTGGTGGAGTGGTGCGTGCGCTACCGCAAGACGGTGATCGTCCTGACCCTCGCCGCCTTCGTCGGCGCGCTGCTGCTGTTCCGCCTGGTGCCGCAGCAGTTCTTCCCGCCCTCGGCGCGCCTGGAGCTGCTGCTGGACATCAAGCTGGCGGAGGGCGCCTCACTGCGCTCTACCGGCGAGGAAGTCCAGCGCCTGGAAAAAATGCTGCAGGGCCATGACGGCATCGACAACTACGTGGCCTACGTCGGCACCGGCTCGCCCCGCTTCTACCTGCCGCTGGACCAGCAATTGCCGGCGGCCAGCTTCGCCCAGGTGGTGGTGCTGGCCAAGGACCTGGAGAGCCGCGAGGCGCTGCGCAAGTGGCTGATCGAGCGGATGAACGAGGACTTCCCGCACCTGCGCAGCCGCATCAGTCGCCTGGAAAACGGGCCGCCGGTGGGCTATCCGGTGCAGTTCCGGGTTTCCGGCGAGGACATCCCGCAGGTTCGCGAACTGGCACGCAAGGTCGCCGACAAGATGCGCGAGAACCCGCACGTGGTGAATGTGCACCTGGATTGGGAAGAGCCGAGCAAGGTGGTGTACCTGAGCATCGACCAGGAGCGCGCCCGTGCCCTGGGGGTGAGCACCGCCAGCCTGTCGCAGTTCCTGCAGAGCGCGCTGACCGGCTCGCACGTGAGCTTCTTCCGCGAAGACAACGAGCTGATCGAGATCCTCCTGCGCGGCACCGAGCAGGAGCGTCGCGACCTGTCGTTGCTGCCGAGCCTGGCGGTGCCGACCGAGAATGGCCGGAGCGTGGCGCTGTCGCAGATCGCTACGCTCGAATACGGCTTCGAAGAGGGCATCATCTGGCACCGCAACCGCCTGCCGACGGTCACCGTGCGCGCCGATATCTACGACGATTCGCTGCCGGCGACCCTGGTCGCGCAGATCGCCCCGACCCTGGAACCGATCCGCGCCGAGCTGCCGGACGGCTACCTGCTGGAGGTGGGCGGCACGGTGGAGGACGCGGCGAAGGGCCAGAGTTCGGTGAACGCCGGCGTGCCGCTGTTCATCGTGGTGGTGTTGAGCCTGCTGATGGTGCAGTTGCGCAGCTTCTCGCGGATGGCGATGGTATTCCTCACCGCACCGCTGGGCCTGATCGGCGTGACCCTGTTCCTGCTGCTGTTCCGCCAGCCGTTCGGCTTCGTGGCGATGCTCGGGACCATCGCCCTGGCCGGCATGATCATGCGCAACTCGGTGATCCTGGTGGACCAGATCGAACAGGACATCAGCCATGGACTGGATCGCTGGCACGCCATCATCGAGGCTACCGTGCGGCGTTTCCGGCCCATCGTGCTGACCGCGCTGGCGGCGGTGCTGGCGATGATCCCGCTGTCGCGCAGCGTGTTCTTCGGGCCGATGGCGGTGGCGATCATGGGCGGGCTGATCGTCGCCACCGTGCTCACCCTGCTGTTCCTGCCGGCGCTCTATGCCGCCTGGTTCCGCGTGAAGAAGGACGAGGCGCGGGCCTGA,MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAAAFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA,MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA,100.00,gnl|BL_ORD_ID|2010|hsp_num:0,2206,,,0,3075,erythromycin; tetracycline
1986,tcs_502,NODE_548_length_4033_cov_7.419081_3 # 3690 # 4031 # -1 # ID=548_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.731,NODE_548_length_4033_cov_7.419081_3 ,3690,4031,-,Strict,690,216.5,MexJ,100.0,3003692,protein homolog model,n/a,n/a,macrolide antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GCCCGGGTGGCCTTCGACGACCGCGCGACTCCGGCCGAACTGGGCCAGAGCGCGCGGGTCTACGTCGCCGCCGCCGAGGCGGTGCCGTTATCGGTTCCCTTGTCGGCGCTGACCGCAGAGGCCGGCCAGGCGTTCGTCTGGGTGGTCGAGCCGGGCAGCTCGACCCTGCGCCGGCAGGCGGTGCGCACCGGTCCCTATGCCGAGGACCGGGTGCCGGTGCTCGAAGGCCTGAAGGCTGGCGACTGGGTGGTGGCCACCGGGGTCCAGGTGCTTCGCGAAGGGCAGCAGGTGCGTCCGATCGACCGGGCCAACCGCACGGTGAAACTGGCGGCCAAGGAGTAG,ARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE,MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE,30.79,gnl|BL_ORD_ID|2009|hsp_num:0,2205,True,loose hit with at least 95 percent identity pushed strict,762,1101,erythromycin; tetracycline
1987,tcs_502,NODE_597_length_3753_cov_5.906284_3 # 1828 # 3291 # -1 # ID=597_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730,NODE_597_length_3753_cov_5.906284_3,1828,3291,-,Strict,920,932.2,OpmD,99.79,3000809,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGCGCTCCTACCCGAACCTTTCGCGCCTGGCGCTGGCCCTGGCGGTCGGCACCGGCCTGGCCGCCTGCAGCGTCGGCCCCGACTACCAGCGTCCGCAGTCGCCGCCGCCACGCGTCGCCAGCGAGCACCTCGGCGAGTTCTCCGGCGAGCGGCGGGAAGCGCCCTGGTGGAGTTTCTTCGACGATCCGCAACTGGTGCGCCTGGTCGACCAGGCGCTGGCGCGCAACCACGACATCCGCGAGGCCCGCGCCAACCTGCGCAGCGCCCGCGCGCTGTTCGACGACCGCTGGCTCGACCAGTTGCCGCAGGTCACCAGCCAGGCCGGCTACAGCCGCAGCATCGAACAACAGCTGGACTACGACGGCGAGCCGCGCCGGCGCCTGGCGGAGAGCTACCGCGCCGGCTTCGACGCGCAGTGGGAAATCGACCTGTTCGGCCGCCTCGGCCGACTTTCCGAAGCCGCCCTGGCCCGCGCCGAAGCGGCCGACGCCGACCTCCGGCTGGTACGCCTGAGCATCGCCGCCGACACCGCCCGCGCCTACTTCGAGATCCAGGGCTACCAGCGCCGGCTGGACGTGGCGCGCGCCCAGGTGCGCAGTTGGCGCGACACCCTGGAGCTGACCCGCAGCAGCCTGCAACTGGGCAGCGGCCTGCCGGAGGACGTGGAGAACGCCCAGGCCAACCTGCTGCGCAGCGAAGCGGCGATTCCGCCACTGACGACCGCGCTGGAGAGCGCCCGCTATCGCCTCGACGTGCTGCGCGGCGAGGCACCCGGCAGCGGCGCGCCGATCCTCGACGGCGGCGCCGCCGCGCCATTGGCGAAGAACCTGCCGCTGGGCGACGTCGACCGCCTGATCCTCCAGCGCCCCGACGTAGTCAGCGCCGAGCGGCAACTGGCAGCGAGCACCGAAGACGTCGGCGCGGCCACCGCCGAACTCTATCCGCGCCTCGACCTGGGCGGCTTCATCGGTTTCTTCGCCCTGCGCAGCGGCGACCTCGGCAGCGCCTCGCGCGCCTTCGAACTGGCGCCCAGCGTCAGTTGGCCGGCGTTCCGCCTGGGCAACGTGCGGGCCCGCCTGCGCGCCGTCGAGGCGCAGTCCGACGCCGCGCTGGCGCGCTACCAGCGCTCCCTGCTGCTGGCCCAGGAGGACGTCGGCAACGCGCTCAACCAACTGGCCGAACACCAGCGTCGGCTGGTCGCCCTGTTCCAGTCCGCGACCCATGGCGCGAACGCCCTGGAGATCGCCAACGAACGCTACCGCGCCGGCGCCGGCAGCTACCTGGCGGTGCTGGAGAACCAGCGCGCGCTGTACCAGATCCGCGAGGAACTGGCGCAGGCGGAGACCGCCTCGTTCGTCAACGTCATCGCGCTCTACAAGGCGCTCGGCTGGGGCAGCGGCGACCTGGCGCCGGGCGCCGGCCAACTGGCCGCCGGCGAAACCGCCGGGGCCAACCGTTGA,MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSEAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR,MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR,100.00,gnl|BL_ORD_ID|449|hsp_num:0,442,,,0,1461,acriflavine; norfloxacin
1988,tcs_502,NODE_597_length_3753_cov_5.906284_4 # 3288 # 3752 # -1 # ID=597_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.680,NODE_597_length_3753_cov_5.906284_4 ,3288,3752,-,Strict,1900,280.0,MexI,100.0,3000808,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,CTGATCACCGTGCCGCTGTCGATCTGCGGCGCGCTGCTGCCGCTGGCGCTGGGCTACGCGACGATGAACATCTATACGCAGATCGGCCTGGTCACCCTGATCGGCCTGATCAGCAAGCACGGCATCCTCATGGTCGAGTTCGCCAACGAACTGCAACTCCACGAGCGCCTCGACCGCCGCGCGGCGATCCTGCGCGCCGCGCAGATCCGCCTGCGGCCGGTGCTGATGACCACCGCGGCAATGGTCTTCGGCCTGGTGCCGCTGCTCTTCGCCAGCGGCGCCGGCGCCGCCAGCCGCTTCGGCCTGGGCGTGGTGATCGTCTCCGGGATGCTGGTCGGCACCCTCTTCACCCTGTTCGTGCTGCCCACCGTCTATACCCTGCTGGCGCGCAACCACGCGGAAGTCGACAAGAGCCCGCGCAGCCGGCAACTGGCCGAGGCCGATCTGCTGGTGAACAAGGCATGA,LITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA,MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA,14.97,gnl|BL_ORD_ID|4691|hsp_num:0,1647,True,loose hit with at least 95 percent identity pushed strict,2625,3087,acriflavine; norfloxacin
1989,tcs_502,NODE_609_length_3683_cov_6.881773_1 # 3 # 1967 # -1 # ID=609_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.681,NODE_609_length_3683_cov_6.881773_1 ,3,1967,-,Strict,1900,1200.7,MexI,100.0,3000808,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACCTTTACCGACCTGTTCGTCCGCCGGCCGGTGCTGGCGCTGGTGGTCAGCACGCTGATCCTGCTGCTCGGCCTGTTCTCCCTGGGCAAGCTGCCGATCCGCCAGTACCCGCTGCTGGAAAGCTCGACCATCACCGTCACCACCGAGTACCCCGGCGCCTCCGCCGATCTCATGCAAGGCTTCGTCACCCAGCCGATCGCCCAGGCGGTGTCGTCGGTGGAGGGCATCGACTACCTTTCCTCGACCTCGGTGCAGGGGCGTAGCGTGGTGACCATCCGCATGCTGCTCAACCGCGATTCGACCCAGGCGATGACCGAGACCATGGCCAAGGTCAACTCGGTGCGCTACAAGCTGCCCGAGCGTGCCTACGACTCGGTGATCGAACGCTCTTCCGGCGAGACCACCGCGGTAGCCTACGTCGGCTTTTCCAGCAAGACCCTGCCGATCCCGGCGTTGACCGACTACCTGTCGCGGGTGGTCGAGCCGATGTTCTCTTCCATCGACGGCGTGGCCAAGGTCCAGACCTTTGGCGGCCAGCGCCTGGCCATGCGCCTCTGGCTCGACGCCGACCGCCTCGCCGGGCGCGGCCTGACCGCCTCCGACGTGGCCGAGGCGATCCGCCGCAACAACTACCAGGCGGCGCCGGGGATGGTGAAGGGGCAGTACGTGCTGTCCAACGTGCGGGTCAACACCGACCTGACCAACGTCGACGACTTCCGCGAGATGGTCATCCGCAACGATGGCAACGGCCTGGTGCGCCTGCGCGACGTCGGTACCGTCGAACTGGGCGCCGCGGCCACCGAGACCAGCGCACTGATGGACGGCGACCCGGCGGTGCACCTGGGGTTGTTCCCGACGCCCACCGGCAACCCGCTGGTGATCGTCGACGGCATCCGCAAGCTGCTGCCGGAGATCCAGAAGACCCTGCCGCCGGATGTCCGCGTCGACCTCGCCTACGAGACTTCGCGCTTCATCCAGGCCTCCATCGACGAGGTGGTGCGGACCCTGGTGGAAGCGCTGCTGATCGTGGTGCTGGTGATCTACCTCTGCCTCGGCTCGCTGCGCAGCGTGCTGATCCCGGTGGCGACCATTCCCCTGTCGATGCTCGGCGCCGCCGCGCTGATGCTGGCCTTCGGCTTCAGCGTCAACCTGCTGACCCTGCTGGCGATGGTGCTGGCCATCGGGCTGGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCCACCGCCACATCGAGGAAGGCAAGTCGCCGGTGGCGGCGGCGCTGATCGGCGCCCGCGAAGTGGCCGGCCCGGTGATCGCCATGACCATCACCCTGGCCGCCGTGTACACCCCCATCGGCCTGATGGGCGGCCTCACCGGCGCGCTGTTCCGCGAGTTCGCCCTGACCCTGGCGGGCGCGGTGATCGTGTCCGGGGTGGTGGCGCTGACCCTGTCGCCGGTGATGAGTTCGCTGCTGCTCCAGGCGCACCAGAACGAGGGGCGCATGGGCCGCGCCGCCGAGTGGTTCTTCGGCGGCCTGACGCGGCGCTACGGGCAGGTCCTGGAGTTCTCCCTGGGCCACCGCTGGCTGACCGGCGGCCTGGCATTGCTGGTGTGCATCAGCCTGCCGCTGCTGTATTCGATGCCCAAGCGCGAACTGGCGCCGACCGAGGACCAGGCCGCGGTGCTCACCGCGATCAAGGCGCCGCAGCACGCCAACCTCGACTATGTCGAACTGTTCGCGCGCAAGCTCGACCAGGTCTACACCAGCATCCCGGAAACCGTCAGCACCTGGATCATCAACGGCACCGACGGACCGGCGGCGAGCTTCGGCGGGATCAACCTGGCGGCCTGGGAAAAACGCGAGCGCGACGCCTCGGCGATCCAGTCCGAGCTGCAAGGCAAGGTCGGCGACGTCGAGGGCAGCAGCATCTTCGCCTTCCAGTTGGCCGCCGGTGCAGATGGTGCTGCGCAGCCC,MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAAGADGAAQP,MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA,63.65,gnl|BL_ORD_ID|4691|hsp_num:0,1647,True,loose hit with at least 95 percent identity pushed strict,0,1941,acriflavine; norfloxacin
1990,tcs_502,NODE_609_length_3683_cov_6.881773_2 # 1980 # 3092 # -1 # ID=609_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.695,NODE_609_length_3683_cov_6.881773_2,1980,3092,-,Perfect,650,689.5,MexH,100.0,3000807,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGCAGAAACCCGTCCTGATCGCCAGTGCCGCGCTCATCTGCGCGGCGGTTATCGGCATCGCCGTCTACGCCACCGGCTCGGCGAAGAAAGACGCCGGCGGTTTCGCCGGCTACCCGCCGGTAAAGGTCGCCCTCGCCTCGGTGGAGCGGCGGGTGGTGCCGCGCGTCTTCGATGGCGTCGGCGAGCTGGAGGCCGGTCGCCAGGTCCAGGTGGCCGCCGAAGCGGCAGGACGGATCACCCGCATCGCCTTCGAATCGGGCCAGCAGGTGCAGCAAGGGCAGTTGCTGGTGCAACTCAACGACGCGGTGGAACAGGCCGAGCTGATCCGTCTCAAGGCGCAGTTGCGCAATGCCGAGATCCTCCATGCCCGTGCGCGCAAGCTGGTAGAGCGCAACGTCGCCTCGCAGGAACAGCTGGACAACGCCGTCGCCGCCCGCGACATGGCGCTCGGCGCGGTGCGCCAGACCCAGGCGCTGATCGACCAGAAGGCGATCCGCGCGCCCTTCTCCGGCCAGCTCGGCATCCGCCGCGTGCACCTCGGCCAGTACCTCGGCGTCGCCGAGCCGGTGGCCAGCCTGGTGGATGCGCGGACCCTGAAAAGCAATTTCTCCCTGGACGAAAGCACCAGTCCCGAGCTGAAGCTCGGCCAGCCCCTCGAGGTCCTGGTCGACGCCTATCCGGGGCGCAGCTTCCCGGCGCGCATCAGCGCCATCGACCCGCTGATCGGCAAGTCGCGCACGGTGCAGGTCCAGGCCTTGCTGGACAACCCCGAAGGCCTGCTCGCCGCCGGCATGTTCGCCAGCATCCGGGTCTCGCGCAAAGCCGACGCGCCGTCGCTGAGCGTGCCGGAAACCGCAGTCACCTACACCGCCTACGGCGACACCGTGTTCGTCGCCCACCAGGACGGCGACCGGCCGCTCAGCGCCAAGCGCGTCTCGGTGCGGATCGGCGAGCGCTGGGACGGTCGCGTGGAAATCCTCCAGGGCCTCGCCGAGGGCGACCGGGTAGTGACTTCCGGACAGATCAACCTGAGCGACGGGATGGCCGTGGAACCGGTCAAGGAAGACACCCTGAGCAGCGCCGCGCCCCCCGTGCCGGTCGCAGGCCGCTGA,MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR,MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR,100.00,gnl|BL_ORD_ID|1344|hsp_num:0,1344,,,0,1110,acriflavine; norfloxacin
1991,tcs_502,NODE_609_length_3683_cov_6.881773_3 # 3100 # 3546 # -1 # ID=609_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.669,NODE_609_length_3683_cov_6.881773_3,3100,3546,-,Perfect,260,277.7,MexG,100.0,3000806,protein homolog model,n/a,n/a,,antibiotic efflux,,ATGCAGCGCTTCATCGATAACTCGCTCGAAAGCAACTGGCTCTGGCTGACCGCCCGGATCTGCCTGGCCCTGATGTTCGTCGCCTCGGGACTGGCGAAGCTGTTCGACTATCAGGCCAGCCTGGAGGAAATGCGCGCCGCCGGCCTGGAGCCGGCCTGGCTGTTCAACATCGCCACCGCCGTGACCCTGCTGGCCGGCTCCGCGCTGGTCCTGCTGGACCGCAAGCTATGGCTCGGCGCCGGGGCGCTGGCGGTGTTCCTGCTGCTGACCATCCTCATCGTCCACACCTTCTGGAGCAAGACCGGCGTCGAAGCCAAGCTGGCGATGTTCTTCGCCCTCGAACACATCGCGGTGATCGGCGGCCTGATCGCCACGGCCATCGCCAGCGCGCAACGCCAGCGGCTGCGCCAGGACGTCTCCGTGGCCGCCACCTACCAGAAGGCCTGA,MQRFIDNSLESNWLWLTARICLALMFVASGLAKLFDYQASLEEMRAAGLEPAWLFNIATAVTLLAGSALVLLDRKLWLGAGALAVFLLLTILIVHTFWSKTGVEAKLAMFFALEHIAVIGGLIATAIASAQRQRLRQDVSVAATYQKA,MQRFIDNSLESNWLWLTARICLALMFVASGLAKLFDYQASLEEMRAAGLEPAWLFNIATAVTLLAGSALVLLDRKLWLGAGALAVFLLLTILIVHTFWSKTGVEAKLAMFFALEHIAVIGGLIATAIASAQRQRLRQDVSVAATYQKA,100.00,gnl|BL_ORD_ID|4685|hsp_num:0,995,,,0,444,
1992,tcs_502,NODE_610_length_3670_cov_4.787146_4 # 2866 # 3198 # 1 # ID=610_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.658,NODE_610_length_3670_cov_4.787146_4,2866,3198,+,Perfect,170,195.3,Pseudomonas aeruginosa emrE,100.0,3004038,protein homolog model,n/a,n/a,aminoglycoside antibiotic,antibiotic efflux,small multidrug resistance (SMR) antibiotic efflux pump,ATGACCAATTATCTCTACCTCGCCATCGCCATCGCCGCCGAAGTGGTCGCCACCACCTCGCTGAAAGCCGTCGCCGGATTCAGCAAGCCACTGCCGCTGCTGCTGGTGGTGGGCGGCTACGTGCTCGCCTTCAGCATGCTCGTGCTGGTCATGCGCACCCTGCCGGTCGGCGTGGTCTACGCCATCTGGTCCGGGCTCGGCATCGTCCTGGTCAGCCTGGTGGCGATGTTCGTCTACGGCCAGCGCCTGGACCCCGCAGCCCTCCTCGGTATCGGCCTGATCATCGCCGGCGTGCTGGTGATCCAGTTGTTCTCCCGCGCTTCGGGGCACTGA,MTNYLYLAIAIAAEVVATTSLKAVAGFSKPLPLLLVVGGYVLAFSMLVLVMRTLPVGVVYAIWSGLGIVLVSLVAMFVYGQRLDPAALLGIGLIIAGVLVIQLFSRASGH,MTNYLYLAIAIAAEVVATTSLKAVAGFSKPLPLLLVVGGYVLAFSMLVLVMRTLPVGVVYAIWSGLGIVLVSLVAMFVYGQRLDPAALLGIGLIIAGVLVIQLFSRASGH,100.00,gnl|BL_ORD_ID|2318|hsp_num:0,2655,,,0,330,gentamicin C; gentamicin
1993,tcs_502,NODE_637_length_3431_cov_3.962963_1 # 1 # 387 # 1 # ID=637_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.703,NODE_637_length_3431_cov_3.962963_1 ,1,387,+,Strict,800,240.0,OprN,100.0,3000805,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GGCCCGAGCATCAGTTGGGCCGCCTTCGACCTCGGCAGCGTGCGTGCCCGCCTGCGAGGCGCCAAGGCCGACGCCGACGCCGCGCTGGCCAGCTACGAACAGCAGGTGCTGCTGGCCCTGGAAGAATCGGCGAATGCCTTCAGCGACTATGGCAAGCGCCAGGAGCGCCTGGTCTCGCTGGTCCGCCAGTCGGAAGCCAGCCGCGCCGCCGCGCAACAGGCGGCGATCCGCTACCGCGAAGGCACCACCGATTTCCTGGTGCTGCTGGACGCCGAACGCGAGCAACTCTCCGCCGAAGATGCCCAGGCCCAGGCCGAGGTCGAGCTGTACCGCGGCATCGTGGCGATCTACCGCTCCCTCGGCGGTGGCTGGCAACCCAGCGCCTGA,GPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA,MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA,27.12,gnl|BL_ORD_ID|293|hsp_num:0,172,True,loose hit with at least 95 percent identity pushed strict,1032,1416,ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
1994,tcs_502,NODE_711_length_2852_cov_6.396741_4 # 2229 # 2852 # -1 # ID=711_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.636,NODE_711_length_2852_cov_6.396741_4,2229,2852,-,Strict,400,447.2,Pseudomonas aeruginosa catB7,100.0,3002679,protein homolog model,n/a,n/a,phenicol antibiotic,antibiotic inactivation,chloramphenicol acetyltransferase (CAT),GAGAGCCCCTTCAGGGGCAAGCTGCTCTCGGAACAGGTCAGCAACCCGAACATACGGGTGGGGCGCTACAGCTACTACTCCGGCTACTATCACGGGCATTCCTTCGACGACTGCGCCCGCTACCTGATGCCGGACCGCGACGACGTGGACAAGCTGGTCATCGGCAGTTTCTGCTCGATCGGCAGTGGCGCCGCCTTCATCATGGCCGGCAACCAGGGACACCGCGCCGAATGGGCGTCGACCTTCCCCTTCCACTTCATGCACGAAGAGCCTGTCTTCGCCGGCGCCGTGAACGGCTATCAGCCAGCCGGCGACACGCTGATCGGCCATGACGTCTGGATCGGTACCGAGGCGATGTTCATGCCAGGCGTACGGGTCGGCCACGGAGCCATCATCGGCAGCCGCGCGCTGGTGACCGGCGATGTCGAGCCCTATGCCATCGTCGGCGGTAACCCGGCCCGGACCATTCGTAAGCGCTTTTCCGATGGCGATATCCAGAACCTGCTGGAAATGGCCTGGTGGGACTGGCCACTGGCCGATATCGAGGCAGCCATGCCACTGCTGTGTACTGGGGATATCCCCGCCTTGTACCGGCACTGGAAACAGCGCCAGGCCACGGCCTGA,ESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIGSFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPVFAGAVNGYQPAGDTLIGHDVWIGTEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWDWPLADIEAAMPLLCTGDIPALYRHWKQRQATA,MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIGSFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPVFAGAVNGYQPAGDTLIGHDVWIGTEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWDWPLADIEAAMPLLCTGDIPALYRHWKQRQATA,97.64,gnl|BL_ORD_ID|2511|hsp_num:0,1042,,,15,636,azidamfenicol; chloramphenicol; thiamphenicol
1995,tcs_502,NODE_735_length_2670_cov_6.137069_3 # 881 # 2089 # -1 # ID=735_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717,NODE_735_length_2670_cov_6.137069_3,881,2089,-,Strict,500,752.7,bcr-1,99.25,3003801,protein homolog model,n/a,n/a,bicyclomycin-like antibiotic,antibiotic efflux,major facilitator superfamily (MFS) antibiotic efflux pump,GTGCCTGCGAGTGCATCGAGGATTCAGGTCGGAAGCGGCGAAGGACGCCTGTTGCTGCTGTTGTCGGCGCTGGTGGCGTTCGGCCCGCTGTCGATCGACATGTATTTGCCGAGCCTGCCGGCGATCGCCGCCGATCTCGGCGCCAGCGATGCCCAGGTGCAGCGGAGCATCAGCGGCTTCCTGGTCGGCTTCTGCTTCGGCATGCTGTTCTACGGCCCCTTGTCCGACCGTTTCGGCCGGCGCCCGGTGCTGCTGGCCGGTATCGCCTTGTACCTGTTCAGCAGCCTGGCCTGCGTGCTGGCCGACAGCGCGGGGCAACTGGTCCTGCTGAGGGTGCTCCAGGCCCTCGGCGGCGGCGCCGCGTCGGTGCTGGCGCGGGCCATGGTGCGCGACCTCTATCCGTTGGGCGAGGCCGCCCGGATGCTGGCATTGATGCACATGGTGACCATGCTGGCACCGCTGGCCGCGCCGCTGCTCGGCGGCTACCTGATGCTCTGGGCCGGCTGGCGCGCGTTGTTCGTGGTCCTGGCGCTGTTCGCCGGGCTCTGCCTGCTGGCGGTCTGGCGGGTCGCCGAAAGCCACCCGCCGGAGCGCCGCGGCGGCAGCCTGGCCCAGGCCTTTCTCGCCTATGGGCGGCTGCTCGGCGACCGTCGCGCGCTGGGCTACGTGCTGTGCATGGGGCTGGCGTTCGCCGGGATGTTCGCCTACATCAGCGCCGCGCCATTCGTGTTCATCGAGCATTTCGGCGTGCGCGCGGAGCGCTTCGGCTGGTTCTTCGGCCTGAACATCCTCGGCGTGATGCTCGCCACCTGGTGCAGCGCGCGCCTGGTGCGCCGCCACGGTCCGCGGCCGCTGCTGCGGGCCGGCAGCCTGCTGGCCTGCGTGTCCGGGCTGTTCCTCCTCGGCTATGCGGCGCTCGGCGAGCGGGGCGGGTTGTGGGCGCTGGTGCCGGGGTTGCTGTGCTTCGTCAGCGTCACCGGCCTGCTCGGCGCCAACTGCATCGCCAGCCTGCTGGCGTTGTATCCCGGACAGGCCGGGGCGGCTTCGGCGGTGGCGGTGTCCGGGCAGTTCGGCCTCGGCTGCCTGGCCAGCCTGGCGGTCGGCTGGCTGGCGCTGCCCGGCGTGCTGCCGATGGCGCTGGTGATGGCCGTCTGCGGCGTCGGCAGCCTGCTCGCGCTGGGCTTGGCCCTGCACGGCGGAAACCGTTGA,MPASASRIQVGSGEGRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCFGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACVLADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR,MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR,100.00,gnl|BL_ORD_ID|2335|hsp_num:0,2303,,,0,1206,bicyclomycin
1996,tcs_502,NODE_817_length_2229_cov_5.445455_1 # 101 # 508 # 1 # ID=817_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.694,NODE_817_length_2229_cov_5.445455_1,101,508,+,Strict,200,280.8,FosA,99.26,3000149,protein homolog model,n/a,n/a,phosphonic acid antibiotic,antibiotic inactivation,fosfomycin thiol transferase,ATGCTCACCGGTCTCAATCACCTGACCCTGGCGGTCGCCGACCTGCCGGCCAGCATCGCCTTCTACCGCGATCTTCTCGGCTTTCGCCTGGAGGCGCGCTGGGACCAGGGCGCCTATCTCGAACTGGGTTCTCTGTGGCTGTGCCTGTCCCGGGAGCCGCAATGCGGCGGGCCGGCCGCGGACTACACGCACTACGCCTTCGGCATCGCCGCCGCGGATTTCGCCCGCTTCGCCGCGCAGCTGCGCGCGCATGGCGTGCGCGAATGGAAGCAGAACCGCAGCGAGGGCGATTCGTTCTACTTCCTCGACCCGGACGGCCATCGCCTGGAGGCCCACGTCGGCGACCTGCGCAGCCGGCTCGCGGCGTGCCGGCAAGCGCCCTATGCGGGAATGCGTTTCGCCGACTAG,MLTGLNHLTLAVADLPASIAFYRDLLGFRLEARWDQGAYLELGSLWLCLSREPQCGGPAADYTHYAFGIAAADFARFAAQLRAHGVREWKQNRSEGDSFYFLDPDGHRLEAHVGDLRSRLAACRQAPYAGMRFAD,MLTGLNHLTLAVADLPASIAFYRDLLGFRLEARWDQGAYLELGSLWLCLSREPQYGGPAADYTHYAFGIAAADFARFAAQLRAHGVREWKQNRSEGDSFYFLDPDGHRLEAHVGDLRSRLAACRQAPYAGMRFAD,100.00,gnl|BL_ORD_ID|1200|hsp_num:0,1222,,,0,405,fosfomycin
1997,tcs_502,NODE_1059_length_1194_cov_7.054936_1 # 1 # 789 # -1 # ID=1059_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.705,NODE_1059_length_1194_cov_7.054936_1 ,1,789,-,Strict,690,503.1,MexJ,100.0,3003692,protein homolog model,n/a,n/a,macrolide antibiotic; tetracycline antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTACCGCCATATCCCGCTCGTCGCCCTGTCCCTGTTTTCCTCCCTGTTCCTCGCCGCCTGCGGCAACGGCACGCCGCCGCCAGCCGCGGCGCGTCCGGCGATCGTCGTCCAGCCCCAGCCGGCGGGGGAGGTGAGCCAGGCCTTTCCCGGCGAGATCCGCGCCCGCCACGAGCCGGAGCTGGCCTTCCGCATCGGCGGCAAGGTCATCCGCCGGCTGGTGGAAGTCGGCGAGCGGGTAAAGAAGGACCAGCCCCTGGCCGAACTCGATCCCCAGGACGTGCGCCTGCAACTGGAGGCGGCGCGGGCCCAGGTCAGTGCCGCCGAGGCCAACTTGCAGACCGTGCGCGCCGAGTACCGGCGCTACCGCACCTTGCTCGACCGCAACCTGGTCAGCCATTCCCAGTTCGAGAACATCCAGAACAGCTACCGCGCCGGCGAGGCGCGGCTGAAGCAGATCCGCGCCGAATTCAACGTCGCCGACAACCAGGCCGGCTACGCCGTGCTGCGCTCGCCCCAGGATGGCGTGATCGCCAGCCGGCGCGTCGAGGTGGGCCAGGTGGTGGCGGCCGGACAGACGGTCTTCAGCCTGGCCGCCGACGGCGAACGCGAGGTGCTGATCGGCCTGCCGGAACACAGCTTCGAACGTTTCCGCATCGGCCAGCCGGTGTCGGTCGAACTCTGGTCGCAACGCGACAGACGCTTCGCCGGGCATATCCGCGAGCTCTCGCCCGCGGCCGATCCGCAATCGCGTACCTTCGCCGCCCGGGTGGCCTTCGACGACCGCGCG,MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRA,MYRHIPLVALSLFSSLFLAACGNGTPPPAAARPAIVVQPQPAGEVSQAFPGEIRARHEPELAFRIGGKVIRRLVEVGERVKKDQPLAELDPQDVRLQLEAARAQVSAAEANLQTVRAEYRRYRTLLDRNLVSHSQFENIQNSYRAGEARLKQIRAEFNVADNQAGYAVLRSPQDGVIASRRVEVGQVVAAGQTVFSLAADGEREVLIGLPEHSFERFRIGQPVSVELWSQRDRRFAGHIRELSPAADPQSRTFAARVAFDDRATPAELGQSARVYVAAAEAVPLSVPLSALTAEAGQAFVWVVEPGSSTLRRQAVRTGPYAEDRVPVLEGLKAGDWVVATGVQVLREGQQVRPIDRANRTVKLAAKE,71.66,gnl|BL_ORD_ID|2009|hsp_num:0,2205,True,loose hit with at least 95 percent identity pushed strict,0,789,erythromycin; tetracycline
1998,tcs_502,NODE_1079_length_1140_cov_6.675068_1 # 1 # 1140 # 1 # ID=1079_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.692,NODE_1079_length_1140_cov_6.675068_1 ,1,1140,+,Strict,900,734.9,PmpM,100.0,3004077,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; aminoglycoside antibiotic; disinfecting agents and antiseptics,antibiotic efflux,multidrug and toxic compound extrusion (MATE) transporter,CTCAAGGAACTGCTGACCCTCGCCGCGCCGATCATGATCGCGCAACTGGCGACCACCGCCATGGGCTTCGTCGATGCGGTGATGGCCGGGCGCGCCAGTCCGCACGACCTGGCAGCGGTGGCGCTGGGCAACTCGATCTGGATCCCGATGTTCCTGCTGATGACCGGCACCCTGCTCGCCACCACGGCCAAGGTCGCCCAGCGCCATGGCGCCGGCGACCAGCCCGGCACCGGGCCGCTGGTGCGCCAGGCGCTGTGGCTGGCGCTGCTGATCGGACCGCTGTCGGGGGCGGTGCTGTGGTGGTTGTCGGAGCCGATCCTCGGCTTGATGAAAGTGCGCCCGGAACTGATCGGGCCGAGCCTGCTGTACCTCAAGGGCATCGCCCTGGGCTTCCCGGCGGCGGCGCTGTACCACGTACTGCGCTGCTACACCAACGGCCTGGGACGGACCCGGCCGAGCATGGTGCTGGGGATCGGCGGGCTGCTGCTGAACATCCCGATCAACTACGCGCTGATCTACGGCCACTTCGGCATGCCGAAGATGGGCGGCCCCGGCTGCGGCTGGGCCACCGGCTCGGTGATGTGGTTCATGTTCCTCGGCATGCTGTTCTGGGTGAACAAGGCCTCGATCTACCGCGCCAGCCAACTGTTCTCGCGCTGGGAGTGGCCGGATCGCGCGACCATCGGCCCGCTGGTGGCGGTCGGCCTGCCGATCGGCATCGCGGTGTTCGCCGAGTCGAGCATCTTCTCGGTGATCGCCCTGCTGATCGGCGGGCTCGACGAGAACGTGGTGGCCGGCCACCAGATCGCCCTGAACTTCAGCGCGCTGGTGTTCATGATTCCTTATTCGCTGGGGATGGCGGTGACCGTGCGGGTCGGCCACAACCTCGGCGCCGGCCTACCGCGCGACGCGCGCTTCGCCGCCGGCGTGGGGATGGCCGCGGCGCTGGGCTACGCCTGCGTCTCGGCGAGCCTGATGTTGTTGCTACGCGAGCAGATCGCCGCGATGTATTCGCCGGACCCGGCGGTGATCGCCATCGCCGCCTCGCTGATCGTGTTCTCCGCGCTGTTCCAGTTCTCCGACGCCCTGCAGGTCACCGCCGCCGGGGCCCTGCGCGGCTACCAGGACACCCGGGTGACG,LKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVT,MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR,79.66,gnl|BL_ORD_ID|2382|hsp_num:0,2734,True,loose hit with at least 95 percent identity pushed strict,51,1191,neomycin; benzalkonium chloride; chlorhexidine
1999,tcs_502,NODE_1103_length_1048_cov_5.710500_1 # 1 # 1047 # -1 # ID=1103_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.682,NODE_1103_length_1048_cov_5.710500_1 ,1,1047,-,Strict,1200,727.6,arnA,99.43,3002985,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,CACTTCGGCCGGCGCACCCCGGCGGACGGCCTGCTCGACTGGCACAGGCCGGCACGGCAGTTGTACGACCTGGTGCGCGCGGTGACCCAGCCCTACCCTGGCGCCTTCTGCCAGGTCGGCGAACAGAAGCTGATCGTCTGGAGCGCCGAGGTGGTCGCCGGCAACCACGGTCGCGAGCCGGGCAGCGTACTGTCCTGCGACCCGCTGCGGATCGCCTGCGGCGAGGACTCGCTGGTGCTGCGCTTCGGCCAGCGCGGCGAGCGCGGCCTGTACCTGGCCGGCACGCAACTGGCCACCGAGCTGGGCCTGGTCGAGGGCGCGCGCCTGCGTGGCGCGGCGTCCGGCCCGCAGCGCCGCACGCGGGTGCTGATCCTCGGGGTCAACGGCTTCATCGGCAACCACCTGTCCGAACGCCTGCTGCGCGACGGGCGCTACGAGGTCCACGGCATGGACATCGGCTCCGACGCCATCGAACGGCTCAAGGCCGACCCGCATTTCCACTTCGTCGAAGGCGACATCGGCATCCATTCGGAGTGGCTCGAATACCATGTGAAGAAATGCGACGTGATCCTGCCGCTGGTGGCCATCGCCACGCCCATCGAGTACACGCGCAACCCGCTGCGGGTGTTCGAACTGGACTTCGAGGAAAACCTGCGGATCGTCCGCTACTGCGTGAAATACGGCAAACGCGTGGTGTTCCCTTCCACCTCCGAGGTCTACGGCATGTGCCAGGACCCGGACTTCGACGAAGACCGCTCGAACCTGGTGGTCGGGCCGATCAACAAGCAGCGCTGGATCTACTCGGTGTCCAAGCAGTTGCTCGACCGGGTGATCTGGGCCTACGGCCAGCAGGGCCTGCGCTTCACCCTGTTCCGTCCGTTCAACTGGATGGGCCCGCGCCTGGACCGCCTGGATTCGGCGCGGATCGGCAGCTCGCGGGCGATCACCCAGCTCATCCTGCACCTGGTCGAAGGCACGCCGATCCGCCTGGTCGACGGCGGCGCGCAGAAGCGCTGCTTCACCGACGTCGACGACGGCATCGAGGCC,HFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEA,MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA,52.72,gnl|BL_ORD_ID|1508|hsp_num:0,1643,True,loose hit with at least 95 percent identity pushed strict,594,1641,polymyxin B
2000,tcs_502,NODE_1242_length_710_cov_5.870778_1 # 1 # 396 # -1 # ID=1242_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.662,NODE_1242_length_710_cov_5.870778_1 ,1,396,-,Strict,800,266.2,cprS,100.0,3005064,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,ATGAAACGCGGCCTGAGCCTGATCCCCATCGTCGGCGGCGGCGTCACCCTGATCCTCGCCGGGGTGTTGCTGGTCTACACGCGCATGCTCGGCGACTACGGCGAGACCGGCGCCCTCTACCTGCTCAGCATGATGATGGAAGAGGAAGGGCTGTACTTCGCCCAGCGCTACCAGGAAGACCCGGCTACGCCGGCGCCGGACAGCTACTACTTCAAGGGCAGCGTCGGCACCGCGGGGCTGCCGCCGAAACTCAGGGAGATGCTCGACACCCCGCCCTACAAGAGCATCGGCGCCATGCAACTGCTCGGCAACTGGGACGACGATGACGAAGAGGAGGATGACGACGCGCCCAGCGACGATGCCTACGTGGTGGTCCGCCAGCCACTGGCCGACGGC,MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADG,MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD,30.63,gnl|BL_ORD_ID|2811|hsp_num:0,3804,True,loose hit with at least 95 percent identity pushed strict,0,396,polymyxin B; colistin A; colistin B
2001,tcs_502,NODE_1242_length_710_cov_5.870778_2 # 393 # 710 # -1 # ID=1242_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.708,NODE_1242_length_710_cov_5.870778_2 ,393,710,-,Strict,400,216.5,cprR,100.0,3005063,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,CGGCGCCGCAGCGGCCAGGCCCAGCGCCTGCAGGTCGACGACCTGGTGATGGACCTCGACAGCCGCCAGGCCAGCCGCGGCGGCACGCCCCTGGCGCTGTCCCCCACCGCCTGGAAGATCCTCGAGTGCCTGATGCGCGCCAGCCCCGCGCTGGTCACCCGCGAGCAGCTGGGGCGCAGCGTCTGGGGCGACGAACCGCCGGAAAGCAACACCCTCAACGTGCACATGCACCACCTGCGCAGCACCGTCGACAAGGGGTTCGCCACCCCTCTGATCCATACCCTGCACAGCGTCGGCTTCCAGCTGGAGCGCAAATGA,RRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK,MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLKPFELPELLVRLQALSRRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK,47.09,gnl|BL_ORD_ID|2810|hsp_num:0,3803,True,loose hit with at least 95 percent identity pushed strict,354,669,polymyxin B; colistin A; colistin B
2002,tcs_502,NODE_1255_length_689_cov_9.865152_1 # 2 # 688 # -1 # ID=1255_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.668,NODE_1255_length_689_cov_9.865152_1 ,2,688,-,Strict,1900,440.3,MexI,100.0,3000808,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,CCGGTGCAGATGGTGCTGCGCAGCCCGCAGGACTATCCGGTGCTCTACCGGACCATGGAAGAGATCAAGCAGAAGGCCCGGCAGAGCGGGCTGTTCGTGGTGGTCGACAGCGACCTCGACTACAACAACCCGGTGGTCCAGGTCCGCATCGACCGCGCCAAGGCCAACAGCCTGGGCATCCGCATGCAGGACATCGGCGAGTCGCTGGCGGTGCTGGTGGGCGAGAACTACGTCAACCGCTTCGGCATGGAGGGCCGCTCCTACGACGTGATCCCACAGAGCCTGCGCGACCAGCGTTTCACTCCGCAAGCGCTGGCACGACAGTTCGTGCGCACCCAGGACGGCAACCTGGTGCCGCTGTCGACGGTGGTCCGGGTGGCGCTTCAGGTCGAACCGAACAAGCTGATCCAGTTCGACCAGCAGAACGCCGCGACCCTCCAGGCGATCCCCGCGCCCGGCGTCTCCATGGGCCAGGCGGTGGCCTTCCTCGACGACGTGGCGCGCGGCCTGCCGGCCGGCTTCAGCCACGACTGGCAATCCGACTCGCGGCAATACACCCAGGAAGGCAACACCCTGGTGTTCGCCTTCCTCGCCGCCCTGGTGGTGATCTACCTGGTGCTCGCCGCGCAGTACGAGAGCCTGGCCGACCCGCTGATCATCCTGATCACCGTGCCGCTGTCGATCTGC,PVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSIC,MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA,22.25,gnl|BL_ORD_ID|4691|hsp_num:0,1647,True,loose hit with at least 95 percent identity pushed strict,1965,2652,acriflavine; norfloxacin
2003,tcs_502,NODE_1295_length_627_cov_3.879599_1 # 3 # 626 # -1 # ID=1295_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.710,NODE_1295_length_627_cov_3.879599_1 ,3,626,-,Strict,850,386.0,opmE,99.04,3003700,protein homolog model,n/a,n/a,macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GCCCGTGCCTCCGGGGAAAGGCTGACGCTCCGCACCCTCGGGGTCGGCGACCCGGCGGGACTGCTGGCGCGTCGCGCCGACATCGCCGCGGCCGAACGCAACCTGGCGGCCGCGACCGCACGTATCGGCGTCGAGACCGCGGGGCTGTATCCGCGGGTCGAGGTACGCGGCTCGATTGGCCTGGTCGCCGGCAATCTCGATGCTTTGGACGAGAGTGGTACGTCCTTCAACGTCCTGAACCCGGTGATTCGCTGGGCGCTACTCGACCGCGGTCGCGTGCGGGCGCGGATCGCCGCCAGCGAGGCCCGTGCGCAGGAGGCATTGATCCTCTACGACCGGACGGTGCTGCGCGCCCTGCAGGAGACCGATGATGCCTTCAACGGCTATGGCGCTGCCGCTGACAGGCTCCGCCTGCGCCTGCTCGAGGCGACGGCCAATCGCGAGGCGGCGCGCCTGGCCCGGGAACGCTTCGTCCAGGGGGACGGCGAGTACCTGGACGTGCTCGAGGCGGAACGCTCGGACTACCTCAGCCGGCGCGCATTGAGCATCGCGCGCACCGAGCAGCGCCTTGCCGTCGTGGGTATCTACAAGGCGCTGGGTGGTGGCTGGGAAGCCTGCGCGGGG,ARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPRVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVRARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAG,MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS,42.36,gnl|BL_ORD_ID|2013|hsp_num:0,2213,True,loose hit with at least 95 percent identity pushed strict,780,1404,erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
2004,tcs_502,NODE_1316_length_584_cov_5.441441_1 # 1 # 582 # 1 # ID=1316_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.716,NODE_1316_length_584_cov_5.441441_1 ,1,582,+,Strict,850,361.7,opmE,99.48,3003700,protein homolog model,n/a,n/a,macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,CAGCGGGCGCTCGCGGCGAACCTCGACATCGCCCTTGCCGGCGCGCGCCTGGACGAAGCGAAGGCGCTGCTGCGCGAGAACCGCGAAGAGTTCCTGCCGCGCGGCGGCCCGGCGTTCGATTACCAGGCCCGGCGGCGCGGCGAGGTGGAAACACCGGCCGGCCAGCAGCGCGACATCGAGACTTATCGCGGCGCGCTGGATGCTTCCTGGGAAATCGACCTGTTCGGTCGGGTGCGGCGCTCGGTGGAGGCCGCCGAGGCGCAGGCGGGCTCGCGCGAGGCCCTGCTGCGCAACGTGCAGGCGAGCGTCGCGGCTACGGTTGCCATGACCTGGTTCCAGCTACAGGGCATCGAGGCCGAACTTGCGGTGGTCCATGACATCGCCGGCAACCAGCGCGACAGCCTGGAGATGGTCGAACGCCTGGTCAGCGCCGGCTCCGCCCACGAGTTCGACCGGTTGCGCGCCGAAGCGTTATTGCACAACGTCGAGGCGGCCGTGCCCGACCTCGAACGGCGCCGCGCCGCCACCCGCAATGCGCTGGCCGTTCTCCTCGCGGAAGCCCCGCAGGCCTTCAGCCCGCCG,QRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMTWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPP,MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS,39.51,gnl|BL_ORD_ID|2013|hsp_num:0,2213,True,loose hit with at least 95 percent identity pushed strict,195,777,erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
2005,tcs_502,NODE_1318_length_581_cov_2.907609_1 # 2 # 208 # 1 # ID=1318_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.681,NODE_1318_length_581_cov_2.907609_1 ,2,208,+,Strict,1200,142.1,arnA,98.53,3002985,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration,pmr phosphoethanolamine transferase,TTCCCGCCCTTCGCCGGCTTCCGCGAGGTGGAGAGCCGCAGCTTCTACAGCGACGGCTACCAGGACGTGGCCCACCGCAAGCCGAGCATCGACAACGCCCGGCGCCTGCTCGACTGGCAGCCCACCATCGAACTGCGCGAGACCATCGGCAAGACCCTCGACTTCTTCCTCCACGAAGCGCTCCGCGAGCGCGAGGCACAGGCGTGA,FPPFAGFREVESRSFYSDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA,MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA,10.27,gnl|BL_ORD_ID|1508|hsp_num:0,1643,True,loose hit with at least 95 percent identity pushed strict,1782,1986,polymyxin B
2006,tcs_502,NODE_1334_length_557_cov_1.706439_1 # 3 # 116 # 1 # ID=1334_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.649,NODE_1334_length_557_cov_1.706439_1 ,3,116,+,Strict,700,75.9,PDC-242,100.0,3006620,protein homolog model,n/a,n/a,monobactam; carbapenem; cephalosporin,antibiotic inactivation,PDC beta-lactamase,CTGGGCCTGGTGATCCTGGCCAACCGCAACTATCCCAATGCCGAGCGGGTGAAGATCGCCTACGCCATCCTCAGCGGCCTGGAGCAGCAGGGCAAGGTGCCGCTGAAGCGCTGA,LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR,MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKASAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR,9.32,gnl|BL_ORD_ID|4318|hsp_num:0,5380,True,loose hit with at least 95 percent identity pushed strict,1080,1191,
2007,tcs_502,NODE_1400_length_458_cov_5.918415_1 # 1 # 207 # -1 # ID=1400_1;partial=10;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.705,NODE_1400_length_458_cov_5.918415_1 ,1,207,-,Strict,850,140.2,opmE,98.55,3003700,protein homolog model,n/a,n/a,macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAAGCCATACCTGCGGTCTTCGTTGAGCGCGCTGATCCTGCTGGGCGGCTGTGCCGCGGTGGGGCCCGACTATGCGCCGCCGAGCGCGTCCGCACCGGCCAGCTTCGGCGCGATGCCGGCGGGTATCGATGGCGGTGGCGTGGAGATCGAGTGGTGGCGCGGGTTCGACGAGCCAGCCCTGGAGTCTCTGATCCAGCGGGCGCTC,MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGGGVEIEWWRGFDEPALESLIQRAL,MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS,14.05,gnl|BL_ORD_ID|2013|hsp_num:0,2213,True,loose hit with at least 95 percent identity pushed strict,0,207,erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
2008,tcs_502,NODE_1400_length_458_cov_5.918415_2 # 204 # 458 # -1 # ID=1400_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.706,NODE_1400_length_458_cov_5.918415_2 ,204,458,-,Strict,1900,154.5,mexQ,100.0,3003699,protein homolog model,n/a,n/a,macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,CGCCTGCGCCTGCGGCCGATCCTGATGACCTCGCTGGCGTTCATCGCCGGCGTGGTGCCGTTGGTCATGGCCAGCGGCGCCGGAGCGGAAATGCGCCAGGCGATGGGCGTCGCGGTATTCGCCGGGATGCTCGGGGTGACGCTGTTCGGCCTGTTCCTCACGCCGGTGTTCTACGTACTGGTACGGGCACTGGCGGCGCGCCTGGAGCGACGCGCCGGCGGCAGCCTGGCGCATCTGGAGGGAGGCCGTCCATGA,RLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP,MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP,7.98,gnl|BL_ORD_ID|2004|hsp_num:0,2212,True,loose hit with at least 95 percent identity pushed strict,2907,3159,erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
2009,tcs_502,NODE_1450_length_383_cov_7.912429_1 # 73 # 381 # 1 # ID=1450_1;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.663,NODE_1450_length_383_cov_7.912429_1 ,73,381,+,Strict,400,208.4,cprR,100.0,3005063,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,ATGCATATCCACGTACTCGTCGTCGAAGACAACTTCGATCTCGCCGGCACCGTCATCGACTACCTCGAGGCCGCCGGGGTGGTCTGCGATCACGCCCGCGACGGCCAGGCCGGCCTCAACCTGGCGCGCGCCAACCGCTACGACGTGATCCTGCTGGACATCATGCTGCCGCGCATCAACGGCCGGCAGGTCTGTCGCCAGCTACGCGAAGCCGGCCTGCAGACCCCGGTACTCATGCTCACCGCCCTGGATACCCTGCAGGACAAGCTCGACGGCTTCGACGCCGGCGCCGACGACTACCTGCTCAAG,MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLK,MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLKPFELPELLVRLQALSRRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK,46.19,gnl|BL_ORD_ID|2810|hsp_num:0,3803,True,loose hit with at least 95 percent identity pushed strict,0,309,polymyxin B; colistin A; colistin B
2010,tcs_502,NODE_1686_length_95_cov_8.590909_1 # 1 # 93 # 1 # ID=1686_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.731,NODE_1686_length_95_cov_8.590909_1 ,1,93,+,Strict,400,61.2,cprR,100.0,3005063,protein homolog model,n/a,n/a,peptide antibiotic,antibiotic target alteration; antibiotic efflux,pmr phosphoethanolamine transferase,GCCGACGACTACCTGCTCAAGCCCTTCGAACTGCCGGAGCTGCTGGTCCGCCTGCAAGCCCTCAGCCGGCGCCGCAGCGGCCAGGCCCAGCGC,ADDYLLKPFELPELLVRLQALSRRRSGQAQR,MHIHVLVVEDNFDLAGTVIDYLEAAGVVCDHARDGQAGLNLARANRYDVILLDIMLPRINGRQVCRQLREAGLQTPVLMLTALDTLQDKLDGFDAGADDYLLKPFELPELLVRLQALSRRRSGQAQRLQVDDLVMDLDSRQASRGGTPLALSPTAWKILECLMRASPALVTREQLGRSVWGDEPPESNTLNVHMHHLRSTVDKGFATPLIHTLHSVGFQLERK,13.90,gnl|BL_ORD_ID|2810|hsp_num:0,3803,True,loose hit with at least 95 percent identity pushed strict,288,381,polymyxin B; colistin A; colistin B
2011,tcs_502,NODE_1747_length_81_cov_11.173077_1 # 2 # 79 # -1 # ID=1747_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.731,NODE_1747_length_81_cov_11.173077_1 ,2,79,-,Strict,1900,53.5,MexI,100.0,3000808,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,AGCATCTTCGCCTTCCAGTTGGCCGCCCTGCCCGGCTCCACCGGCGGCCTGCCGGTGCAGATGGTGCTGCGCAGCCCG,SIFAFQLAALPGSTGGLPVQMVLRSP,MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA,2.53,gnl|BL_ORD_ID|4691|hsp_num:0,1647,True,loose hit with at least 95 percent identity pushed strict,1914,1992,acriflavine; norfloxacin
2012,tcs_502,NODE_1763_length_72_cov_4.079208_1 # 3 # 71 # -1 # ID=1763_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.681,NODE_1763_length_72_cov_4.079208_1 ,3,71,-,Strict,800,56.2,ParS,100.0,3005067,protein homolog model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux; reduced permeability to antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr),CAATGGCACGGCGGCTATGCGGAAGCGCTGGAAACGCCGCAGGGAGGCGCCTCCTTCCGCCTGACCTGG,QWHGGYAEALETPQGGASFRLTW,MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR,5.37,gnl|BL_ORD_ID|2812|hsp_num:0,3805,True,loose hit with at least 95 percent identity pushed strict,1203,1272,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
2013,tcs_502,NODE_1771_length_70_cov_1.731707_1 # 1 # 69 # -1 # ID=1771_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.681,NODE_1771_length_70_cov_1.731707_1 ,1,69,-,Strict,500,51.6,PDC-541,100.0,3008888,protein homolog model,n/a,n/a,monobactam; carbapenem; cephalosporin,antibiotic inactivation,PDC beta-lactamase,CAGCGCCTGCTGAACAAGACCGGTTCCACCAACGGCTTCGGCGCCTACGTGGCGTTCGTCCCGGGCCGC,QRLLNKTGSTNGFGAYVAFVPGR,MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASNGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR,5.82,gnl|BL_ORD_ID|6080|hsp_num:0,8306,True,loose hit with at least 95 percent identity pushed strict,1002,1071,
2014,tcs_502,NODE_45_length_18539_cov_6.165478_4 # 5405 # 6319 # -1 # ID=45_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.689,NODE_45_length_18539_cov_6.165478_4,5405,6319,-,Strict,500,525.4,MexT,99.63,3000814,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGAACCGAAACGACCTGCGCCGCGTCGATCTGAACCTGCTGATCGTGTTCGAGACTCTGATGCACGAACGCAGCGTGACCCGCGCCGCAGAGAAACTGTTCCTCGGCCAGCCGGCCATCAGCGCCGCGCTGTCGCGCCTGCGCACGCTGTTCGACGACCCGCTGTTCGTCCGTACCGGACGCAGCATGGAGCCCACCGCGCGAGCCCAGGAAATCTTCGCCCACCTGTCGCCGGCGCTGGACTCCATCTCCACCGCCATGAGCCGCGCCAGCGAGTTCGATCCGGCGACCAGCACCGCGGTGTTCCGCATCGGCCTTTCCGACGACGTCGAGTTCGGCCTGTTGCCGCCCCTGCTCCGCCGCCTGCGCGCGGAGGCGCCGGGGATCGTCCTCGTCGTGCGCCGCGCCAACTATCTATTGATGCCGAACCTGCTGGCCTCGGGGGAGATCTCGGTGGGCGTCAGCTACACCGACGAACTGCCGGCCAACGCCAAGCGCAAGACCGTGCGCCGCAGCAAGCCGAAGATCCTCCGCGCCGACTCCGCGCCCGGCCAACTGACCCTCGACGACTACTGCGCGCGACCGCACGCGCTGGTGTCCTTCGCCGGCGACCTCAGCGGCTTCGTCGACGAGGAACTGGAGAAATTCGGCCGCAAGCGCAAGGTGGTCCTGGCGGTGCCGCAGTTCAACGGCCTCGGCACCCTCCTGGCCGGCACCGACATCATCGCCACCGTGCCCGACTACGCCGCCCAGGCGCTGATCGCCGCCGGCGGCCTACGCGCCGAGGACCCACCGTTCGAGACCCGGGCCTTCGAACTGTCGATGGCTTGGCGCGGCGCCCAGGACAACGATCCGGCCGAACGCTGGCTGCGCTCGCGGATCAGCATGTTCATCGGCGATCCGGACAGTCTCTGA,MNRNDLRRVDLNLLIVFETLMHERSVTRAAEKLFLGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLSPALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGIVLVVRRANYLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHALVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAGGLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL,MPVSDPMPLRHLARPRPVSHARLDGEPPRLQPLAPGNEERHEPKRPAPRRSEPADRVRDPDARTQRDPRRRETVPRPAGQPAISAALSRLRTLFDDPLFVRTGRSMEPTARAQEIFAHLSPALDSISTAMSRASEFDPATSTAVFRIGLSDDVEFGLLPPLLRRLRAEAPGFVLVVRRANYLLMPNLLASGEISVGVSYTDELPANAKRKTVRRSKPKILRADSAPGQLTLDDYCARPHALVSFAGDLSGFVDEELEKFGRKRKVVLAVPQFNGLGTLLAGTDIIATVPDYAAQALIAAGGLRAEDPPFETRAFELSMAWRGAQDNDPAERWLRSRISMFIGDPDSL,87.61,gnl|BL_ORD_ID|1479|hsp_num:0,1608,,,234,1041,ciprofloxacin; trimethoprim; chloramphenicol
2015,tcs_502,NODE_45_length_18539_cov_6.165478_5 # 6540 # 7559 # 1 # ID=45_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.669,NODE_45_length_18539_cov_6.165478_5,6540,7559,+,Strict,660,674.9,MexS,100.0,3000813,protein overexpression model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGTCCCGAGTGATCCGTTTTCATCAGTTTGGCCCGCCAGAGGTCCTCAAATGCGAAGAGCTGCCGACCCCGGCGCCGGCCGCAGGGGAAGTCCTGGTGCGTGTCCAGGCGATCGGCGTGAGCTGGAAGGATGTGCTCTGGCGTCAGAACCTGGCCCCGGAGCAGGCTGCGCTGCCGTCCGGTCTCGGCTTCGAACTGGCCGGCGAGGTGCTGGCGGTCGGCGCCGGCGTCGGCGACCTGCCGCTGGGTTCCCGCGTGGCCAGTTTCCCCGCCCATACCCCCGATCATTATCCGGCCTATGGCGACGTGGTGCTGATGCCACGCGCGGCCCTGGCGGTCTACCCCGAGGTACTCACCCCGGTGGAGGCCAGCGTCTACTACACCGGCCTGCTGGTGGCCTATTTCGGCCTGGTCGACCTGGCCGGGTTGAAGGCCGGGCAGACCGTGCTGATCACCGAGGCGGCGCGCATGTACGGACCGGTCTCGATCCAGTTGGCCAAGGCTCTCGGCGCGCGGGTGATCGCTTCCACCAAGTCCGCCGAGGAGCGCGAGTTCCTCCGCGAGCAGGGCGCCGACAAGGTGGTGGTGACCGACGAGCAGGACCTGGTCCTGGAAGTCGAGCGCTTCACCGAGGGCAAGGGCGTCAATGTCATCCTCGACGAATTGGGCGGCCCGCAGATGACCCTGCTCGGCGATGTCTCCGCCACCCGCGGCAAGCTGGTGCTGTATGGCTGCAACGGCGGCAACGAGTCGGCGTTCCCGGCCTGCGCTGCGTTCAAGAAGCACCTGCAGTTCTACCGCCACTGCCTGATGGATTTCACCGGTCATCCGGAGATGGGCCTGGAACGCAACGACGAGTCGGTGAGCAAGGCCCTCGCGCACATCGAGCAACTGACCCGCGATCGCCTGCTCAAGCCGGTGGTCGACCGGGTATTCGAGTTCGACCAGGTGGTCGAGGCGCACCGCTACATGGAAACCTGTCCGAAGCGCGGCCGGGTGGTGATCCACGTCGCCGATTGA,MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD,MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD,100.00,gnl|BL_ORD_ID|1037|hsp_num:0,1041,,,0,1017,ciprofloxacin; trimethoprim; chloramphenicol
2016,tcs_502,NODE_64_length_15611_cov_6.713259_3 # 4976 # 5539 # -1 # ID=64_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.637,NODE_64_length_15611_cov_6.713259_3,4976,5539,-,Strict,310,370.5,Type A NfxB,100.0,3004059,protein overexpression model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ATGACCCTGATTTCCCATGACGAGCGACTCATCAAGGCGCTGGCAGTCGCTATCGTCGACCGCCCGCGAGCGACGCTGAAGGAACTGGCCGAGGCGGCCGGCGTAAGCAAGGCCACCCTGCACCGCTTCTGCGGCACGCGGGACAACCTGGTGCAGATGCTCGAGGACCACGGAGAGACCGTACTGAACCAGATCATCCAGGCCTGCGACCTGGAGCATGCCGAGCCTCTGGAGGCGTTGCAGCGCCTGATCAAGGAACACCTCACCCACCGCGAGCTGCTGGTATTCCTGGTATTCCAGTACCGCCCGGACTTCCTCGACCCGCACGGTGAAGGCGCACGCTGGCAGTCCTACCTGGAAGCGCTGGACGCCTTCTTCCTGCGCGGACAGCAGAAAGGCGTGTTTCGCATCGACATCACGGCGGCCGTGTTCACCGAACTGTTCATCACCCTGGTCTACGGCATGGTCGATGCGGAACGTCGCGGACGGGCGGCCAGCTCCAATTCCGCGCATACCCTGGAGCAGATGTTCCTCCATGGCGCCTCCAATCCGGCTCGCTCCTGA,MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS,MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS,100.00,gnl|BL_ORD_ID|2343|hsp_num:0,2691,,,0,561,erythromycin; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin
2017,tcs_502,NODE_67_length_15394_cov_7.535373_7 # 6784 # 7227 # -1 # ID=67_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.631,NODE_67_length_15394_cov_7.535373_7,6784,7227,-,Strict,270,295.8,MexR,100.0,3000506,protein overexpression model,n/a,n/a,,antibiotic target alteration; antibiotic efflux,,ATGAACTACCCCGTGAATCCCGACCTGATGCCCGCGCTGATGGCGGTCTTCCAGCATGTGCGGACGCGCATCCAGAGCGAGCTCGATTGCCAGCGACTCGACCTGACCCCGCCCGACGTCCATGTATTGAAGCTTATCGACGAACAACGCGGGCTGAACCTGCAGGACCTGGGACGCCAGATGTGCCGCGACAAGGCACTGATCACCCGGAAGATCCGCGAGCTGGAGGGAAGAAACCTGGTCCGCCGCGAGCGCAACCCCAGCGACCAGCGCAGCTTCCAGCTCTTCCTCACCGACGAGGGGCTGGCCATCCACCAGCATGCGGAGGCCATCATGTCACGCGTGCATGACGAGTTGTTTGCCCCGCTCACCCCGGTTGAACAGGCCACCCTGGTGCATCTCCTCGACCAGTGCCTGGCCGCGCAACCGCTTGAGGATATTTAA,MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQMCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPLTPVEQATLVHLLDQCLAAQPLEDI,MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQMCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPLTPVEQATLVHLLDQCLAAQPLEDI,100.00,gnl|BL_ORD_ID|2338|hsp_num:0,1474,,,0,441,
2018,tcs_502,NODE_423_length_5220_cov_6.146793_3 # 3809 # 4441 # 1 # ID=423_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.675,NODE_423_length_5220_cov_6.146793_3,3809,4441,+,Strict,390,420.6,MexZ,100.0,3003709,protein overexpression model,n/a,n/a,macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penicillin beta-lactam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,GTGGCCAGGAAAACCAAAGAGGAATCCCAGAAAACCCGCGACGGCATACTCGATGCCGCCGAGCGGGTTTTCCTGGAAAAGGGCGTGGGCACCACTGCCATGGCCGACCTGGCGGACGCCGCCGGGGTTTCTCGCGGTGCGGTCTACGGCCACTACAAGAACAAGATCGAGGTCTGCCTGGCGATGTGCGACCGCGCCTTCGGCCAGATCGAGGTACCCGACGAAAACGCCAGGGTGCCGGCGCTGGATATCCTCCTGCGCGCCGGCATGGGCTTTCTCCGCCAGTGCTGCGAGCCCGGTTCGGTGCAGCGGGTGCTGGAGATCCTCTACCTCAAGTGCGAACGCAGCGACGAGAACGAGCCGCTGTTGCGCCGCCGCGAGCTGCTCGAGAAGCAGGGGCAACGCTTCGGCCTCCGGCAGATCCGCCGGGCGGTGGAGCGCGGCGAACTGCCGGCGCGGCTGGACGTCGAGCTGGCCAGCATCTATCTGCAATCGCTCTGGGACGGCATCTGCGGCACCCTGGCCTGGACCGAGCGCCTGCGCGACGATCCCTGGAACCGCGCCGAACGCATGTTCCGCGCCGGCCTCGACAGCCTGCGCAGTTCTCCCTACCTGTTGCTGGCGGACGCCTGA,VARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA,MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA,100.00,gnl|BL_ORD_ID|4700|hsp_num:0,2223,,,0,630,erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
2019,tcs_502,NODE_441_length_5010_cov_8.184501_3 # 981 # 1619 # -1 # ID=441_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.640,NODE_441_length_5010_cov_8.184501_3,981,1619,-,Strict,375,429.9,nalD,100.0,3000819,protein overexpression model,n/a,n/a,,antibiotic efflux,,ATGCGACGCACAAAGGAAGATTCTGAAAAAACCCGTACGGCCATCCTCCTGGCCGCCGAGGAACTGTTCCTGGAAAAGGGCGTGTCCCATACCAGCCTGGAACAGATCGCCAGGGCCGCCGGGGTGACCCGTGGCGCCGTCTACTGGCACTTCCAGAACAAGGCCCACCTGTTCAACGAGATGCTCAACCAGGTACGCCTGCCGCCGGAGCAACTCACCGAGCGCCTGTCCGGCTGCGATGGCAGCGACCCGCTGCGCTCGCTCTACGACCTCTGCCTGGAGGCCGTGCAATCGTTGCTGACGCAGGAGAAGAAGCGCCGCATCCTGACCATCCTGATGCAACGTTGCGAATTCACCGAGGAACTGCGCGAGGCGCAGGAACGCAACAACGCCTTCGTGCAGATGTTCATCGAACTCTGCGAGCAGTTGTTCGCCCGCGACGAATGCCGTGTGCGGCTGCATCCGGGCATGACCCCGAGGATCGCCTCGCGCGCCTTGCACGCGCTGATCCTGGGCCTGTTCAACGACTGGTTGCGCGACCCGCGCCTGTTCGATCCGGATACGGACGCGGAACACCTGCTGGAGCCGATGTTCCGTGGCCTGGTGCGCGACTGGGGTCAGGCCAGCTCGGCGCCGTAG,MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP,MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP,100.00,gnl|BL_ORD_ID|2337|hsp_num:0,1213,,,0,636,
2020,tcs_502,NODE_726_length_2728_cov_5.877732_3 # 1014 # 1655 # -1 # ID=726_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656,NODE_726_length_2728_cov_5.877732_3,1014,1655,-,Strict,400,414.1,nalC,99.06,3000818,protein overexpression model,"S209R, G71E",n/a,,antibiotic efflux,,ATGAACGATGCTTCTCCCCGTCTGACCGAACGCGGCAGGCAACGCCGCCGCGCCATGCTCGACGCCGCTACCCAGGCCTTTCTCGAACACGGTTTCGAAGGCACCACCCTGGACATGGTGATAGAACGGGCCGGTGGTTCACGGGGGACCCTGTACAGCTCCTTCGGCGGCAAGGAGGGCCTGTTCGCCGCGGTGATCGCCCACATGATCGAGGAAATCTTCGACGACAGCGCCGATCAGCCGCGCCCCGCCGCCACGCTGAGCGCCACCCTCGAGCATTTCGGCCGGCGCTTTCTCACCAGCCTGCTCGATCCCCGCTGCCAGAGCCTCTATCGCCTGGTGGTGGCGGAATCCCCGCGGTTTCCGGCGATCGGCAAGTCCTTCTACGAGCAGGGGCCGCAGCAGAGCTATCTGCTGCTCAGCGAGCGACTGGCCGCGGTCGCTCCTCACATGGACGAGGAAACGCTCTACGCGGTGGCCTGCCAGTTTCTCGAGATGCTCAAGGCCGACCTGTTCCTCAAGGCCCTCAGCGTGGCCGACTTCCAGCCGACCATGGCGCTGCTGGAAACCCGCCTCAAGCTGTCGGTGGACATCATCGCCTGCTACCTGGAACACCTGTCGCAGCGCCCCGCGCAGGGCTGA,MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEGLFAAVIAHMIEEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPRFPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVADFQPTMALLETRLKLSVDIIACYLEHLSQRPAQG,MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEGLFAAVIAHMIGEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPRFPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVADFQPTMALLETRLKLSVDIIACYLEHLSQSPAQG,100.00,gnl|BL_ORD_ID|2124|hsp_num:0,1670,,,0,639,
5,tcs_031618_03,NODE_2241_length_346_cov_1.586751_1 # 1 # 345 # -1 # ID=2241_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.617,NODE_2241_length_346_cov_1.586751_1 ,1,345,-,Strict,2110,216.9,MexF,95.65,3000804,protein homolog model,n/a,n/a,fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic,antibiotic efflux,resistance-nodulation-cell division (RND) antibiotic efflux pump,ACCGTGGTAGTGCGCGCCAACTTCCCGGGTGCCAACCCCAAAGTCATCGGTGAAACCGTGGCCGCGCCGTTGGAGCAAGCCATCACTGGTGTCGAGAACATGCTGTACATGTCCTCGCAGTCGACCGCCGACGGCAAGCTGACCCTAACCATCACCTTCGCCCTGGGCACCGACCTGGACAACGCGCAGGTGCAGGTACAAAACCGTGTGACGCGCACCCAGCCCAAGCTGCCGGAGGAAGTGACGCGCATCGGTATTACCGTGGACAAGGCCTCCCCCGACCTGACCATGGTGGTGCACTTGACCTCGCCGGACAAACGCTACGACATGCTCTACCTGTCCAAC,TVVVRANFPGANPKVIGETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKLPEEVTRIGITVDKASPDLTMVVHLTSPDKRYDMLYLSN,MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA,10.83,gnl|BL_ORD_ID|2356|hsp_num:0,1300,True,loose hit with at least 95 percent identity pushed strict,129,474,ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
